More than half of the publishers listed alongside IntechOpen (18 out of 30) are Social Science and Humanities publishers. IntechOpen is an exception to this as a leader in not only Open Access content but Open Access content across all scientific disciplines, including Physical Sciences, Engineering and Technology, Health Sciences, Life Science, and Social Sciences and Humanities.
\\n\\n
Our breakdown of titles published demonstrates this with 47% PET, 31% HS, 18% LS, and 4% SSH books published.
\\n\\n
“Even though ItechOpen has shown the potential of sci-tech books using an OA approach,” other publishers “have shown little interest in OA books.”
\\n\\n
Additionally, each book published by IntechOpen contains original content and research findings.
\\n\\n
We are honored to be among such prestigious publishers and we hope to continue to spearhead that growth in our quest to promote Open Access as a true pioneer in OA book publishing.
Simba Information has released its Open Access Book Publishing 2020 - 2024 report and has again identified IntechOpen as the world’s largest Open Access book publisher by title count.
\n\n
Simba Information is a leading provider for market intelligence and forecasts in the media and publishing industry. The report, published every year, provides an overview and financial outlook for the global professional e-book publishing market.
\n\n
IntechOpen, De Gruyter, and Frontiers are the largest OA book publishers by title count, with IntechOpen coming in at first place with 5,101 OA books published, a good 1,782 titles ahead of the nearest competitor.
\n\n
Since the first Open Access Book Publishing report published in 2016, IntechOpen has held the top stop each year.
\n\n\n\n
More than half of the publishers listed alongside IntechOpen (18 out of 30) are Social Science and Humanities publishers. IntechOpen is an exception to this as a leader in not only Open Access content but Open Access content across all scientific disciplines, including Physical Sciences, Engineering and Technology, Health Sciences, Life Science, and Social Sciences and Humanities.
\n\n
Our breakdown of titles published demonstrates this with 47% PET, 31% HS, 18% LS, and 4% SSH books published.
\n\n
“Even though ItechOpen has shown the potential of sci-tech books using an OA approach,” other publishers “have shown little interest in OA books.”
\n\n
Additionally, each book published by IntechOpen contains original content and research findings.
\n\n
We are honored to be among such prestigious publishers and we hope to continue to spearhead that growth in our quest to promote Open Access as a true pioneer in OA book publishing.
\n\n
\n\n
\n'}],latestNews:[{slug:"stanford-university-identifies-top-2-scientists-over-1-000-are-intechopen-authors-and-editors-20210122",title:"Stanford University Identifies Top 2% Scientists, Over 1,000 are IntechOpen Authors and Editors"},{slug:"intechopen-authors-included-in-the-highly-cited-researchers-list-for-2020-20210121",title:"IntechOpen Authors Included in the Highly Cited Researchers List for 2020"},{slug:"intechopen-maintains-position-as-the-world-s-largest-oa-book-publisher-20201218",title:"IntechOpen Maintains Position as the World’s Largest OA Book Publisher"},{slug:"all-intechopen-books-available-on-perlego-20201215",title:"All IntechOpen Books Available on Perlego"},{slug:"oiv-awards-recognizes-intechopen-s-editors-20201127",title:"OIV Awards Recognizes IntechOpen's Editors"},{slug:"intechopen-joins-crossref-s-initiative-for-open-abstracts-i4oa-to-boost-the-discovery-of-research-20201005",title:"IntechOpen joins Crossref's Initiative for Open Abstracts (I4OA) to Boost the Discovery of Research"},{slug:"intechopen-hits-milestone-5-000-open-access-books-published-20200908",title:"IntechOpen hits milestone: 5,000 Open Access books published!"},{slug:"intechopen-books-hosted-on-the-mathworks-book-program-20200819",title:"IntechOpen Books Hosted on the MathWorks Book Program"}]},book:{item:{type:"book",id:"960",leadTitle:null,fullTitle:"Cancer of the Uterine Endometrium - Advances and Controversies",title:"Cancer of the Uterine Endometrium",subtitle:"Advances and Controversies",reviewType:"peer-reviewed",abstract:"The book Cancer of the Uterine Endometrium - Advances and Controversies brings together an international collaboration of authors who share their contributions for the management of endometrial carcinoma. The scope of the text is not basic, but rather aims to provide a comprehensive and updated source of advances in the diagnosis and therapeutic strategies in this field of gynecologic cancer. Each section in the book attempts to provide the most relevant evidence-based information in the biology and genetics, modern imaging, surgery and staging, and therapies for endometrial cancer. It is hoped that future editions will bring additional authors to contribute to this endeavor. To this end, it is our patients who will benefit from this work.",isbn:null,printIsbn:"978-953-51-0142-0",pdfIsbn:"978-953-51-6844-7",doi:"10.5772/1467",price:119,priceEur:129,priceUsd:155,slug:"cancer-of-the-uterine-endometrium-advances-and-controversies",numberOfPages:194,isOpenForSubmission:!1,isInWos:1,hash:"e31a8846983568317bbe451b6e32b4c6",bookSignature:"J. Salvador Saldivar",publishedDate:"February 29th 2012",coverURL:"https://cdn.intechopen.com/books/images_new/960.jpg",numberOfDownloads:29009,numberOfWosCitations:5,numberOfCrossrefCitations:1,numberOfDimensionsCitations:3,hasAltmetrics:0,numberOfTotalCitations:9,isAvailableForWebshopOrdering:!0,dateEndFirstStepPublish:"January 25th 2011",dateEndSecondStepPublish:"February 22nd 2011",dateEndThirdStepPublish:"June 29th 2011",dateEndFourthStepPublish:"July 29th 2011",dateEndFifthStepPublish:"November 26th 2011",currentStepOfPublishingProcess:5,indexedIn:"1,2,3,4,5,6",editedByType:"Edited by",kuFlag:!1,editors:[{id:"71352",title:"Dr.",name:"J.S.",middleName:"Salvador",surname:"Saldivar",slug:"j.s.-saldivar",fullName:"J.S. Saldivar",profilePictureURL:"https://mts.intechopen.com/storage/users/71352/images/system/71352.jpg",biography:"J. Salvador Saldivar, MD, MPH, is an Assistant Professor in the Department of Obstetrics and Gynecology at Texas Tech University Health Sciences Center-Paul L. Foster School of Medicine in El Paso, Texas, USA. Dr. Saldivar is Board Certified in Obstetrics and Gynecology. He received his medical degree from the University of Illinois at Chicago College of Medicine and completed his residency training in OB/GYN at Texas Tech University Health Sciences Center in El Paso. He received a Masters of Public Health from the University of Texas School of Public Health and training in gynecologic oncology at the MD Anderson Cancer Center in Houston, Texas. He finished his Clinical Fellowship in Gynecologic Oncology at the University of British Columbia and the British Columbia Cancer Agency in Vancouver, British Columbia, Canada. His areas of interests include genetic risk assessment in high risk gynecologic cancer families, minimally invasive robotic surgery, management of complicated gynecologic cancers and fertility-sparing surgery.",institutionString:null,position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"1",totalChapterViews:"0",totalEditedBooks:"1",institution:{name:"Texas Tech University Health Sciences Center",institutionURL:null,country:{name:"United States of America"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,coeditorOne:null,coeditorTwo:null,coeditorThree:null,coeditorFour:null,coeditorFive:null,topics:[{id:"1079",title:"Genitourinary Oncology",slug:"genitourinary-oncology"}],chapters:[{id:"29765",title:"Molecular Biology of Endometrial Carcinoma",doi:"10.5772/26614",slug:"molecular-biology-of-endometrial-carcinoma",totalDownloads:2004,totalCrossrefCites:0,totalDimensionsCites:1,signatures:"Ivana Markova and Martin Prochazka",downloadPdfUrl:"/chapter/pdf-download/29765",previewPdfUrl:"/chapter/pdf-preview/29765",authors:[{id:"67316",title:"Prof.",name:"Martin",surname:"Procházka",slug:"martin-prochazka",fullName:"Martin Procházka"},{id:"70436",title:"Dr.",name:"Ivana",surname:"Marková",slug:"ivana-markova",fullName:"Ivana Marková"}],corrections:null},{id:"29766",title:"The Role of ErbB Receptors in Endometrial Cancer",doi:"10.5772/26858",slug:"the-role-of-epidermal-growth-factor-system-in-endometrial-cancer",totalDownloads:1516,totalCrossrefCites:0,totalDimensionsCites:0,signatures:"Adonakis Georgios and Androutsopoulos Georgios",downloadPdfUrl:"/chapter/pdf-download/29766",previewPdfUrl:"/chapter/pdf-preview/29766",authors:[{id:"68048",title:"Prof.",name:"Georgios",surname:"Adonakis",slug:"georgios-adonakis",fullName:"Georgios Adonakis"}],corrections:null},{id:"29767",title:"Hereditary Endometrial Carcinoma",doi:"10.5772/27743",slug:"hereditary-endometrial-carcinoma",totalDownloads:1459,totalCrossrefCites:0,totalDimensionsCites:0,signatures:"J. Salvador Saldivar",downloadPdfUrl:"/chapter/pdf-download/29767",previewPdfUrl:"/chapter/pdf-preview/29767",authors:[{id:"71352",title:"Dr.",name:"J.S.",surname:"Saldivar",slug:"j.s.-saldivar",fullName:"J.S. Saldivar"}],corrections:null},{id:"29768",title:"Diagnostic Value of Dynamic Contrast-Enhanced MRI in Endometrial Cancer",doi:"10.5772/28108",slug:"dynamic-enhanced-mri-scan-diagnosis-of-endometrial-cancer-with-staging",totalDownloads:3280,totalCrossrefCites:0,totalDimensionsCites:0,signatures:"Ting Zhang, Ai-Lian Liu, Mei-Yu Sun, Ping Pan, Jin-Zi Xing and Qing-Wei Song",downloadPdfUrl:"/chapter/pdf-download/29768",previewPdfUrl:"/chapter/pdf-preview/29768",authors:[{id:"72758",title:"Prof.",name:"Ailian",surname:"Liu",slug:"ailian-liu",fullName:"Ailian Liu"},{id:"136603",title:"Dr.",name:"Ting",surname:"Zhang",slug:"ting-zhang",fullName:"Ting Zhang"},{id:"136729",title:"Dr.",name:"Li",surname:"Hao",slug:"li-hao",fullName:"Li Hao"},{id:"136730",title:"Dr.",name:"Sheng",surname:"Wang",slug:"sheng-wang",fullName:"Sheng Wang"},{id:"136731",title:"Dr.",name:"Vijay",surname:"Anand",slug:"vijay-anand",fullName:"Vijay Anand"}],corrections:null},{id:"29769",title:"Modern External Beam Radiotherapy Techniques for Endometrial Cancer",doi:"10.5772/27038",slug:"modern-radiotherapy-techniques-for-endometrial-cancer",totalDownloads:3147,totalCrossrefCites:0,totalDimensionsCites:0,signatures:"Ruijie Yang and Junjie Wang",downloadPdfUrl:"/chapter/pdf-download/29769",previewPdfUrl:"/chapter/pdf-preview/29769",authors:[{id:"68633",title:"Dr.",name:"Ruijie",surname:"Yang",slug:"ruijie-yang",fullName:"Ruijie Yang"}],corrections:null},{id:"29770",title:"Controversies in the Surgery of Endometrial Cancer",doi:"10.5772/26181",slug:"controversies-in-the-surgery-of-endometrial-cancer",totalDownloads:3304,totalCrossrefCites:1,totalDimensionsCites:1,signatures:"F. Odicino, G.C. Tisi, R. Miscioscia and B. Pasinetti",downloadPdfUrl:"/chapter/pdf-download/29770",previewPdfUrl:"/chapter/pdf-preview/29770",authors:[{id:"65775",title:"Dr.",name:"Franco",surname:"Odicino",slug:"franco-odicino",fullName:"Franco Odicino"}],corrections:null},{id:"29771",title:"Controversies Regarding the Utility of Lymphadenectomy in Endometrial Cancer",doi:"10.5772/25584",slug:"controversies-regarding-the-utility-of-lymphadenectomy-in-endometrial-cancer",totalDownloads:2021,totalCrossrefCites:0,totalDimensionsCites:0,signatures:"Frederik Peeters and Lucy Gilbert",downloadPdfUrl:"/chapter/pdf-download/29771",previewPdfUrl:"/chapter/pdf-preview/29771",authors:[{id:"63827",title:"Dr.",name:"Lucy",surname:"Gilbert",slug:"lucy-gilbert",fullName:"Lucy Gilbert"},{id:"77474",title:"Dr.",name:"Frederik",surname:"Peeters",slug:"frederik-peeters",fullName:"Frederik Peeters"}],corrections:null},{id:"29772",title:"Treatment Strategies and Prognosis of Endometrial Cancer",doi:"10.5772/30494",slug:"treatment-strategies-and-prognosis-in-endometrial-cancer",totalDownloads:7363,totalCrossrefCites:0,totalDimensionsCites:1,signatures:"Gunjal Garg and David G. Mutch",downloadPdfUrl:"/chapter/pdf-download/29772",previewPdfUrl:"/chapter/pdf-preview/29772",authors:[{id:"82808",title:"Dr.",name:"David",surname:"Mutch",slug:"david-mutch",fullName:"David Mutch"}],corrections:null},{id:"29773",title:"Reducing the Risk of Endometrial Cancer in Patients Receiving Selective Estrogen Receptor Modulator (SERM) Therapy",doi:"10.5772/25821",slug:"reducing-the-risk-of-endometrial-cancer-in-patients-receiving-serm-therapy",totalDownloads:1176,totalCrossrefCites:0,totalDimensionsCites:0,signatures:"Victor G. Vogel",downloadPdfUrl:"/chapter/pdf-download/29773",previewPdfUrl:"/chapter/pdf-preview/29773",authors:[{id:"64662",title:"Dr.",name:"Victor",surname:"Vogel",slug:"victor-vogel",fullName:"Victor Vogel"}],corrections:null},{id:"29774",title:"Adjuvant Chemotherapy for Endometrial Cancer",doi:"10.5772/26492",slug:"adjuvant-chemotherapy-for-endometrial-cancer",totalDownloads:3740,totalCrossrefCites:0,totalDimensionsCites:0,signatures:"N. Susumu, H. Nomura, W. Yamagami, A. Hirasawa, K. Banno, H. Tsuda, S. Sagae and D. Aoki",downloadPdfUrl:"/chapter/pdf-download/29774",previewPdfUrl:"/chapter/pdf-preview/29774",authors:[{id:"56684",title:"Dr.",name:"Kouji",surname:"Banno",slug:"kouji-banno",fullName:"Kouji Banno"},{id:"66842",title:"Dr.",name:"Nobuyuki",surname:"Susumu",slug:"nobuyuki-susumu",fullName:"Nobuyuki Susumu"},{id:"66856",title:"Dr.",name:"Hiroyuki",surname:"Nomura",slug:"hiroyuki-nomura",fullName:"Hiroyuki Nomura"},{id:"66857",title:"Dr.",name:"Hiroshi",surname:"Tsuda",slug:"hiroshi-tsuda",fullName:"Hiroshi Tsuda"},{id:"66859",title:"Dr.",name:"Satoru",surname:"Sagae",slug:"satoru-sagae",fullName:"Satoru Sagae"},{id:"66860",title:"Prof.",name:"Daisuke",surname:"Aoki",slug:"daisuke-aoki",fullName:"Daisuke Aoki"},{id:"107921",title:"Dr.",name:"Wataru",surname:"Yamagami",slug:"wataru-yamagami",fullName:"Wataru Yamagami"},{id:"107922",title:"Dr.",name:"Akira",surname:"Hirasawa",slug:"akira-hirasawa",fullName:"Akira Hirasawa"}],corrections:null}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}},relatedBooks:[{type:"book",id:"3274",title:"Advances in Prostate Cancer",subtitle:null,isOpenForSubmission:!1,hash:"fb7257d982e3228ceb9320f595ae1c58",slug:"advances-in-prostate-cancer",bookSignature:"Gerhard Hamilton",coverURL:"https://cdn.intechopen.com/books/images_new/3274.jpg",editedByType:"Edited by",editors:[{id:"67794",title:"Prof.",name:"Gerhard",surname:"Hamilton",slug:"gerhard-hamilton",fullName:"Gerhard Hamilton"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1312",title:"Advances in Cancer Management",subtitle:null,isOpenForSubmission:!1,hash:"dc1cad15f23e313cd067e7e7b4511005",slug:"advances-in-cancer-management",bookSignature:"Ravinder Mohan",coverURL:"https://cdn.intechopen.com/books/images_new/1312.jpg",editedByType:"Edited by",editors:[{id:"58197",title:"Prof.",name:"Ravinder",surname:"Mohan",slug:"ravinder-mohan",fullName:"Ravinder Mohan"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"559",title:"Bladder Cancer",subtitle:"From Basic Science to Robotic Surgery",isOpenForSubmission:!1,hash:"117cbfaa858282ed2cdb9a81ce411def",slug:"bladder-cancer-from-basic-science-to-robotic-surgery",bookSignature:"Abdullah Erdem Canda",coverURL:"https://cdn.intechopen.com/books/images_new/559.jpg",editedByType:"Edited by",editors:[{id:"69657",title:"Prof.",name:"Abdullah Erdem",surname:"Canda",slug:"abdullah-erdem-canda",fullName:"Abdullah Erdem Canda"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"789",title:"Emerging Research and Treatments in Renal Cell Carcinoma",subtitle:null,isOpenForSubmission:!1,hash:"616688465519d2b5bcb1d867a3806714",slug:"emerging-research-and-treatments-in-renal-cell-carcinoma",bookSignature:"Robert J. Amato",coverURL:"https://cdn.intechopen.com/books/images_new/789.jpg",editedByType:"Edited by",editors:[{id:"73752",title:"Dr.",name:"Robert",surname:"Amato",slug:"robert-amato",fullName:"Robert Amato"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1845",title:"Prostate Cancer",subtitle:"Diagnostic and Therapeutic Advances",isOpenForSubmission:!1,hash:"3be3f6b756cec080cfcacd2251b62a5c",slug:"prostate-cancer-diagnostic-and-therapeutic-advances",bookSignature:"Philippe E. Spiess",coverURL:"https://cdn.intechopen.com/books/images_new/1845.jpg",editedByType:"Edited by",editors:[{id:"64476",title:"Dr.",name:"Philippe E.",surname:"Spiess",slug:"philippe-e.-spiess",fullName:"Philippe E. Spiess"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3441",title:"Renal Tumor",subtitle:null,isOpenForSubmission:!1,hash:"8113c9de84f8da9eec92bea7f394e8ef",slug:"renal-tumor",bookSignature:"Jindong Chen",coverURL:"https://cdn.intechopen.com/books/images_new/3441.jpg",editedByType:"Edited by",editors:[{id:"158564",title:"Prof.",name:"Jindong",surname:"Chen",slug:"jindong-chen",fullName:"Jindong Chen"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"5256",title:"Human Papillomavirus",subtitle:"Research in a Global Perspective",isOpenForSubmission:!1,hash:"8d66d3c0bc41a12be8217ca0cee52b60",slug:"human-papillomavirus-research-in-a-global-perspective",bookSignature:"Rajamanickam Rajkumar",coverURL:"https://cdn.intechopen.com/books/images_new/5256.jpg",editedByType:"Edited by",editors:[{id:"120109",title:"Dr.",name:"Rajamanickam",surname:"Rajkumar",slug:"rajamanickam-rajkumar",fullName:"Rajamanickam Rajkumar"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3395",title:"Human Papillomavirus and Related Diseases",subtitle:"From Bench to Bedside - A Diagnostic and Preventive Perspective",isOpenForSubmission:!1,hash:"c6c3820fb6deb675bd38fa1954ec4f56",slug:"human-papillomavirus-and-related-diseases-from-bench-to-bedside-a-diagnostic-and-preventive-perspective",bookSignature:"Davy Vanden Broeck",coverURL:"https://cdn.intechopen.com/books/images_new/3395.jpg",editedByType:"Edited by",editors:[{id:"93213",title:"Dr.",name:"Davy",surname:"Vanden Broeck",slug:"davy-vanden-broeck",fullName:"Davy Vanden Broeck"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"792",title:"Renal Cell Carcinoma",subtitle:null,isOpenForSubmission:!1,hash:"8edc0abe98983dc0d07eeb89cdfb3288",slug:"renal-cell-carcinoma",bookSignature:"Hendrik Van Poppel",coverURL:"https://cdn.intechopen.com/books/images_new/792.jpg",editedByType:"Edited by",editors:[{id:"74532",title:"Dr.",name:"Hendrik",surname:"Van Poppel",slug:"hendrik-van-poppel",fullName:"Hendrik Van Poppel"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1985",title:"Prostate Cancer",subtitle:"Original Scientific Reports and Case Studies",isOpenForSubmission:!1,hash:"51d83bcaa97cb41331a0e6cc466f237f",slug:"prostate-cancer-original-scientific-reports-and-case-studies",bookSignature:"Philippe E. Spiess",coverURL:"https://cdn.intechopen.com/books/images_new/1985.jpg",editedByType:"Edited by",editors:[{id:"64476",title:"Dr.",name:"Philippe E.",surname:"Spiess",slug:"philippe-e.-spiess",fullName:"Philippe E. Spiess"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],ofsBooks:[]},correction:{item:{id:"74026",slug:"corrigendum-to-calf-sex-influence-in-bovine-milk-production",title:"Corrigendum to: Calf-Sex Influence in Bovine Milk Production",doi:null,correctionPDFUrl:"https://cdn.intechopen.com/pdfs/74026.pdf",downloadPdfUrl:"/chapter/pdf-download/74026",previewPdfUrl:"/chapter/pdf-preview/74026",totalDownloads:null,totalCrossrefCites:null,bibtexUrl:"/chapter/bibtex/74026",risUrl:"/chapter/ris/74026",chapter:{id:"73504",slug:"calf-sex-influence-in-bovine-milk-production",signatures:"Miguel Quaresma and R. Payan-Carreira",dateSubmitted:"April 21st 2020",dateReviewed:"September 10th 2020",datePrePublished:"October 8th 2020",datePublished:"January 20th 2021",book:{id:"8545",title:"Animal Reproduction in Veterinary Medicine",subtitle:null,fullTitle:"Animal Reproduction in Veterinary Medicine",slug:"animal-reproduction-in-veterinary-medicine",publishedDate:"January 20th 2021",bookSignature:"Faruk Aral, Rita Payan-Carreira and Miguel Quaresma",coverURL:"https://cdn.intechopen.com/books/images_new/8545.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",editors:[{id:"25600",title:"Prof.",name:"Faruk",middleName:null,surname:"Aral",slug:"faruk-aral",fullName:"Faruk Aral"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}},authors:[{id:"38652",title:"Dr.",name:"Rita",middleName:null,surname:"Payan-Carreira",fullName:"Rita Payan-Carreira",slug:"rita-payan-carreira",email:"rtpayan@gmail.com",position:null,institution:{name:"University of Évora",institutionURL:null,country:{name:"Portugal"}}},{id:"309250",title:"Dr.",name:"Miguel",middleName:null,surname:"Quaresma",fullName:"Miguel Quaresma",slug:"miguel-quaresma",email:"miguelq@utad.pt",position:null,institution:{name:"University of Trás-os-Montes and Alto Douro",institutionURL:null,country:{name:"Portugal"}}}]}},chapter:{id:"73504",slug:"calf-sex-influence-in-bovine-milk-production",signatures:"Miguel Quaresma and R. Payan-Carreira",dateSubmitted:"April 21st 2020",dateReviewed:"September 10th 2020",datePrePublished:"October 8th 2020",datePublished:"January 20th 2021",book:{id:"8545",title:"Animal Reproduction in Veterinary Medicine",subtitle:null,fullTitle:"Animal Reproduction in Veterinary Medicine",slug:"animal-reproduction-in-veterinary-medicine",publishedDate:"January 20th 2021",bookSignature:"Faruk Aral, Rita Payan-Carreira and Miguel Quaresma",coverURL:"https://cdn.intechopen.com/books/images_new/8545.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",editors:[{id:"25600",title:"Prof.",name:"Faruk",middleName:null,surname:"Aral",slug:"faruk-aral",fullName:"Faruk Aral"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}},authors:[{id:"38652",title:"Dr.",name:"Rita",middleName:null,surname:"Payan-Carreira",fullName:"Rita Payan-Carreira",slug:"rita-payan-carreira",email:"rtpayan@gmail.com",position:null,institution:{name:"University of Évora",institutionURL:null,country:{name:"Portugal"}}},{id:"309250",title:"Dr.",name:"Miguel",middleName:null,surname:"Quaresma",fullName:"Miguel Quaresma",slug:"miguel-quaresma",email:"miguelq@utad.pt",position:null,institution:{name:"University of Trás-os-Montes and Alto Douro",institutionURL:null,country:{name:"Portugal"}}}]},book:{id:"8545",title:"Animal Reproduction in Veterinary Medicine",subtitle:null,fullTitle:"Animal Reproduction in Veterinary Medicine",slug:"animal-reproduction-in-veterinary-medicine",publishedDate:"January 20th 2021",bookSignature:"Faruk Aral, Rita Payan-Carreira and Miguel Quaresma",coverURL:"https://cdn.intechopen.com/books/images_new/8545.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",editors:[{id:"25600",title:"Prof.",name:"Faruk",middleName:null,surname:"Aral",slug:"faruk-aral",fullName:"Faruk Aral"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}}},ofsBook:{item:{type:"book",id:"8843",leadTitle:null,title:"Mucosal Immunology",subtitle:null,reviewType:"peer-reviewed",abstract:"
\r\n\tThis book will focus on the wide specter of mucosal inflammation intending to provide the reader with a comprehensive overview of the current knowledge on the topic. More and more studies are focused on finding different aspects of mucosal inflammation since it is involved in the pathogenesis of many diseases - from gut to lungs, urogenital system, etc. To better understand the causes of its occurrence as well as the search for therapeutic strategies, many resources are invested in scientific developments in this field.
\r\n
\r\n\tFacts about the role of calprotectin and other biomarkers were accumulated. Participation of neutrophils appears an attractive way to explain the involvement of different subpopulations of immunocompetent cells and cytokines in mucosal inflammation. Over the last five years, scientific developments in the field have discovered more genes involved in the pathogenesis of mucosal inflammation elucidating the interaction of innate immune mechanisms with the microorganisms in the gut and their role in maintaining intestinal homeostasis. Besides, the science aims at identifying and characterizing immune and non-immune cells involved in the emergence and maintenance of chronic inflammation.
\r\n
\r\n\tThe book aims to cover the developing diagnostic methods for identifying the mucosal inflammation, towards a better analysis of the inflammation, understanding of the relationship between genetic and proteomic markers and response to therapy; and improving therapeutic options for patients who have mucosal inflammation.
",isbn:null,printIsbn:"979-953-307-X-X",pdfIsbn:null,doi:null,price:0,priceEur:0,priceUsd:0,slug:null,numberOfPages:0,isOpenForSubmission:!1,hash:"2e7bde3621cdf64518356b76e3132542",bookSignature:"Dr. Tsvetelina Velikova",publishedDate:null,coverURL:"https://cdn.intechopen.com/books/images_new/8843.jpg",keywords:"Inflammation, Neutrophils, Cytokines, Mucosal Biomarkers, Gut Tolerance, Antigen Tolerance, Mayo Score, Lesions, Acute Inflammation, Chronic Inflammation, Gut Permeability, Asthma",numberOfDownloads:null,numberOfWosCitations:0,numberOfCrossrefCitations:null,numberOfDimensionsCitations:null,numberOfTotalCitations:null,isAvailableForWebshopOrdering:!0,dateEndFirstStepPublish:"June 16th 2020",dateEndSecondStepPublish:"July 7th 2020",dateEndThirdStepPublish:"September 5th 2020",dateEndFourthStepPublish:"November 24th 2020",dateEndFifthStepPublish:"January 23rd 2021",remainingDaysToSecondStep:"8 months",secondStepPassed:!0,currentStepOfPublishingProcess:5,editedByType:null,kuFlag:!1,biosketch:"Dr. Velikova research focuses on autoimmune disorders, such as celiac disease, IBD, diabetes, asthma, as well as on the delicate autoimmunity mechanisms involving Th17 and Treg cells, cytokines, biomarkers, novel biologic therapies. She has been engaged in fifteen projects in the field of immunology and internal medicine. She is an editorial board member and reviewer for several medical journals and has publications in eminent journals and book chapters in the field of gastrointestinal immunology.",coeditorOneBiosketch:null,coeditorTwoBiosketch:null,coeditorThreeBiosketch:null,coeditorFourBiosketch:null,coeditorFiveBiosketch:null,editors:[{id:"180979",title:"Dr.",name:"Tsvetelina",middleName:null,surname:"Velikova",slug:"tsvetelina-velikova",fullName:"Tsvetelina Velikova",profilePictureURL:"https://mts.intechopen.com/storage/users/180979/images/system/180979.jpg",biography:"Dr. Tsvetelina Velikova received her MD and Ph.D. degrees, both with honors, from the Medical University of Sofia, Bulgaria. Subsequently, she became involved in active immunology research and teaching. Dr. Velikova also received advanced training in Clinical Immunology at University Hospital St. Ivan Rilski, Sofia, Bulgaria. \r\nShe is currently an assistant professor of Clinical immunology affiliated to the Sofia University and University Hospital Lozenetz, Bulgaria. \r\nHer research focuses on autoimmune disorders, such as celiac disease, IBD, diabetes, asthma, as well as on the delicate autoimmunity mechanisms involving Th17 and Treg cells, cytokines, biomarkers, novel biologic therapies and their implication in clinical practice.\r\nDr. Velikova has been engaged in fifteen projects in the field of immunology and internal medicine. She is an editorial board member and reviewer for several medical journals and has publications in eminent journals and book chapters in the field of gastrointestinal immunology.",institutionString:"Lozenetz Hospital",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"1",totalChapterViews:"0",totalEditedBooks:"0",institution:{name:"Lozenetz Hospital",institutionURL:null,country:{name:"Bulgaria"}}}],coeditorOne:null,coeditorTwo:null,coeditorThree:null,coeditorFour:null,coeditorFive:null,topics:[{id:"16",title:"Medicine",slug:"medicine"}],chapters:null,productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"},personalPublishingAssistant:{id:"177731",firstName:"Dajana",lastName:"Pemac",middleName:null,title:"Ms.",imageUrl:"https://mts.intechopen.com/storage/users/177731/images/4726_n.jpg",email:"dajana@intechopen.com",biography:"As a Commissioning Editor at IntechOpen, I work closely with our collaborators in the selection of book topics for the yearly publishing plan and in preparing new book catalogues for each season. This requires extensive analysis of developing trends in scientific research in order to offer our readers relevant content. Creating the book catalogue is also based on keeping track of the most read, downloaded and highly cited chapters and books and relaunching similar topics. I am also responsible for consulting with our Scientific Advisors on which book topics to add to our catalogue and sending possible book proposal topics to them for evaluation. Once the catalogue is complete, I contact leading researchers in their respective fields and ask them to become possible Academic Editors for each book project. Once an editor is appointed, I prepare all necessary information required for them to begin their work, as well as guide them through the editorship process. I also assist editors in inviting suitable authors to contribute to a specific book project and each year, I identify and invite exceptional editors to join IntechOpen as Scientific Advisors. I am responsible for developing and maintaining strong relationships with all collaborators to ensure an effective and efficient publishing process and support other departments in developing and maintaining such relationships."}},relatedBooks:[{type:"book",id:"6550",title:"Cohort Studies in Health Sciences",subtitle:null,isOpenForSubmission:!1,hash:"01df5aba4fff1a84b37a2fdafa809660",slug:"cohort-studies-in-health-sciences",bookSignature:"R. Mauricio Barría",coverURL:"https://cdn.intechopen.com/books/images_new/6550.jpg",editedByType:"Edited by",editors:[{id:"88861",title:"Dr.",name:"R. Mauricio",surname:"Barría",slug:"r.-mauricio-barria",fullName:"R. Mauricio Barría"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1591",title:"Infrared Spectroscopy",subtitle:"Materials Science, Engineering and Technology",isOpenForSubmission:!1,hash:"99b4b7b71a8caeb693ed762b40b017f4",slug:"infrared-spectroscopy-materials-science-engineering-and-technology",bookSignature:"Theophile Theophanides",coverURL:"https://cdn.intechopen.com/books/images_new/1591.jpg",editedByType:"Edited by",editors:[{id:"37194",title:"Dr.",name:"Theophanides",surname:"Theophile",slug:"theophanides-theophile",fullName:"Theophanides Theophile"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3092",title:"Anopheles mosquitoes",subtitle:"New insights into malaria vectors",isOpenForSubmission:!1,hash:"c9e622485316d5e296288bf24d2b0d64",slug:"anopheles-mosquitoes-new-insights-into-malaria-vectors",bookSignature:"Sylvie Manguin",coverURL:"https://cdn.intechopen.com/books/images_new/3092.jpg",editedByType:"Edited by",editors:[{id:"50017",title:"Prof.",name:"Sylvie",surname:"Manguin",slug:"sylvie-manguin",fullName:"Sylvie Manguin"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3161",title:"Frontiers in Guided Wave Optics and Optoelectronics",subtitle:null,isOpenForSubmission:!1,hash:"deb44e9c99f82bbce1083abea743146c",slug:"frontiers-in-guided-wave-optics-and-optoelectronics",bookSignature:"Bishnu Pal",coverURL:"https://cdn.intechopen.com/books/images_new/3161.jpg",editedByType:"Edited by",editors:[{id:"4782",title:"Prof.",name:"Bishnu",surname:"Pal",slug:"bishnu-pal",fullName:"Bishnu Pal"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"72",title:"Ionic Liquids",subtitle:"Theory, Properties, New Approaches",isOpenForSubmission:!1,hash:"d94ffa3cfa10505e3b1d676d46fcd3f5",slug:"ionic-liquids-theory-properties-new-approaches",bookSignature:"Alexander Kokorin",coverURL:"https://cdn.intechopen.com/books/images_new/72.jpg",editedByType:"Edited by",editors:[{id:"19816",title:"Prof.",name:"Alexander",surname:"Kokorin",slug:"alexander-kokorin",fullName:"Alexander Kokorin"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1373",title:"Ionic Liquids",subtitle:"Applications and Perspectives",isOpenForSubmission:!1,hash:"5e9ae5ae9167cde4b344e499a792c41c",slug:"ionic-liquids-applications-and-perspectives",bookSignature:"Alexander Kokorin",coverURL:"https://cdn.intechopen.com/books/images_new/1373.jpg",editedByType:"Edited by",editors:[{id:"19816",title:"Prof.",name:"Alexander",surname:"Kokorin",slug:"alexander-kokorin",fullName:"Alexander Kokorin"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"57",title:"Physics and Applications of Graphene",subtitle:"Experiments",isOpenForSubmission:!1,hash:"0e6622a71cf4f02f45bfdd5691e1189a",slug:"physics-and-applications-of-graphene-experiments",bookSignature:"Sergey Mikhailov",coverURL:"https://cdn.intechopen.com/books/images_new/57.jpg",editedByType:"Edited by",editors:[{id:"16042",title:"Dr.",name:"Sergey",surname:"Mikhailov",slug:"sergey-mikhailov",fullName:"Sergey Mikhailov"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"371",title:"Abiotic Stress in Plants",subtitle:"Mechanisms and Adaptations",isOpenForSubmission:!1,hash:"588466f487e307619849d72389178a74",slug:"abiotic-stress-in-plants-mechanisms-and-adaptations",bookSignature:"Arun Shanker and B. Venkateswarlu",coverURL:"https://cdn.intechopen.com/books/images_new/371.jpg",editedByType:"Edited by",editors:[{id:"58592",title:"Dr.",name:"Arun",surname:"Shanker",slug:"arun-shanker",fullName:"Arun Shanker"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"878",title:"Phytochemicals",subtitle:"A Global Perspective of Their Role in Nutrition and Health",isOpenForSubmission:!1,hash:"ec77671f63975ef2d16192897deb6835",slug:"phytochemicals-a-global-perspective-of-their-role-in-nutrition-and-health",bookSignature:"Venketeshwer Rao",coverURL:"https://cdn.intechopen.com/books/images_new/878.jpg",editedByType:"Edited by",editors:[{id:"82663",title:"Dr.",name:"Venketeshwer",surname:"Rao",slug:"venketeshwer-rao",fullName:"Venketeshwer Rao"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"4816",title:"Face Recognition",subtitle:null,isOpenForSubmission:!1,hash:"146063b5359146b7718ea86bad47c8eb",slug:"face_recognition",bookSignature:"Kresimir Delac and Mislav Grgic",coverURL:"https://cdn.intechopen.com/books/images_new/4816.jpg",editedByType:"Edited by",editors:[{id:"528",title:"Dr.",name:"Kresimir",surname:"Delac",slug:"kresimir-delac",fullName:"Kresimir Delac"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}]},chapter:{item:{type:"chapter",id:"41123",title:"IL-13, Asthma and Glycosylation in Airway Epithelial Repair",doi:"10.5772/51970",slug:"il-13-asthma-and-glycosylation-in-airway-epithelial-repair",body:'
1. Introduction
1.1. Clinical assessment of asthma
Pulmonary function tests (PFTs/spirometry) are routinely used clinically to diagnose asthma. Forced expiratory volume in one second (FEV1) is a measure of airflow and is influenced largely by the resistance in the airways. During an “asthma attack”, the airways narrow owing to mucus hypersecretion and smooth muscle contraction, which results in a sharp increase in airway resistance and reduction in FEV1. In the clinics, this can be reproduced by exposing patients with asthma to non-specific smooth muscle contractile agonists such as methacholine. A fall in FEV1 at a relatively low dose of methacholine indicates airway hyperresponsiveness (AHR). In asthmatic patients this drop in FEV1 can be reversed by inhaled bronchodilators such as β2-agonists (e.g. salbutamol), which relaxes airway smooth muscles. AHR is often used as a diagnostic criterion for asthma.
Asthma is increasingly considered a syndrome, with diverse overlapping pathologies and phenotypes contributing to significant heterogeneity in clinical manifestation, disease progression, and treatment response [1]. Severe uncontrolled asthmatics make up approximately 5-10% of the population of asthmatics, yet they consume around 50% of the treatment resources [2]. Spirometric tests are incapable of exposing the underlying pathologies or phenotypes which combine within an individual to produce the asthmatic disease. In contrast specific biomarkers may enable more accurate sub-phenotyping of disease by indicating the pathology within an individual, and assist clinicians to better tailor the type and/or dose of therapy. In this way biomarkers have the potential to guide more effective personalized treatment regimes in asthma.
1.2. The causes of asthma
Several studies have used lung biopsies taken from non-asthmatic patients and those who died from fatal asthma to show the airways of asthmatics possess characteristic structural differences, shown in Figure 1. These include but are not limited to; increased eosinophil numbers in asthmatics, and areas of focal bronchial epithelial denudation [3]. The contents of the bronchial lumen can also be examined using the bronchoalveolar lavage (BAL) technique, in which warm saline is instilled into a segmental bronchus of a patient and removed. BAL fluid-based studies confirmed the previous research that inflammatory cell influx and epithelial damage occur in the airways of asthmatics [3] [4]. It is a point of some debate as to whether the epithelial damage is caused by inflammation, is a cause of inflammation, or whether epithelial damage and airway inflammation are concurrent but unrelated processes. We shall discuss the potential role of the epithelium and epithelial repair in asthma in more detail later.
1.3. Inflammation in asthma
The rationale for treating severe asthmatics with steroids is centred on the assumption that the disease is driven by uncontrolled airway inflammation. The classical paradigm of the acute inflammatory response in allergic asthma is briefly; inhaled allergenic antigens are captured by professional antigen-presenting dendritic cells, macrophages, or epithelial cells. Antigens presented by these cells are recognized by T-cells which proliferate and differentiate. Primed Th2 cells bind to B cells and release cytokines including triggering maturation of antigen-specific B cell populations into plasma cells. Plasma B cells release antigen-specific IgE that binds to IgE-receptors on mast cells in the airways, causing release of histamine-containing granules. Extracellular histamine released from mast cells binds to membrane receptors on airway smooth muscle cells triggering a rise in intracellular calcium, muscle contraction and airway narrowing. Although this paradigm has gained acceptance as an important mechanism in asthma, there is significant variation in specific cell types involved between individuals. In the setting of chronic asthma, eosinophils are thought to play a major role in maintaining airway inflammation in the long-term. Neutrophils are occasionally the predominate inflammatory cell present in the airways of chronic asthmatics, suggesting multiple underlying pathologies of disease. Neutrophilic vs. eosinophilic asthma are clinically indistinguishable by pulmonary function testing, but such pathological variation may have important implications regarding treatment as patients with “neutrophilic asthma” tend to be relatively unresponsive to steroid treatment [5]. A rapid and definitive method for determining the nature of airways inflammation in a diagnosed asthmatic is therefore needed to guide the clinician’s selection of therapy.
1.4. IL-13 and asthma
Interleukin-13 (IL-13) is a pleiotropic Th2 cytokine secreted from a variety of inflammatory cells and structural cells, including the airway epithelium. IL-13 is upregulated in the airways of patients with allergic asthma exposed to allergen; segmental allergen challenge of atopic asthmatics triggered an increase of IL-13 protein and transcript in bronchoalveolar lavage, and the source was identified as mononuclear inflammatory cells [6]. Experiments in small mammals and in vitro studies using human cells, have demonstrated IL-13 triggers many of the pathophysiological characteristics of asthma, independent of the IgE and eosinophil inflammatory mechanisms classically associated with allergic disease [7] [8]. Genetic studies in humans have demonstrated the gene loci for IL-13 and the IL-4 receptor portion of the IL-13Rα1 receptor have a strong genetic association to asthma susceptibility and severity [9]. IL-13 can act directly on the airway epithelium in various ways; previous studies have demonstrated IL-13 exposure of cultured human airway epithelial cells triggers an matrix-metalloproteinase-7 (MMP-7)-dependent release of the pro-inflammatory chemokine, soluble Fas-ligand, potentially leading to local inflammation and epithelial damage via removal of the protective Fas-ligand-mediated epithelial immune barrier [10]. Mucous hypersecretion is a common observation in asthmatic airways; acute treatment of differentiated cultures of primary human airway epithelial cells with IL-13 induces a hypersecretory phenotype [11], which develops into an asthma-like mucous hyperplasia with a 5-10-fold increase in goblet cell density and MUC5AC (the predominant airway mucin) detection after 14 day treatment [12]. Murine studies confirm IL-13 is required and sufficient to directly induce epithelial mucous hyperplasia in vivo in the absence of intermediate inflammatory cells [13]. Mucins including MUC5AC are highly glycosylated proteins, it thus follows that increased mucous production will necessitate an increase in the activity of associated transferase enzymes. In the H292 airway epithelial cell line, IL-13 treatment has been shown to increase the activity of the M and L isoforms of core 2 beta1,6 N-acetylglucosaminyltransferase (C2GnT) via activation of a JAK/STAT signaling pathway [14]. Thus, IL-13 acts directly on the airway epithelium to trigger development of an asthma-like phenotype, at least in part by increasing protein glycosylation via upregulation of glucosyltransferase activity.
1.5. Current treatments for asthma
Asthma is rarely fatal but often leads to significant patient morbidity. For over thirty years the mainstay therapy for asthma has been inhaled β2-agonists (βA), which relax the airway smooth muscles, causing bronchodilation, and inhaled glucocorticosteroids (i.e. steroids), which ameliorate airway inflammation and reduce the risk of asthma exacerbations. Steroids are anti-inflammatory drugs but also have many unwanted side-effects, particularly at high doses, including; weight-gain due to changes in body metabolism, and a reduction in bone mineral density, potentially leading to brittle bones. Therefore the decision to treat a patient with steroids should not be taken lightly. Inhaled β2-agonists (s) are the most effective bronchodilators available and their main mechanism of action is via the relaxation of airway smooth muscle [15]. βAs interact with G-protein-coupled cell surface β2-adrenoceptors (β2AR) on bronchial smooth muscle cells and activate adenyl cyclase, causing a rise in intracellular cAMP, this results in relaxation of the smooth muscle and bronchodilation. Long term βA treatment can result in a loss of response which shows variation between individuals. Desensitisation due to chronic βA treatment is caused by a down-regulation of receptor transcription, secondary to a reduced activity of the CREB (cyclic AMP response element binding protein) transcription factor [15]. The β2-adrenoceptor gene possesses at least three possible GRE binding sites for the activated GCR, and GCs have been shown to increase β2AR transcription two-fold in human lung preparations in vitro and also in rat lungs in vivo. The downregulation of β2AR transcription resulting from long-term βA treatment can therefore be reversed by a GC, so there is no net change in the level of β2ARs expressed in the bronchial epithelium or airway smooth muscle of animals treated with a combination of GCs and βAs [15]. The very large β2AR reservoir in airway smooth muscle cells may mean that this upregulation by GCs is functionally unimportant in vivo [15]. Many asthmatics who are unresponsive to high doses of steroids show a marked improvement in symptoms when given steroids with βA together. Thus there may be a true synergy between the two classes of drugs as β2-adrenoceptor agonists enhance the function of GCs both in vitro and in vivo, possibly by increasing the nuclear localisation of activated GCRs. Low-dose theophylline has been prescribed as an asthma treatment for many years, however it has now been relegated to a third-line therapy according to the global asthma guidelines (reviewed in [16]). Theophylline is a weak, non-specific cyclic nucleotide phosphodiesterase (PDE) inhibitor, and recently these PDE inhibitory characteristics have re-ignited interest in this drug as a possible asthma treatment.
Monoclonal antibodies have gained recent credence as a potential means to target therapy against specific receptors and signalling pathways. Omalizumab, a biologic agent that binds to IgE, has shown some promise as a means of controlling some difficult to treat asthma patients who are poorly controlled with standard inhaled steroid and β-agonist combination therapy (reviewed in [17]). Interleukin-5 (IL-5) is an important cytokine for eosinophil differentiation, maturation, migration into the circulation and survival. Various studies have implicated the eosinophil as being the primary cell responsible for airway hyperresponsiveness in asthma, thus anti-IL-5 antibodies have been developed (such as mepolizumab) with the intention of reducing airways hyperresponsiveness by preventing eosinophil recruitment and survival in the airway. Clinical trials have demonstrated such inhaled anti-IL-5 therapy does indeed reduce airway eosinophilia, but does not have a clinically-beneficial effect on lung function [18, 19]. Considering the highly important role IL-13 is thought to play in asthma, it is unsurprising that therapies are being developed to specifically target IL-13. Lebrikizumab, an anti-IL-13 monoclonal antibody, has just completed phase II clinical trials in which patients with poorly-controlled asthma were given the drug subcutaneously at 4 weekly intervals for 6 months [20]. This study found anti-IL-13 therapy did significantly improve lung function, but only in a sub-group of asthma patients who exhibited high serum periostin levels, a surrogate marker of high airway IL-13 [20]. These studies demonstrate highly-targeted therapies may be useful in asthma, but each individual drug will probably only prove effective in a specific sub-group of asthmatic patients. The potential for such personalised medicine highlights the importance for accurate phenotyping of asthmatic individuals, discussed in the biomarkers section of this chapter (Section 5).
1.6. Carbohydrates and asthma
Carbohydrate decoration of proteins has been associated with asthmatic disease. Two case-control studies have investigated the role of the histoblood group antigens; H(O), A, B, or AB in asthma susceptibility. They found in human subjects the O-secretor mucin glycan (H-antigen) phenotype is associated with an increased susceptibility to recurrent asthma exacerbations [21].
2. Normal airway structure
From the level of the bronchioles upwards, the stratified epithelium lining the airway lumen rests on a basal lamina or ‘true’ basement membrane, a specialised ‘mat’ of extracellular matrix proteins. Below the basal lamina is a layer of collagenous matrix, termed the reticular basement membrane, in which fibroblasts are embedded in a sporadic arrangement. Farther below the fibroblastic layer are arranged bundles of smooth muscle myocytes, blood vessels and afferent nerve endings.
2.1. Structural changes to the airway in asthma
Although asthma is considered an inflammatory disease, there are many structural changes in the airways. Figure 1. shows cross-sections through the large airways of two patients, one normal and one severe asthmatic. The Movat’s pentachrome stain clearly highlights the various architectural remodeling events occurring in the asthmatic airway. Obstruction of the airways from excessive mucus production is a common finding in severe asthmatics, blue staining in the epithelium and the lumen demonstrates mucous cell hyperplasia, with excessive mucus deposition into the airway. Under the asthmatic epithelium a thicker basement membrane is present which contains several different extracellular matrix (ECM) factors (including tenascin-C) compared to normals [22]. Deeper into the airway, red-stained muscle mass is increased in the asthmatic owing to a combination of smooth muscle hypertrophy and hyperplasia (reviewed in [23]). The airways of severe asthmatics also demonstrate a fibrotic response with increased connective tissue deposition and fibroblast and myofibroblast proliferation. Opinion is divided as to whether inflammation precedes airway remodeling, or whether the two occur in parallel (reviewed in [15, 24, 25]). Evidence tends to favour the latter because; firstly, remodeling occurs very early on in the disease, and in some cases in the absence of inflammation [26], secondly, there is only a weak link between airway inflammation and symptoms [27], and thirdly, epidemiological data demonstrate steroids do not work in all asthmatics [5]. In reality it is likely effective therapies will need to target both airway inflammation and remodeling.
2.2. Airway epithelial structure and function
The bronchial epithelium lines the inner wall of the respiratory tract in a continuous layer; it forms the interface between inspired air and the internal milieu as well as being the primary target for inhaled respiratory drugs. In the larger airways and down the respiratory tree to the level of the bronchioles the epithelium is at least two cells thick (reviewed. in [28]). Although there are at least eight morphologically and functionally distinct epithelial cell types present in the respiratory tract, they can be classified into three main groups; basal, ciliated columnar, and secretory columnar (reviewed in [29]).
Figure 1.
The airways in asthma undergo significant structural remodeling. Medium-sized airways from a normal and severe asthmatic patient were sectioned and stained using Movat’s pentachrome stain. The epithelium (Ep) in asthma shows mucous hyperplasia and hyper secretion (blue), and significant basement membrane (Bm) thickening. Smooth muscle (Sm) volume is also increased in asthma. Bv = blood vessel. Scale bar = 100µm.
Basal cells
Basal epithelial cells are pyramidal-shaped cells with a low cytoplasm to nucleus ratio, although found throughout the airway, their contribution to epithelial volume decreases with airway size (reviewed in [29]). Basal cells are anchored to the underlying basement membrane and to other cells via specialised adhesion structures discussed below (Figure 2.) [4, 30]. Historically the basal cell has been considered to be the stem cell of the bronchial epithelium (reviewed in [31]), however animal studies suggest there may be alternative stem cells located in the airway epithelium, including secretory cells, and cells located at specialised niches including the broncho-alveolar junction and the neuroepithelial bodies.
Columnar ciliated cells
Columnar epithelial cells lie above the basal cell layer and line the airway lumen, in direct contact with the inspired air. Ciliated cells are terminally differentiated columnar cells and are the most common cell-type in the bronchial epithelium, accounting for around 50% of all epithelial cells and 80% of terminally-differentiated apical cells in the human trachea [32], reviewed in [29]. Their main function is the removal of particulate matter by means of the mucociliary pathway. Ciliated cells arise from either a basal or secretory cell pre-cursor and possess around 300 cilia per cell, directly beneath the cilia are observed numerous mitochondria and a dense microtubule system, reflecting the high metabolic demands of particle clearance [29] [33].
Secretory cells
Secretory cells are also present at the apical surface, comprising 15 to 20% of the normal tracheobronchial epithelium [32]. In the larger airways the mucus-secreting goblet cell represents the predominant secretory cell and is the main source of airway mucus. These cells are characterised by membrane-bound electron-lucent acidic-mucin granules which are released into the airway lumen to trap inhaled particles and pathogens, prior to removal from the respiratory tract by coordinated cilia beating. Serous cells and Clara cells are relatively rare secretory cells in the larger airways present in large airways, but Clara cells are the main secretory epithelial cell type of the bronchioles, particularly the most distal bronchioles (reviewed in [34]). Several studies in rodents indicate the progenitor cell of the bronchial epithelium is not the basal cell but it is in fact the non-ciliated, secretory columnar cell. Both goblet and clara cells have been observed to undergo de-differentiation and proliferation during in vivo wound repair [4] [35-38].
2.3. Airway epithelial carbohydrate expression
The airway epithelial surface is covered by a layer of airway surface liquid (ASL), mainly of epithelial origin. A layer of mucins form a mucous layer that overlies the thin watery periciliary layer (PCL). The predominant mucins in the airways are MUC5AC and MUC5B secreted by goblet cells and submucosal glands respectively. Mucins are highly glycosylated proteins; 70-80% of their molecular weight are carbohydrate, and the structural characteristics of the mucous layer depends on interaction between the carbohydrate side-chains of mucin proteins. Studies of airway mucins in disease, demonstrate mucins are both oversulphated and hyper-sialylated in patients with cystic fibrosis and in chronic bronchitis patients with significant infections [39]. Pseudomonas aeruginosa, the pathogen responsible for the majority of morbidity and mortality in cystic fibrosis patients, uses the sialylated and sulphated Lewis-x determinants as attachment sites. Thus mucin glycosylation patterns may significantly affect infection in the airway. Specific lectin-binding assays have been used to characterise carbohydrate expression patterns in differentiated human airway epithelium [40]. Out of 38 lectin probes tested, seven bound specifically to basal cells, seven to columnar cells, and three specifically labelled secretory cells. The 1HAEo- and 16HBE14o- airway epithelial cell lines were also probed with the same lectin panel, revealing identical carbohydrate expression to the basal epithelial cells in the human tissue [40]. Thus the different cell types in the pseudostratified epithelium of the airways, express specific patterns of carbohydrates, possibly reflecting their different functions.
2.4. Airway epithelial functions
The primary function of the bronchial epithelium is to serve as a continuous physical barrier and as such it functions as part of the non-specific immune system, preventing pollutants, bacteria, viruses, allergens, and other potentially noxious substances transferring from inspired air into the underlying mesenchyme. This defence is mediated by several adhesive mechanisms which have been elucidated through transmission electron microscopy and immunohistochemical studies of bronchial epithelial biopsies [4] [30] (Figure 2.). Belt-like tight junctions (zonula occludens) seal the lateral apices of columnar cells, regulating para-cellular transport, whilst columnar cells adhere to each other via classical E-cadherin mediated adherens junctions [30]. Desmosomal cadherins mediate strong cell-cell adhesion and desmosomes are present between basal cells and particularly at the junction of basal and columnar cell layers [30]. Basal cells are in turn anchored to the basement membrane via specialised integrin-mediated cell-ECM junctions. Integrin heterodimers function by dynamically linking the contractile machinery of the cell’s cytoskeletal network to the external matrix at specialised sites termed focal adhesions or focal contacts. The airway epithelium expresses several integrin heterodimers, including the α6β4 integrin which binds to laminin-5 in the basement membrane forming a hemidesmosome anchor with the ECM.
The bronchial epithelium is more than a passive barrier; it performs a variety of roles allowing it to function as a dynamic regulator of the innate immune system [39]. The mucociliary pathway represents the principle mechanism of particle clearance in the airway. Inhaled particles and pathogens (bacteria, viruses) are trapped in mucus prior to removal from the respiratory tract by coordinated cilia beating. In addition to producing mucus, secretory cells are the source of a variety of mediators capable of having direct effects on inhaled noxious agents; including anti-oxidants and a variety of anti-bacterial agents; lactoferrin, lysozyme, β-defensins and also opsonins, components of the complement system that coat bacteria to facilitate phagocytosis by macrophages (reviewed in [39]). Various immunoglobin isotypes are secreted onto mucosal surfaces where they act in a protective manner by opsonising bacteria and other pathogens, rendering them relatively harmless and activating phagocytosis and digestion by tissue macrophages. Allergen-specific IgA is secreted by activated B lymphocytes (plasma cells) in the sub-mucosa, dimeric IgA (dIgA) selectively binds to the polymeric Ig receptor (pIgR) expressed on the basal surface of basal airway epithelial cells. The pIgR-IgA complex is subsequently internalised and is transported to the apical surface via the endosomal pathway ready for secretion into the airway lumen. Dimeric secretory IgA (sIgA) is released into the airway lumen as a 1:1 combination of dIgA and a portion of the pIgR known as secretory component (SC), which protects the IgA from digestion by proteases on the mucosal surface [40, 41]. SC is a highly glycosylated protein containing 15% N-linked carbohydrate. Glycosylated SC binds IL-8, inhibiting IL-8-mediated neutrophil chemotaxis and transendothelial migration. This interaction is dependent on SC glycosylation state as de-glycosylation with peptide N-glycosidase F abolishes the SC-IL-8 complex [42].
Figure 2.
Adhesion mechanisms in the human bronchial epithelium. Tight junctions seal the lateral apices of columnar cells which adhere to each other via adherens junctions. Desmosomes mediate basal-basal and columnar-basal cell attachments, whilst hemidesmosomes anchor basal cells to the basal lamina. (Adapted from Roche et al. [30]).
3. Epithelial injury and repair
All epithelial tissues are regularly damaged as a consequence of exposure to environmental insults. Rapid repair following injury is crucial for restoring adequate barrier function, with subsequent cellular differentiation required to regenerate normal epithelial structure and function. The repair processes in all epithelial types have common elements producing an orderly progression of events including; cell spreading at the margins of the wound, cell migration into the wound, cell proliferation and finally re-differentiation (Figure 3). In vivo investigations of wound repair have demonstrated that migration and proliferation are both critical for the rapid restitution of the bronchial epithelium after injury [35-38]. Hamster tracheal epithelia were mechanically denuded to leave behind a bare (and sometimes damaged) basal lamina and wound repair was monitored until a morphologically normal epithelium was restored. Following epithelial removal, plasma promptly exudes into the injured site from the underlying vasculature to cover the denuded basement membrane, facilitating the binding of serum proteins to cellular receptors that stimulate repair of the damaged epithelium. At 12h post-wounding, viable secretory and basal cells at the wound margins de-differentiate, flatten into a squamous morphology, and migrate at about 0.5μm/min to cover the wound site.
Figure 3.
Airway epithelial repair involves a series of events including, cell spreading, migration, proliferation and differentiation. Following epithelial injury, neighboring cells flatten, spread and migrate to cover the site of injury. Subsequent proliferation and differentiation restores the epithelial structure and barrier function. The different stages of repair are mediated and facilitated by a diverse array of growth factors, cytokines and cell surface receptors, adhesion molecules, and intracellular enzymes, many of which are glycosylated. These glycans can modulate the function of proteins and lipids thereby regulating the repair process.
Proliferation is also an intrinsic component of epithelial repair. In the aforementioned hamster tracheal injury studies, mitosis rates at 12h post-injury are low (0.4%) but by 24h a wave of proliferation occurs primarily in secretory cells, resulting in a multi-layered epidermoid metaplasia [35]. At 48h post-wounding proliferation rates decrease (although mitosis is still significantly above basal levels), from this time point onwards the upper-most cells of the metaplastic epidermis start to slough off, resulting in a gradual loss of the metaplastic phenotype, with subsequent regeneration of a functional mucociliated phenotype achieved by apical cell re-differentiation. In small wounds normal mucociliary structure is restored by 120h but some persistent metaplasia persists in larger wounds through 168h post-wounding [38]. Although both secretory and basal cells are involved in epithelial repair, secretory cells play a dominant role in these experiments, consistently demonstrating higher mitosis rates than any other epithelial cell type [35-38]. In vitro studies using muco-ciliated human bronchial epithelial cells grown in air-liquid interface (ALI) culture, demonstrate that scrape wound repair is achieved by rapid spreading and migration of cells at the wound edge, followed by proliferation of basal cells outside of the wound area [43]. Acute wound repair speeds were inhibited slightly by the steroid dexamethasone, but the same drug potentiated the ability of long-term ALI cultures to repair repeated wounds [43].
In vivo studies demonstrate epithelial repair is accompanied by a corresponding proliferation of the underlying mesenchyme. Hamster tracheal epithelial damage is followed at 24h by capillary endothelial cell division, and at 36h many fibroblasts were observed to be in mitosis [35-37]. Mesenchymal proliferation persisted for a longer period than the epithelial response and supports several in vitro studies demonstrating epithelial damage can influence the phenotype and proliferation of underlying fibroblasts [44, 45].
3.1. Airway epithelial wound repair is compromised in asthmatics
The patho-physiological changes observed in the asthmatic airway may be due to reactivation of the epithelial-mesenchymal trophic unit (EMTU), triggered by an abnormal epithelium that is held in a repair phenotype [24]. In vitro studies support the hypothesis that epithelial-derived factors are capable of altering the phenotype of adjacent mesenchymal cells [43, 44]. The mechanisms involved in initiating and maintaining the epithelial repair response in asthma are largely unknown, however recent studies have demonstrated the airway epithelium in asthmatics is intrinsically altered compared to normals, and that these differences persist for extended periods in culture [45, 46]. There is considerable evidence to suggest the airway epithelium is capable of orchestrating the inflammatory immune response, as following injury, epithelial cells release a variety of pro-inflammatory cytokines, chemokines and growth factors. Acute inflammation is a necessary aspect of wound repair, however if epithelial damage persists, or the epithelial repair response is not shut-off, then potentially deleterious chronic inflammation may result (Figure 4.).
3.2. Mechanisms of cellular migration
Many disorders characterized by impaired re-epithelialization, are not a result of inadequate proliferation, but are due to impaired cell migration over the denuded site [47-49]. Cell migration requires a coordinated, highly complex series of events including; changes to the cell cytoskeleton, modification of the surrounding ECM and modulation of adhesions to ECM substrate and to other cells. The majority of these processes are regulated by the Rho-like family of small GTPases including, RhoA, B, C, E, Rac1, 2, 3 and Cdc42 (Figure 3.) (reviewed in [50, 51]) that function by acting as “molecular switches”, cycling between an
Figure 4.
Injury and repair cycle of the airway epithelium in asthma. Complete repair requires glycosylation as a means of regulation of essential elements. Aberrant glycosylation would result in a defect in the mechanisms of repair, the accumulation of epithelial damage and persistent airway inflammation. Modified from Davies [46].
inactive GDP-bound state and an active GTP-bound form at the plasma membrane [52]. GTPases are able to regulate the transmission of signals from cell surface receptors, such as integrin-mediated cell-ECM adhesion, or growth factor ligation, to downstream intracellular signalling pathways, influencing the cell cytoskeleton, gene transcription, and the cell cycle (reviewed in [53]). Rho induces formation of stress fibres, integrin-mediated focal adhesions, and actomyosin-mediated cell body contraction [54], Rac-dependent actin polymerisation leads to lamellipodium extension and membrane ruffles at the leading edge of the cell [55], and Cdc42 induces formation of microspikes/filopodia [56].
Figure 5.
Cellular processes occurring during migration. The transition from a stationary state to a migratory phenotype involves several distinct mechanisms, Rho-like GTPases regulate the majority of these processes and the individual GTPases most directly linked to each are: (1.) Rac-dependent actin (blue) polymerisation leads to lamellipodium extension at the leading edge of the cell, (2.) new ECM adhesions are formed at the lamellipodium via focal contacts (red), also regulated by Rac, (3.) cell body contraction is dependent on actomyosin contraction (blue arrows) and is dependent on Rho activity, (4.) tail detachment is possibly affected by GTPase activity but the protease calpain is important for degradation of focal adhesions at the rear of migrating cells, (5.) cadherin-mediated cell-cell adhesions (green) are dependent on Rho and Rac activity and are often downregulated during migration. MMP-mediated ECM degradation is necessary for migration, even in cells migrating over a basement membrane.
Several in vitro studies have demonstrated activity of the RhoGTPase family is essential for airway epithelial wound repair; activation of protein kinase A (PKA) facilitates scrape wound closure in cultured bovine airway epithelial cells via inhibition of Rho activity and decreased focal contact attachments [57]. The 16HBE human airway epithelial cell line has been used to demonstrate coordination of RhoA and Rac1 activities are vital for efficient wound closure [58]. Detachment of the trailing edge is often a limiting factor of cellular migration speed, detachment is possibly affected by GTPase activity but the protease calpain is important for degradation of focal adhesions at the rear of migrating cells. Rho-GTPases are also involved in cell proliferation during airway epithelial repair; the scaffold IQ domain GTPase-activating protein (IQGAP1), an effector of Rho GTPases, is upregulated during 16HBE scrape wound repair and facilitates closure by increasing via a ß-catenin-mediated transcription of genes involved in cell cycle regulation such as CyclinD1 [59, 60].
3.3. The effect of intracellular protein glycosylation on epithelial repair
The activity of the Rho-GTPase family is highly regulated by glycosylation. Clostridium difficile toxins A and B (TcdA and TcdB) are major virulence factors for the induction of antibiotic-associated diarrhea and pseudomembranous colitis. These toxins possess potent cytotoxicity against cultured cell lines by inducing disaggregation of the cytoskeleton. TcdA and TcdB cellular toxicity is dependent on their intrinsic glucosyltransferase activity, they modify Rho-like GTPases by using UDP-glucose as a co-substrate [61]. RhoA undergoes mono-O-glucosylation at threonine-37, and Rac1 and Cdc42 are glucosylated at the homologous amino acid threonine-35. The threonine residue at position 37 of Rho (position 35 of Rac or Cdc42) is highly conserved and is located in the so-called effector region, it participates in co-ordination of the bound magnesium ion and thereby plays a pivotal role in nucleotide binding [62]. Glucose binding to residues within the effector region inhibits Rho-GTPase activity leading to drastic alteration of the cell cytoskeleton via several potential mechanisms including; inhibition of effector coupling, inhibition of nucleotide exchange (thereby directly blocking GTPase activity), by altering the sub-cellular localization of the GTPase, and finally by altering the stability of the enzyme within the cell (Reviewed in [52], [63]). TcdA has also been shown to induce apoptosis of intestinal epithelial cells via activation of caspases-3, -8 and -9 [64]. To date there is no direct experimental evidence linking Rho-GTPase glucosylation to the inhibition of wound repair in airway epithelial cells. However as this family of enzymes play such a fundamental role in repair of the airway epithelium, and the structure and function of the Rho-family of GTPases is very highly conserved, it is logical to presume that glycosylation would also play a pivotal role in regulating GTPase activity and thus wound repair.
3.4. Role of cell surface glycoconjugates in epithelial repair
Many proteins essential for normal cell physiology including adhesion molecules and cell surface receptors are glycosylated [65,66]. Alteration in the glycosylation pattern of many glycoproteins leads to changes in their function. It has been shown that impaired glycosylation of receptors often leads to abnormal intracellular trafficking, ligand binding and downstream signal transduction ability [67-70]. Tsuda et al. demonstrated that removal of sialic acid from erythropoietin leads to loss of its in vivo activity [71]. Complex carbohydrate structures attached to cell surface proteins and lipids have functional roles in cell motility [72], adhesion [73], proliferation [74], and growth potential [75] in several cell types. It also has been demonstrated that certain apical cell-surface carbohydrates are altered during cellular differentiation [76]. Thus many cellular functions are regulated and dependent upon glycoproteins. Because of the role of glycosylated structures in cell-cell and cell-matrix interaction, it is not surprising that there is a growing interest to explore the role for and regulation of these cell-surface carbohydrates in epithelial repair.
Lectins are naturally occurring proteins that can be isolated from a variety of plants and animals. Each lectin binds to a specific sugar moiety. As such, lectins are exquisitely selective tools to identify or block specific glycoconjugate motifs and have been extensively employed to study the role of cell-surface sugars and complex carbohydrates in cellular function [77, 78]. A variety of approaches have been employed to unravel the role(s) of carbohydrates in the multiple steps of the repair process. Some studies have investigated the expression pattern of different carbohydrates after injury using lectins as probes. Using three methods for localizing or quantifying lectin-binding sites Gipson et al. compared cell-surface of normal and migrating corneal epithelium of the rat. In their study they found that cell-surface of migrating epithelia express different sugar moieties relative to cell membranes of stratified stationary epithelia. There was a dramatic increase in concanavalin A (ConA) and wheat germ agglutinin (WGA) binding on migrating cells relative to stationary cells. The authors also showed that migrating cells have an increase in glycoprotein production determined by an increase in the incorporation of radiolabelled leucine and glucosamine. In addition they found that N-glycosylation of epithelial cells is necessary for epithelial cell migration [79, 80]. Sweatt et al. demonstrated an increase in N-acetylgalactosamine in cell-surface glycoconjugates at the site of epithelial injury in pig cornea [81]. Dorscheid et al. has previously characterized cell-surface glycosylation in non-secretory cells of central human airway epithelium and airway epithelial cell lines utilizing lectin-binding patterns [82]. In this study it was shown that galactose- or galactosamine-specific lectins labeled basal epithelial cells and cell lines derived from basal cells. Lectins specific for several different carbohydrate structures bound columnar epithelial cells, and certain fucose-specific lectins labeled subsets of the airway epithelial cells. The cellular specificity of these differences suggests they may be relevant in various cellular functions. It has also been demonstrated that following mechanical injury of guinea pig tracheal epithelium, glycosylation profiles in the repairing epithelium change over time [83]. These changes may represent either the expression of one or more new glycoproteins, or changes in glycosylation of constitutive proteins, required for activation or a change in cell function needed for repair to proceed. Studies have shown that injury of the respiratory epithelium enhances P. aeruginosa adhesion and it has been speculated that changes of cell surface glycoconjugates related to wound repair, cell migration and/or spreading may favor P. aeruginosa adhesion [84].
In a previous study, Dorscheid et al. examined the functional role of cell surface carbohydrates in an in vitro model of wound repair after mechanical injury of human airway epithelial cells. The results demonstrated that N-glycosylated glycoproteins, particularly those with a terminal fucose residue, are essential in the adhesion and migration of airway epithelial cells and facilitate closure of epithelial wounds in monolayer culture [85]. Recently, Allahverdian et al. studied the role of a fucose containing tetrasaccharide, sialyl-Lewis X (sLex) [NeuAcα2-3Galβ1-4(Fucα1-3)GlcNAc], in airway epithelial repair. Increased presentation of sLex was observed in areas of epithelial damage relative to areas of intact epithelium. In an in vitro model of bronchial epithelial repair, cell surface expression of sLex was shown to be significantly increased following mechanical injury of airway epithelial cell monolayers and inhibition of sLex completely prevented repair [86]. Further studies demonstrated that sLex decoration of epidermal growth factor receptor (EGFR) plays an important role in mediating airway epithelial wound repair [87]. Allahverdian et al. demonstrated that sLex co-localizes with EGFR and blocking of sLex with a neutralizing antibody resulted in reduced phosphorylation of EGFR and prevented repair. The final step in the synthesis of sLex is catalysed by a specific α-1,3-fucosyltransferase, fucosyltransferase-IV (FucT-IV). Reduction in EGFR phosphorylation and repair were similarly observed when FucT-IV gene expression was knocked down using small interfering RNA (siRNA). These studies demonstrate the importance of cell surface carbohydrates in mediating airway epithelial repair.
It has been shown previously by Donaldson et al. that the plant lectin concanavalin A (ConA), which binds glucose and mannose moieties, can inhibit migration of newt epidermal cells [88]. Gipson et al. cultured rat corneas with 3 mm central epithelial abrasions in the presence of four plant lectins. In this study the authors demonstrated that blocking glucose, mannose, and glucosamine sites on corneal epithelial cell surfaces and/ or the epithelial basement membrane reversibly slows or inhibits epithelial migration [78]. Using the same culture model of bronchial epithelial repair, Patchell et al. has demonstrated that following mechanical wounding of intact monolayers, the lectins Allomyrina dichotoma (AlloA) and chick pea agglutinin (CPA) differentially stain human airway epithelial cells in damaged areas relative to the staining of intact epithelial monolayers [89]. While AlloA positive staining cells are those that appear to be migrating from areas distant to the wound and accumulating in the wound, CPA positive staining cells are restricted to the leading edge of the wound. Moreover, the addition of the above lectins following mechanical wounding inhibited the repair. These results suggest that AlloA and CPA bind specific carbohydrate structures involved in normal epithelial repair. Further work is being carried out to determine the identity of the relevant proteins associated with these carbohydrate ligands.
In a study by Trinkaus-Randall et al., the effect of specific carbohydrate moieties of the basal lamina on the attachment and spreading of rabbit corneal epithelial cells was studied. Corneal epithelial basal cells were plated onto freshly denuded basal lamina and three lectins WGA, ConA and RCA were used to block specific sugar moieties in the basal lamina. This study showed that lectin binding of glucose, mannose, and galactose moieties on the basal lamina significantly altered the extent of cellular spreading, while the binding of glucosamine inhibited attachment. This study demonstrated that alteration of specific sugar moieties on the native basal lamina dramatically affects the ability of basal cells of corneal epithelium to attach or spread [90]. Using an in vitro model of airway epithelial repair Adam et al. demonstrate that lectin WGA which binds to N-acetyl glucosamine residues inhibits the repair of epithelial damage without altering cell viability, while other N-acetyl glucosamine binding lectins do not affect the repair process [81].
These studies clearly demonstrate the critical role of carbohydrates in the process of epithelial repair. However, carbohydrates must either modify a protein or lipid to regulate its function or participate in binding to a specific receptor to effect the desired action. As such, the biological role of glycans can be broadly divided into two groups. One group depends on the structural and modulatory properties of glycans and the other relies on specific recognition of glycan structures (generally receptor proteins or lectins).
3.5. Galectins, annexins and epithelial injury – repair
Galectins and annexins are two of possibly many families of proteins with carbohydrate binding capabilities. Although their role in epithelial repair remains unclear, recent studies highlight their importance in these processes. Galectins are a specific family of lectins with an affinity for β-galactose-containing oligosaccharides that have no enzymatic activity. To date, as many as 14 galectins have been identified, and they have been found in non-mammalian species such as birds, amphibians, fish, worms, sponges and fungi. The binding affinities of galectins are often greater for the oligosaccharides than the monosaccharide galactose. The expression of galectins is conserved however; their expression is often tissue specific and developmentally regulated. Different cells express a unique complement of galectins. Of the 14 galectins, eight have been identified in the nucleus and cytoplasm and participate in specific cellular functions. Nine galectins have been found extracellularly. Their presentation on the cell surface remains a mystery since they lack a signal sequence for secretion via the classical secretory pathway for membrane proteins.
Studies have shown that galectin-1 and galectin-3 have the potential to mediate cell-matrix interactions [92-95]. Their ubiquitous expression makes it difficult to understand the mechanism of their involvement in this process. In corneal epithelial cells, galectin-3 and galectin-7 have been characterized as mediators of epithelial cell migration, an essential component of epithelial wound repair [96, 97]. Galectin immunostaining in healing wounds is more intense relative to normal epithelium, primarily at the leading edge and at areas of cell-matrix interactions [97]. Furthermore, wound repair was impaired in gal-3-/- mice in the wound model systems of either alkali burn wounds that leave the corneal stroma intact or laser ablation wounds that result in damage to the underlying basement membrane. This impaired repair was not seen in gal-1-/- mice. The authors propose that this effect is mediated by the lectin domain binding complementary glycoconjugates in the ECM and cell surface molecules resulting in enhanced cell-cell and cell-matrix interactions [97]. Similar work has demonstrated that galectin-7 also plays a role in corneal epithelial repair [96]. Although obvious differences exist between tissues, galectins may play a similar role in other epithelial organs and epithelial repair such as the lung and intestinal tract.
Annexins are a family of proteins that bind acidic phospholipids in a calcium dependant manner. Similar to galectins, annexins are largely cytoplasmic, however; several annexins have been detected on the cell surface of a variety of cells. Like galectins, annexins also lack a signal sequence for the cell surface presentation [98]. Annexins are proteins that have been associated with many cellular functions however their role remains poorly understood. Recent work has suggested that annexins possess carbohydrate binding abilities. This was first observed with annexin A4 when it was shown that it binds a variety of glycans [99]. Recent studies have suggested that annexin II (AII) is also capable of binding carbohydrates however this work is still in preliminary stages. Previously, the binding of tissue-type plasminogen activator (t-PA) was shown to bind HepG2 cells, however, following enzymatic removal of α-fucose residues on t-PA, this binding was dramatically decreased [100]. Subsequently, AII has been shown to be a cell surface receptor for t-PA [101]. The importance of α-fucose on t-PA may be a result of the carbohydrate binding of AII. Patchell et al. has shown that AII is presented on the cell surface and acts as a mediator of epithelial repair. AII was shown to be actively involved in wound repair in cells at the leading edge of the wound. Interestingly, the initial isolation purification of AII was achieved using a lectin, chick pea agglutinin, suggesting that itself, or an associated protein is glycosylated. Their tight association with the membrane and potential carbohydrate binding may influence the several functions associated with these relatively poorly understood proteins. On the surface of cells, AII has previously been shown to be involved in the migration of prostate cancer and lung carcinoma cells [102, 103]. In the case of metastatic cells, the regulation of cell migration and cell death is lost, however, under the appropriate levels of control, similar mechanisms of migration may be involved in the normal processes of wound repair. Following mechanical injury to rat cornea, at the leading edge of the wound AII translocates to the cell surface and interacts with the matrix protein tenascin-C [104]. The interaction of AII with tenascin-C results in the loss of focal adhesions and cell migration in endothelial cells and has been shown to initiate downstream signaling pathways. These findings combined with previous results suggest that AII is involved in cell migration and repair. However, the mechanism of AII involvement in these cellular events is unknown but likely involves a fucose binding lectin activity to coordinate the needed response.
As a cell surface molecule, it has been suggested that AII is the human cytomegalovirus receptor [105]. Following the initial interaction with heparan sulfate proteoglycan, the virus particle is primed for membrane fusion and infection [106, 107]. As a membrane fusion protein, AII could potentially act as a receptor to other enveloped viruses such as respiratory syncytial virus (RSV). Recently, AII has been shown to bind RSV and was characterized as a potential cell surface protein that can promote RSV infection [108]. These findings along with data that has identified AII on the surface of airway epithelial cells provide strong evidence AII may be a cell fusion receptor allowing RSV infection of the respiratory tract. Viruses are a common source of lung injury, specifically the epithelium. Epithelial cells, as a protective mechanism, become highly apoptotic following virus infection to prevent further infection and viral persistence [109]. Viral infectivity of several enveloped viruses is dependent upon carbohydrate interactions between the viral proteins and their receptors. The end result is injury to the epithelium that requires repair. Altered glycosylation then may either increase the resulting injury from RSV infection or impair the AII coordinated repair.
3.6. MMPs in asthma, glycosylation and repair
Matrix-metalloproteinases (MMPs) are a family of zinc-dependant endopeptidases that digest all components of the extracellular matrix (ECM) and many non-ECM substrates including growth factors, cytokines, and their receptors [110, 111]. Several MMPs are increased in airway tissue and broncho-alveolar lavage (BAL) fluid of asthmatics including MMP-1, -2, -3, -7, -8 and -9 [112, 113], suggesting a link between increased airway proteolytic activity and the asthma phenotype. In vivo studies have shown MMPs play a direct role in the development of allergic airway inflammation [114] and hyperresponsiveness [115-117]. Inflammatory cells, particularly neutrophils and alveolar macrophages, were thought to be the major source of increased proteinases in asthma and other inflammatory lung diseases [118, 119], however several groups have demonstrated structural cells of the lung including the epithelium, also synthesize MMPs and their endogenous tissue inhibitors (TIMPs) [10, 120-125]. MMPs perform many biological functions, they are integral to connective tissue homeostasis and their activities are strictly coordinated during epithelial wound repair [124-126]. Many growth factors such as TGF-β and VEGF bind to sites in the ECM forming “reservoirs”, and are released during ECM digestion [112]. Recent studies have provided strong evidence that dysregulated airway MMP activity in the lung epithelium may contribute to airway inflammation and the progression of tissue remodeling in asthma. MMP-7 expression is altered in the epithelium of asthmatics which may contribute to airway inflammation via cleavage and release of cytokines and chemokines including IL-25 and soluble FasL [10, 127]. It is possible that aberrant MMP expression in the airway epithelium contributes to inflammation and lung remodeling in asthma via proteolytic alterations in cytokine and chemokine signaling.
3.7. IgCAMs in asthma, repair and the effects of IL-13
Immunoglobulin-cell adhesion molecules (Ig-CAMs) are a diverse family of cell adhesion molecules characterised by the presence of one or more copies of a structure known as the Ig fold [128]. These receptors are expressed on a variety of cell types and are vital for many different biological processes, including neural development and immune system function [129]. In the adult, Ig-CAMs regulate the recruitment and subsequent activation of circulating lymphocytes, studies show they are also expressed in the epithelium and vasculature of the bronchial mucosa and levels of two Ig-CAMs, ICAM-1 and CD44 (hyaluronic acid receptor), are increased in the epithelium of asthmatics [130, 131]. Recent data also suggests a third Ig-CAM, CD147 (EMMPRIN – Extracellular matrix Metalloprotease Inducer) is increased in the epithelium of patients with chronic obstructive pulmonary disease (COPD) [132]. CD147 is over-expressed by metastatic cells of the skin, bladder, breast, and lung [92]. In cancer CD147 stimulates synthesis of various MMPs via homophilic interaction of CD147 oligomers on adjacent cells [134]. CD147 is potentially involved in various signaling pathways relevant to remodeling in airways disease, for an in depth review see [135]. Studies have shown CD147 is endogenously expressed at low levels in the basal cells of various stratified epithelia including the airway. Airway epithelial CD147 expression is increased in murine models of lung injury [136] and in several inflammatory airway diseases including pulmonary fibrosis [137] and interstitial pneumonias, where increased CD147 is associated with MMP-2, -7 (matrilysin) and -9 levels in the lungs of patients [138]. Recent studies have demonstrated CD147 is increased in the airway epithelium and BAL of patients with COPD, and signaling via CD147 regulates MMP-9 expression in cultured bronchial epithelial cells [132]. CD147 is potentially important in asthma; in a mouse model of allergic asthma, inhalation of a CD147-neutralizing monoclonal antibody reduced ovalbumin (OVA)-induced airway mucin production and airway hyperreactivity, whilst partially inhibiting the recruitment of eosinophils and effector CD4+ T cells into lung tissue [139]. The authors attributed the reduced airways inflammation to an inhibition of the interaction between CD147 on inflammatory cells with cyclophilin chemokines. The reduction in OVA-induced mucous production suggests CD147 inhibition directly affects the epithelium.
MMP activity is dependent upon the close spatial juxtaposition of enzyme and substrate, therefore targeted MMP localization is a further mechanism of regulation. Specific MMP-substrate interactions can be facilitated and regulated at the cell surface via association of MMPs with chaperone molecules. CD44 is strongly upregulated in injured asthmatic airways and at the leading edge of repairing bronchial epithelial cells [43, 140], yet its function during airway epithelial repair is unknown. Studies suggest CD44 may co-ordinate MMP-substrate interactions at the plasma membrane by functioning as a docking molecule. In repairing reproductive epithelium, the v3 isoform of CD44 (CD44v3) forms a signaling complex with MMP-7 which is presented at the cell surface in close proximity to a potential substrate, pro-Heparin-Binding Epidermal-like Growth Factor (pro-HB-EGF). MMP-7 cleaves pro-HB-EGF into an active soluble form which triggers recruitment and activation of the Erb-B4 receptor (a member of the EGFR family) [141]. The EGF pathway is essential for efficient repair of the bronchial epithelium [43], and a similar mechanism of targeted MMP-7 presentation may occur during lung epithelial repair. Carbohydrate modification of proteins is essential for the creation of such micro-environments at the cell surface; in this case the interaction of MMP-7 (an non-glycosylated protease) with CD44 is dependent on the presence of branched glycosylated side-chains on the extracellular portion of the CD44 molecule. It is logical to extrapolate that a deficiency in the post-translational modification of CD44 could lead to a lack of MMP-7 binding, a reduction in HB-EGF activation, and a consequent inhibition of epithelial repair.
3.8. How carbohydrates mediate cell-cell interaction and migration
The glycans attached to matrix molecules such as collagens and proteoglycans are important for the maintenance of tissue structure, porosity, and integrity. Such molecules also contain binding sites for specific types of glycans, which in turn help with the overall organization of the matrix. Glycans are also involved in the proper folding of newly synthesized polypeptides in the endoplasmic recticulum and /or in the subsequent maintenance of protein solubility and conformation [66]. In this manner, altered glycosylation of matrix proteins may change adhesion properties and the potential of cell to migrate. This is due to either an altered conformation of the extracellular matrix of a change in the carbohydrate ligands available to bind.
Glycosylation of growth factor receptors has tremendous effects on the receptor function. Several studies have focused on the role of EGF and its family of receptors on epithelial repair [24, 142]. EGF, a well known mitogen for epithelial cells, has been used in to stimulate epithelial wound healing in guinea pigs as well as human airway cell monolayers and differentiated cells in vitro [43, 143]. EGFR is known to be up-regulated upon the creation of a wound on airway epithelial monolayers in culture and correlated to the damaged areas of epithelium [24]. Increased tyrosine phosphorylation of the EGFR has also been observed after mechanical injury even in the absence of exogenous ligand [24]. While a critical role of signaling mediated by EGFR in repairing damaged epithelium has been well demonstrated in many epithelial systems, an important role for core glycosylation of extracellular domain of EGFR in ligand binding and tyrosine kinase activity has also been documented [105-107]. The extracellular domain of EGFR has 10 to 11 potential site for N-glycosylation. It has been shown that glycosylation is necessary for ligand binding and tyrosine kinase activity of EGFR [144-146]. Carbohydrate moieties of EGFR are critical for the direct interaction of the receptor with other structures [147]. Moreover, glycosylation defines localization of EGFR to specific domain of plasma membrane which could facilitate association of the receptor with other molecules and its transactivation [148]. Modification of receptor N-glycans can also regulate receptor trafficking and duration of cell surface residency [149]. A direct association between changes in glycosylation of EGFR and cellular events involved in epithelial repair such as migration and proliferation remains to be identified. It could be inferred that role of carbohydrates in epithelial repair is partly through their remarkable role in modulation of EGFR and other growth factor receptors.
The specificity of carbohydrate interactions allows for the high degree of selectivity found within the cell. Whether it is in regulating receptor activation, cell-cell or cell-matrix interactions or cell migration, defects in these processes may result in abnormalities and altered phenotypes. Their understanding will provide new avenues for research and therapies.
4. IL-13 structure
Interleukin-13 (IL-13) is a type I cytokine, comprised of four short α-helical hydrophobic bundles joined by two disulfide bonds [111]. The cDNA of IL-13 has a single open reading frame that encodes 132 amino acids, including a 20-amino acid signal sequence that is cleaved from the mature secreted protein [112]. IL-13 has four predicted N-linked glycosylation sites and can either exist as a 17kDa glycoprotein or 10-12kDa unglycosylated protein [113]. IL-13 has been demonstrated to be secreted predominantly as the 10-12kDa unglycosylated protein [113]. In a study conducted by Liang et al., the distribution and expression levels of unglycosylated and glycosylated IL-13 was demonstrated to differ between human bronchial smooth muscle cells (BSMC) and lymphocytes [114]. Intracellularly, BSMC were shown to express higher levels of 12kDa unglycosylated IL-13, while lymphocytes expressed more of the 17kDa glycosylated form. However, lymphocytes secreted significantly higher levels of 12kDa unglycosylated IL-13 compared to BSMC. These findings suggest that cellular distribution of unglycosylated and glycosylated forms of IL-13 is tissue and cell type-dependent and may reflect the role of IL-13 in each cell type. The study also demonstrated that IL-13 secretion is regulated by human sulfatase modifying factor 2 (SUMF2), a protein predominantly found in the endoplasmic reticulum and highly expressed in BSMC [114]. SUMF2 was shown to physically interact with IL-13 and regulate its secretion irrespective of the glycosylation status of IL-13 in BSMC. Lymphocytes were shown to express lower levels of SUMF2 and to secrete higher levels of IL-13 compared to BSMC, further supporting the role of SUMF2 in regulating IL-13 secretion.
The glycosylation state of IL-13 can also affect its activity and potency to induce certain effector functions such as the up-regulation of low affinity IgE receptor, CD23 on the surface of monocytes. A functional study conducted by Vladich et al. [115] demonstrated that eukaryotic COS-7 cell-derived IL-13 was significantly more active in inducing the surface expression of CD23 on peripheral blood mononuclear cells (PBMC) compared to two different commercially available prokaryotic E. Coli-derived IL-13. The difference in bio-activity between the prokaryotic and eukaryotic-derived IL-13 molecules can be attributed to the fact that prokaryotic systems often lack post-translational modification steps such as glycosylation that take place in eukaryotic cells. These findings suggest the importance of glycosylation for IL-13 bio-activity.
4.1. IL-13 function
IL-13 is a pleiotropic cytokine that exerts its effect on a wide variety of cell types. IL-13 has a variety of functions which are critical to immune homeostasis and repair, but when uncontrolled contribute to the asthma phenotype. IL-13 is predominantly produced by T helper type 2 (Th2) cells [116] and to a lesser extent by mast cells, basophils, and eosinophils [117, 118]. IL-13 is also produced by a variety of non-hematopoietic cells including airway epithelial cells [119] and bronchial smooth muscle cells [114]. As a Th2 cytokine, IL-13 shares numerous overlapping characteristics with IL-4, where both cytokines promote B cell proliferation, IgE class switching and synthesis in B cells, and induce surface expression of antigens such as CD23 and major histocompatibility complex (MHC) class II [120]. These similarities between IL-13 and IL-4 function can be explained by the fact that the cytokines share a common receptor subunit, IL-4 receptor α subunit (IL-4Rα). However unlike IL-4, IL-13 does not exert direct effects on T cells and cannot elicit Th2 differentiation in naïve T cells; IL-13 is instead involved in mediating downstream Th2-effector functions [121]. In monocytes and macrophages, IL-13 can inhibit the production of various pro-inflammatory mediators such as prostaglandins, reactive oxygen species, IL-1, and TNF-α [113, 122]. IL-13 can also enhance the expression of several members of the integrin family that play important roles in adhesion, including CD11b, CD11c, CD18, and CD29 as well as induce surface expression of CD23 and MHC class II in monocytes and macrophages [121]. Furthermore, IL-13 has been reported to have direct effects on eosinophils, including promoting eosinophil survival, activation, and recruitment [123, 124].
IL-13 has important functions on non-hematopoietic cells, including endothelial cells, smooth muscle cells, fibroblasts, and epithelial cells. In endothelial cells IL-13 is a potent inducer of vascular cell adhesion molecule 1 (VCAM-1), which plays a role in eosinophil recruitment [125]. IL-13 has been shown to enhance proliferation and cholinergic-induced contractions of smooth muscle cells in vitro [126, 127]. In epithelial cells, IL-13 is a potent inducer of growth factors [128, 129] and chemokine expression [130]. It also induces epithelial cell proliferation [128], alters mucociliary differentiation [131], resulting in mucin production and goblet cell metaplasia [7, 132, 133].
4.2. IL-13Rα1 structure and function
IL-13 signals via a receptor system that consists of IL-13 receptor α1 (IL-13Rα1)/IL-4 receptor α subunit (IL-4Rα) and IL-13 receptor α2 (IL-13Rα2). Both IL-13Rα1 and IL-13Rα2 belong to the type I cytokine receptor family, which possess several definitive features, including a W-S-X-W-S motif, four conserved cysteine residues, fibronectin type II modules in the extracellular domain and proline-rich box regions in the intracellular domain [134]. The two receptors share 33% homology and 21% identity at the amino acid level [135] and their respective genes have both been mapped to the X chromosome [136]. Kinetic analysis have revealed that IL-13Rα1 and IL-13Rα2 both bind specifically only to IL-13 and not IL-4, while IL-13 alone has no measurable affinity for IL-4Rα [137].
IL-13Rα1 is widely expressed on both hematopoietic and nonhematopoietic cells except human and mouse T cells and mouse B cells [112]. It is a 65-70kDa glycosylated trans-membrane receptor protein with 10 predicted N-glycosylation sites in the extracellular domain [138]. The cDNA for human IL-13Rα1 encodes a 427-amino acid sequence, including a 60-amino acid intracellular domain and 21-amino acid signal sequence [139]. A mutational analysis demonstrated that Leu319 and Tyr321 in the cytokine receptor homology module (CRH) of human IL-13Rα1 are critical residues for binding to IL-13 [135]. Interestingly, these residues are in close proximity to the predicted glycosylation sites of IL-13Rα1, suggesting that the glycosylation state of IL-13Rα1 could potentially influence receptor-ligand interactions.
IL-13Rα1 binds IL-13 with low affinity by itself but binds IL-13 with high affinity when heterodimerized with IL-4Rα to form a functional signalling receptor [138]. This signalling complex is known as the type II IL-4/IL-13 receptor and it also serves as an alternate receptor for IL-4. IL-13 is known to primarily signal through IL-13Rα1/IL-4Rα by first binding to IL-13Rα1 chain with low affinity and then heterodimerizing with IL-4Rα to become a stable, high affinity signalling complex [137]. The formation of IL-13Rα1/IL-4Rα results in the activation of the Jak kinases, Jak1 and Tyk2, followed by the recruitment of the transcription factor, signal transducer and activator of transcription 6 (STAT6) to the receptor. STAT6 is then phosphorylated and forms functional dimers that translocate to the nucleus to bind specific canonic DNA elements and initiate transcription of downstream genes [140]. Some examples of downstream targets of IL-13Rα1 activation include eotaxin [141], MUC5AC [142], and, arginase I which is an enzyme important in the development of airway hyperreactivity [143].
4.3. IL-13Rα2 structure and function
IL-13Rα2 is a 56kDa glycoprotein that is expressed by a variety of cell types including monocytes, airway epithelial cells, fibroblasts, and keratinocytes [144, 145]. The cDNA of human IL-13Rα2 encodes a 380-amino acid protein with a 26-amino acid signal sequence and a 17-amino acid intracellular domain [146]. IL-13Rα2 contains four predicted glycosylation sites [147] and the glycosylation state of IL-13Rα2 has been demonstrated to be important in its interactions with IL-13 [148]. IL-13Rα2 exists in three cellular compartments: on the cell surface as a single trans-membrane receptor, in the cytosol within large intracellular pools, and in the extracellular space as a soluble form [149]. In fibroblasts and airway epithelial cells, IL-13Rα2 has been demonstrated to be predominantly localized to intracellular pools that can be rapidly mobilized to the membrane upon stimulation by IL-13 and IL-4 [150].
IL-13Rα2 has been considered for a long time as a decoy receptor which does not directly contribute to IL-13 signaling, but serves as a negative regulator to terminate IL-13 responses by directly binding to IL-13. The notion that this receptor had no signaling function arose from the fact that it has a short cytoplasmic tail that is missing two known signalling motifs [151] and does not bind JAKs or STATs [152]. IL-13Rα2 has also been shown to be internalized quickly upon IL-13 binding [152]. Unlike IL-13Rα1, IL-13Rα2 alone has very high affinity for IL-13 [146] and this is further increased when IL-13Rα2 exists as a soluble form [153]. N-linked glycosylation in the extracellular domain of IL-13Rα2 has shown to be necessary for optimal IL-13 binding, demonstrating the importance of glycosylation in IL-13 signalling [148].
Recent investigations have suggested that IL-13Rα2 acts as a signaling receptor not merely as a decoy receptor. Dienger et al. showed that IL-13Rα2 knockout mice have attenuated rather than enhanced allergic airway responses, suggesting that under some circumstances, IL-13Rα2 may contribute to IL-13 signaling [118] and reduce inflammation. Further evidence of anti-inflammatory properties comes from models of allergic asthma and chronic helminth infection where IL-10 and IL-13Rα2 coordinately suppress Th2-mediated inflammation and pathology [154]. Fichtner-Feigl et al. has demonstrated that IL-13 signals through the IL-13Rα2 to mediate TGF-β production via the transcription factor, AP-1 in macrophages. [129]. These studies provide evidence that IL-13Rα2 can serve as a functional signalling receptor but the role of glycosylation in regulating its signalling function has yet to be elucidated.
4.4. IL-13 genetic and clinical linkage to asthma
The gene encoding IL-13 consists of four exons and three introns and is located on chromosome 5q31 [155]. The chromosomal region 5q31 also contains genes for other molecules associated with asthma such as IL-4, IL-3, IL-9 and GM-CSF [156]. Previous studies have demonstrated strong associations between asthma and several single nucleotide polymorphisms (SNP) in the IL-13 gene, including +2043G>A and -1111C>T [156, 157]. +2043G>A is within the IL-13 coding sequence and causes a positively charged arginine (R) to be substituted by a neutral glutamine (Q) at position 130, forming the IL-13 R130Q variant [158]. Position 130 is in the α-D segment of the IL-13 molecule, where it has been demonstrated to interact with IL-13Rα1 [159]. Compared to wildtype IL-13, the R130Q variant has previously been reported to have lower affinity for soluble IL-13Rα2 due to slower association rates with the receptor [176]. IL-13R130Q is also more active compared to wildtype IL-13 in inducing STAT-6 activation and CD23 expression in monocytes [115]. The enhanced activity of IL-13R130Q may be explained by its decreased affinity to IL-13Rα2.
4.5. Roles of IL-13 in airway epithelial repair
IL-13 has been demonstrated to be critical in mediating normal airway epithelial wound repair. In an in vitro model, Allahverdian et al. demonstrated that normal bronchial epithelial cells produce and secrete IL-13 in response to mechanical injury. IL-13 then mediates repair by inducing the production and autocrine/ paracrine release of HB-EGF, which subsequently activates EGFR and downstream signalling pathways required for repair [119]. In another in vitro study, thymic stromal lymphopoietin (TSLP) was shown to promote bronchial epithelial proliferation and repair via the upregulation of IL-13 production, providing further evidence for the critical role of IL-13 in repair [160]. IL-13 also plays a role in promoting normal airway epithelial health. Treatment of normal bronchial epithelial cells with IL-13 and IL-9 alone and in combination was shown to significantly reduce spontaneous cell apoptosis and to be protective against dexamethasone-induced cell apoptosis [161].
5. The use of biomarkers in asthma diagnosis and therapeutic intervention
Asthma is increasingly recognised as a heterogeneous syndrome with multiple patient phenotypes reflecting the varied underlying pathologies present in each individual. Pulmonary function testing has severe limitations; spirometry can identify a broad spectrum of asthmatics, but it is incapable of discerning sub-types of disease and therefore which individuals will respond to specific treatment regimes. Tissue biopsies and inflammatory cell counting in induced sputum, are accepted measures of determining airway inflammation, however both techniques are invasive, expensive and difficult to standardize, making them unsuitable for routine clinical use. Biomarkers hold the promise of being able to rapidly and specifically diagnose and monitor various sub-types of asthma in a non-invasive manner. The advantages and disadvantages of current and potential future biomarkers of airway inflammation for the diagnosis and monitoring of asthma in the clinic are reviewed in [162].
5.1. “Invasive” airway biomarkers
Tissue biopsies: To date the most accurate method to assess lung inflammation (and remodeling) is by histological examination of lung tissue. Sub-types of inflammatory cells can be identified in tissue sections using specific stains. Unfortunately the process of taking bronchial biopsies via bronchoscopy is invasive and requires experienced, skilled pathologists for tissue examination. In addition, clinical studies demonstrate a disconnect between the numbers of inflammatory cells counted in airway biopsies, and lung function in asthmatics [27].
Induced sputum: One alternative method of directly assessing airway inflammation is by sputum induction. A patient inhales nebulized hypertonic saline to trigger sputum production in the airways. The sputum is then coughed out along with any inflammatory cells present in the airway lumen. The main assumption is that the inflammatory infiltrate in the airway lumen reflects that in the tissue. Cytospins of the resulting sputum samples are then stained using similar techniques to tissue biopsies to examine the specific type of cellular infiltrate in the sputum. The principal output is the differential inflammatory cell count, expressed as a percentage, based on the manual counting of cells (eosinophils, neutrophils, lymphocytes, macrophages, and epithelial cells). The protein content of induced sputum may also have some value in diagnosing asthma. High mobility group box-1 (HMGB-1), a ligand of the receptor for advanced glycation end products (RAGE), is a mediator in many inflammatory disorders. HMGB-1 is increased in the sputum of asthmatic patients, along with endogenous secretory RAGE, a soluble receptor that inhibits RAGE signalling [163]. Sputum induction is considerably less invasive than a tissue biopsy, but this technique is nonetheless uncomfortable for the patient. As many children are unwilling to undergo sputum collection in follow-up visits this technique tends to be limited to patients aged 8 years and above (although sputum induction has been performed successfully on younger children)[164]. Although the techniques of sputum induction and processing are well validated, they are time-consuming, require skilled people, and results are often difficult to reproduce and vary across centers.
5.2. Exhaled biomarkers
Less invasive means of obtaining airway biomarkers are desirable, particularly as diagnostic or disease monitoring tools in pediatric patients. The composition of exhaled breath is correlated to various disease states. This has been exploited by cancer researchers who have pioneered the use of gas sensor arrays, or “electronic noses”, to aid the diagnosis of lung cancer [165]. As asthma is also a disease of the airways, it follows that the composition of exhaled breath will also be altered in the disease. The advent of so-called “breathomics” promises to revolutionize the way clinicians diagnose and treat asthmatics.
Fractional exhaled nitric oxide (FeNO): To date FeNO is the most widely used exhaled biomarker of airway inflammation in asthma. Levels of NO in exhaled breath can be measured relatively quickly in the clinic although the gas analyzers required are expensive [164]. FeNO is often increased in steroid naïve asthmatics and severe asthmatics, and is correlated with airway eosinophilia [166, 167]. FeNO is derived from the action of inducible NO synthase (iNOS) expressed by the airway epithelium [168] however the precise mechanism of how eosinophilia triggers iNOS activity in epithelial cells is undefined. It is unlikely that FeNO measurements per se would give any indication of the carbohydrate modifications of proteins in a patient, therefore this method will not be discussed further herein. For a more in-depth discussion of FeNO as a biomarker in asthma readers are referred to a recent review by Wadsworth et al. [162].
Exhaled Breath Condensate: The collection of exhaled breath condensate (EBC) and subsequent measure of inflammatory biomarkers is a relatively recent development. Exhaled breath condenses when it comes into contact with a cooled collector, allowing the collection of respiratory particles, droplets and water vapour. The pH of the EBC has been shown to relate to airway inflammation, low EBC pH indicates poorly controlled eosinophilic asthma in a similar manner to high FeNO [169]. It is unlikely that a single biomarker will be able to reflect the various pathologies which are present in a heterogeneous disease such as asthma. Therefore additional markers of airway inflammation will be needed to provide information complementary to that gained from FeNO or pH measurements. Many proteins are present in EBC and this method has been postulated as a means to allow the objective proteomic analysis of exhaled breath. As with pH, several of these proteins are markers of oxidative stress including, cysteinyl leukotrienes, leukotriene B4, 8-isoprostane and hydrogen peroxide, although inflammatory proteins such as IL-6, IL-8, TNF-α may also be useful markers [170] (reviewed in [164]). Other proteins which do not obviously fit into any inflammatory pathway including; actin, cytokeratins, albumin, and hemoglobin have also been shown to be increased in the EBC of asthmatic patients [171].
5.3. Non-exhaled biomarkers
Serum proteins: As described above, biomarker studies in asthma have tended to concentrate on changes to the composition of exhaled breath. Although primarily a disease of the airways, there is mounting evidence to suggest there is also a systemic component to asthma [172]. If this is the case then circulating metabolites may be able to act as biomarkers of disease. Blood collection, serum isolation and analysis are highly standardized techniques of a minimally invasive nature and are therefore an ideal source of reproducible data. Serum proteins are already gaining credence as biomarkers in other inflammatory lung diseases. In COPD for example, not all smokers develop the disease, so being able to identify those who are at risk would be useful. Studies have shown circulating levels of pulmonary and activation-regulated chemokine (PARC)/CCL-18 are increased in COPD patients [173] and COPD patients who exhibit a rapid fall in FEV1 tend to have high circulating levels of fibrinogen [174]. Even accepted markers of cardiac dysfunction, cardiac troponin-T and N-terminal pro-brain natriuretic peptide (NT-proBNP) have been associated with increased mortality in patients with COPD, suggesting a cardiac component to the disease [175]. Several serum biomarkers have been demonstrated to be associated with asthma, including eosinophil cationic protein (ECP). ECP levels increase in response to allergen challenge, and decrease after allergen avoidance or inhaled corticosteroids (ICS) therapy, albeit in a less responsive manner than sputum eosinophils or FeNO (reviewed in [164]). In the clinic however, serum ECP levels do not reflect treatment-induced functional changes in chronic asthmatics, and serum ECP is unable to predict steroid responsiveness (reviewed in [164]). One randomized trial demonstrated that patients whose asthma management was based on serum ECP levels, experienced no improvement in symptoms compared to those treated using traditional monitoring techniques [176]. In addition, raised serum ECP levels may not be a specific marker of asthma; studies in pediatric patients have demonstrated serum ECP is also raised in cystic fibrosis and viral bronchiolitis [177]. Studies using purified ECP demonstrate it undergoes N-linked glycosylation and its cytotoxic activity against a cultured human small cell lung cancer cell line is dependent on both gene polymorphisms and glycosylation state [178]. Thus, rather than measuring total ECP, it is likely that analysing the proportion of total ECP which is glycosylated would prove to be a more specific biomarker for monitoring asthma progression. Other novel biomarkers are also altered in the circulation of patients with asthma. CCL-17 is a chemokine released from dendritic cells and epithelial cells after allergen contact, and is involved in the recruitment of Th2 cells into the lungs. Studies have shown sputum levels of CCL-17 is increased in the lungs of asthmatic adults,[179] whilst serum levels of CCL-17 is increased in children with asthma and is lowered in steroid-treated children with asthma [180]. In asthma, structural cells of the airway including the epithelium, release various pro-inflammatory chemokines such as IL-6 and IL-8 which trigger subsequent infiltration by immune cells. The epithelium also releases proteinases which are capable and necessary for the cleavage and activation of chemokinetic activity of molecules such as Fas-ligand and IL-25 [10] [127]. It is possible circulating levels of these chemokines and proteinases may provide an early warning for an imminent asthma exacerbation, or even indicate the particular sub-type of inflammation occurring in the patient.
Urinary metabolites: Data mentioned above suggests that the metabolism of patients with asthma is altered compared to normals. Urine is possibly the least invasive biofluid for biomarker measurements and is therefore highly suitable for the study and assessment of asthma in young children. Clinical studies have shown urinary biomarkers are potentially useful in asthma; levels of the downstream histamine metabolite, N-methylhistamine, is increased in the urine of patients with asthma, is increased after allergen challenge or exacerbation, and is reduced in asthmatic children taking anti-allergy medication [183, 184]. The human histamine receptor (hH1R) is a G-protein-coupled receptor, GPCRs are a large family of transmembrane receptors that are dependent on glycosylation for correct expression, trafficking and signaling. Studies using hH1R-expressing insect cells have shown that the receptor is N-glycosylated at a specific asparagene residue, Asn5 [185], whether glycosylation affects receptor activity, and how hH1R glycosylation could be measured in patients is unknown.
One recent study used nuclear magnetic resonance spectroscopy (1H-NMR) to measure levels of 70 metabolites in the urine of children with and without asthma. NMR is an attractive method for urinary biomarker examination as it is able to provide qualitative and quantitative data on multiple compounds in a complex biofluid, without requiring significant pre-treatment of the sample. Urine was collected from control children without asthma (C), with stable asthma in the outpatient department (AO), and in children with unstable disease hospitalized for an asthma exacerbation (AED). NMR examination of urinary metabolites showed a 94% success rate in identifying AO children versus C, and a similar success rate was seen when diagnosing AED versus AO asthma [186]. This study suggests the measurement of urinary metabolites is a potentially valuable technique to help clinicians diagnose and monitor asthma in children.
6. Closing remarks
In addition to forming a barrier against inhaled toxins, pathogens and allergens, the airway epithelium performs numerous innate immune and transport functions necessary for airway health and homeostasis. Damage to the epithelial layer is a common occurrence, thus complex repair mechanisms have evolved to rapidly restore the epithelial barrier, with subsequent regeneration of the fully functional differentiated tissue. In asthmatic airways, these epithelial repair mechanisms are compromised.
The post-translational modification of proteins by glycosylation is capable of drastically affecting function via changes to; sub-cellular localisation and secretion, enzyme substrate binding, receptor-ligand binding, protein stability and degradation amongst others. Many of the proteins involved in the complex repair mechanisms defined in the airway epithelium are dependent on correct glycosylation in order to function correctly. There is accumulating evidence to suggest glycosylation is altered in airway diseases such as asthma. In addition, an important cytokine in asthma, IL-13, has a significant effect on the glycosylation state of the epithelial lining of the airway, and IL-13 signalling itself is affected by glycosylation of its receptors. Thus altered glycosylation of the airway epithelium, will have significant effects on the repair and regeneration of a functional airway epithelial barrier.
Asthma is a complex syndrome, individuals with asthma can be classified into a number of sub-phenotypes who will respond to different types of therapies. In order to facilitate the accurate diagnosis of asthmatics the development of specific bio-markers is required. Considerable research is being conducted into the use of non-invasive exhaled, urinary, or blood-borne markers of asthmatic disease to aid diagnosis in adults and children. To date the majority of biomarker research has concentrated on the identification of proteins linked to disease, rather than identifying differences in post-translational modifications. As glycosylation plays a fundamental role in regulating protein function, it is highly likely that future biomarkers for asthma will need focus on identifying alterations to the carbohydrate structures of proteins, particularly those involved in airway epithelial repair.
\n',keywords:null,chapterPDFUrl:"https://cdn.intechopen.com/pdfs/41123.pdf",chapterXML:"https://mts.intechopen.com/source/xml/41123.xml",downloadPdfUrl:"/chapter/pdf-download/41123",previewPdfUrl:"/chapter/pdf-preview/41123",totalDownloads:3578,totalViews:634,totalCrossrefCites:0,totalDimensionsCites:3,hasAltmetrics:0,dateSubmitted:"December 14th 2011",dateReviewed:"July 30th 2012",datePrePublished:null,datePublished:"November 21st 2012",dateFinished:null,readingETA:"0",abstract:null,reviewType:"peer-reviewed",bibtexUrl:"/chapter/bibtex/41123",risUrl:"/chapter/ris/41123",book:{slug:"carbohydrates-comprehensive-studies-on-glycobiology-and-glycotechnology"},signatures:"Samuel J. Wadsworth, S. Jasemine Yang and Delbert R. Dorscheid",authors:[{id:"141889",title:"Dr.",name:"Del",middleName:null,surname:"Dorscheid",fullName:"Del Dorscheid",slug:"del-dorscheid",email:"del.dorscheid@hli.ubc.ca",position:null,institution:null},{id:"153539",title:"Dr.",name:"Samuel",middleName:null,surname:"Wadsworth",fullName:"Samuel Wadsworth",slug:"samuel-wadsworth",email:"Samuel.Wadsworth@hli.ubc.ca",position:null,institution:null},{id:"154075",title:"Dr.",name:"Jasemine",middleName:null,surname:"Yang",fullName:"Jasemine Yang",slug:"jasemine-yang",email:"Jasemine.Yang@hli.ubc.ca",position:null,institution:null}],sections:[{id:"sec_1",title:"1. Introduction",level:"1"},{id:"sec_1_2",title:"1.1. Clinical assessment of asthma",level:"2"},{id:"sec_2_2",title:"1.2. The causes of asthma",level:"2"},{id:"sec_3_2",title:"1.3. Inflammation in asthma",level:"2"},{id:"sec_4_2",title:"1.4. IL-13 and asthma ",level:"2"},{id:"sec_5_2",title:"1.5. Current treatments for asthma",level:"2"},{id:"sec_6_2",title:"1.6. Carbohydrates and asthma",level:"2"},{id:"sec_8",title:"2. Normal airway structure",level:"1"},{id:"sec_8_2",title:"2.1. Structural changes to the airway in asthma",level:"2"},{id:"sec_9_2",title:"2.2. Airway epithelial structure and function",level:"2"},{id:"sec_10_2",title:"2.3. Airway epithelial carbohydrate expression",level:"2"},{id:"sec_11_2",title:"2.4. Airway epithelial functions",level:"2"},{id:"sec_13",title:"3. Epithelial injury and repair",level:"1"},{id:"sec_13_2",title:"3.1. Airway epithelial wound repair is compromised in asthmatics",level:"2"},{id:"sec_14_2",title:"3.2. Mechanisms of cellular migration",level:"2"},{id:"sec_15_2",title:"3.3. The effect of intracellular protein glycosylation on epithelial repair",level:"2"},{id:"sec_16_2",title:"3.4. Role of cell surface glycoconjugates in epithelial repair",level:"2"},{id:"sec_17_2",title:"3.5. Galectins, annexins and epithelial injury – repair",level:"2"},{id:"sec_18_2",title:"3.6. MMPs in asthma, glycosylation and repair",level:"2"},{id:"sec_19_2",title:"3.7. IgCAMs in asthma, repair and the effects of IL-13",level:"2"},{id:"sec_20_2",title:"3.8. How carbohydrates mediate cell-cell interaction and migration",level:"2"},{id:"sec_22",title:"4. IL-13 structure",level:"1"},{id:"sec_22_2",title:"4.1. IL-13 function",level:"2"},{id:"sec_23_2",title:"4.2. IL-13Rα1 structure and function",level:"2"},{id:"sec_24_2",title:"4.3. IL-13Rα2 structure and function",level:"2"},{id:"sec_25_2",title:"4.4. IL-13 genetic and clinical linkage to asthma",level:"2"},{id:"sec_26_2",title:"4.5. Roles of IL-13 in airway epithelial repair",level:"2"},{id:"sec_28",title:"5. The use of biomarkers in asthma diagnosis and therapeutic intervention",level:"1"},{id:"sec_28_2",title:"5.1. “Invasive” airway biomarkers",level:"2"},{id:"sec_29_2",title:"5.2. Exhaled biomarkers",level:"2"},{id:"sec_30_2",title:"5.3. Non-exhaled biomarkers",level:"2"},{id:"sec_32",title:"6. Closing remarks",level:"1"}],chapterReferences:[{id:"B1",body:'WenzelS. EAsthma: defining of the persistent adult phenotypesLancet, 2006804813'},{id:"B2",body:'AdcockI. Mand KItoSteroid resistance in asthma: a major problem requiring novel solutions or a non-issue? Curr Opin Pharmacol, 2004257262'},{id:"B3",body:'DjukanovicRet alQuantitation of mast cells and eosinophils in the bronchial mucosa of symptomatic atopic asthmatics and healthy control subjects using immunohistochemistry.Am Rev Respir Dis, 1990863871'},{id:"B4",body:'MontefortSet alThe site of disruption of the bronchial epithelium in asthmatic and non-asthmatic subjects.Thorax1992499503'},{id:"B5",body:'GreenR. Het alAnalysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroidsThorax, 2002875879'},{id:"B6",body:'HuangS. Ket alIL-13 expression at the sites of allergen challenge in patients with asthma.J Immunol, 199526882694'},{id:"B7",body:'Wills-karpMet alInterleukin-13: central mediator of allergic asthma.Science, 199822582261'},{id:"B8",body:'CohnLet alTh2-induced airway mucus production is dependent on IL-4Ralpha, but not on eosinophils.J Immunol, 199961786183'},{id:"B9",body:'BegheBet alPolymorphisms in IL13 pathway genes in asthma and chronic obstructive pulmonary diseaseAllergy, 2010474481'},{id:"B10",body:'WadsworthS. Jet alIL-13 and TH2 cytokine exposure triggers matrix metalloproteinase 7-mediated Fas ligand cleavage from bronchial epithelial cells. J AllergyClin Immunol, 2010366374e1-8.'},{id:"B11",body:'DanahayHet alInterleukin-13 induces a hypersecretory ion transport phenotype in human bronchial epithelial cellsAm J Physiol Lung Cell Mol Physiol, 2002L226L236'},{id:"B12",body:'AthertonH. CGJonesand HDanahayIL-13-induced changes in the goblet cell density of human bronchial epithelial cell cultures: MAP kinase and phosphatidylinositol 3-kinase regulation.Am J Physiol Lung Cell Mol Physiol, 2003L730L739'},{id:"B13",body:'WhittakerLet alInterleukin-13 mediates a fundamental pathway for airway epithelial mucus induced by CD4 T cells and interleukin-9.Am J Respir Cell Mol Biol, 2002593602'},{id:"B14",body:'BeumP. Vet alMucin biosynthesis: upregulation of core 2 beta 1,6 N-acetylglucosaminyltransferase by retinoic acid and Th2 cytokines in a human airway epithelial cell line.Am J Physiol Lung Cell Mol Physiol, 2005L116L124'},{id:"B15",body:'BarnesP. JThe role of inflammation and anti-inflammatory medication in asthma.Respir Med, 2002Suppl A: S915'},{id:"B16",body:'BarnesP. JUpdate on asthma. Isr Med Assoc J, 20036872'},{id:"B17",body:'KraftMAsthma phenotypes and interleukin-13--moving closer to personalized medicine.N Engl J Med, 201111411144'},{id:"B18",body:'Flood-pagePet alA study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma.Am J Respir Crit Care Med, 200710621071'},{id:"B19",body:'OByrneP.M., The demise of anti IL-5 for asthma, or not.Am J Respir Crit Care Med, 200710591060'},{id:"B20",body:'CorrenJet alLebrikizumab treatment in adults with asthmaN Engl J Med, 201110881098'},{id:"B21",body:'InnesA. Let alThe H antigen at epithelial surfaces is associated with susceptibility to asthma exacerbationAm J Respir Crit Care Med, 2011189194'},{id:"B22",body:'LaitinenAet alTenascin is increased in airway basement membrane of asthmatics and decreased by an inhaled steroid.Am J Respir Crit Care Med, 1997Pt 1): 951958'},{id:"B23",body:'HirstS. JAirway smooth muscle as a target in asthmaClin Exp Allergy, 2000Suppl 1: 5459'},{id:"B24",body:'HolgateS. Tet alEpithelial-mesenchymal interactions in the pathogenesis of asthma.J Allergy Clin Immunol, 2000Pt 1): 193204'},{id:"B25",body:'HackettT. Land D. AKnightThe role of epithelial injury and repair in the origins of asthma.Curr Opin Allergy Clin Immunol, 20076368'},{id:"B26",body:'MalmstromKet alLung function, airway remodelling and inflammation in symptomatic infants: outcome at 3 yearsThorax2011157162'},{id:"B27",body:'SontJ. Ket alRelationship between the inflammatory infiltrate in bronchial biopsy specimens and clinical severity of asthma in patients treated with inhaled steroids.Thorax, 1996496502'},{id:"B28",body:'JefferyP. KRemodeling in asthma and chronic obstructive lung disease.Am J Respir Crit Care Med, 2001Pt 2): S28S38'},{id:"B29",body:'KnightD. Aand S. THolgateThe airway epithelium: structural and functional properties in health and disease. Respirology2003432446'},{id:"B30",body:'RocheW. Ret alCell adhesion molecules and the bronchial epithelium.Am Rev Respir Dis, 1993Pt 2): S79S82'},{id:"B31",body:'EvansM. Jet alCellular and molecular characteristics of basal cells in airway epitheliumExp Lung Res, 2001401415'},{id:"B32",body:'RhodinJ. AThe ciliated cell. Ultrastructure and function of the human tracheal mucosa.Am Rev Respir Dis, 1966p. Suppl:115'},{id:"B33",body:'PhilippouSet alThe morphological substrate of autonomic regulation of the bronchial epithelium.Virchows Arch A Pathol Anat Histopathol, 1993469476'},{id:"B34",body:'NettesheimPJ. SKooand TGrayRegulation of differentiation of the tracheobronchial epitheliumJ Aerosol Med, 2000207218'},{id:"B35",body:'KeenanK. PJ. WCombsand E. MMcdowellRegeneration of hamster tracheal epithelium after mechanical injuryI. Focal lesions: quantitative morphologic study of cell proliferation. Virchows Arch B Cell Pathol Incl Mol Pathol, 1982193214'},{id:"B36",body:'KeenanK. PJ. WCombsand E. MMcdowellRegeneration of hamster tracheal epithelium after mechanical injuryIII. Large and small lesions: comparative stathmokinetic and single pulse and continuous thymidine labeling autoradiographic studies. Virchows Arch B Cell Pathol Incl Mol Pathol, 1982231252'},{id:"B37",body:'KeenanK. PJ. WCombsand E. MMcdowellRegeneration of hamster tracheal epithelium after mechanical injuryII. Multifocal lesions: stathmokinetic and autoradiographic studies of cell proliferation. Virchows Arch B Cell Pathol Incl Mol Pathol, 1982215229'},{id:"B38",body:'KeenanK. PT. SWilsonand E. MMcdowellRegeneration of hamster tracheal epithelium after mechanical injuryIV. Histochemical, immunocytochemical and ultrastructural studies. Virchows Arch B Cell Pathol Incl Mol Pathol, 1983213240'},{id:"B39",body:'TamAet alThe airway epithelium: more than just a structural barrierTher Adv Respir Dis, 2011255273'},{id:"B40",body:'JohansenF. Eand C. SKaetzelRegulation of the polymeric immunoglobulin receptor and IgA transport: new advances in environmental factors that stimulate pIgR expression and its role in mucosal immunity.Mucosal Immunol, 2011598602'},{id:"B41",body:'WoofJ. Mand M. WRussellStructure and function relationships in IgA.Mucosal Immunol, 2011590597'},{id:"B42",body:'MartinNand I. DPavordBronchial thermoplasty for the treatment of asthmaCurr Allergy Asthma Rep, 20098895'},{id:"B43",body:'WadsworthS. JH. SNijmehand I. PHallGlucocorticoids increase repair potential in a novel in vitro human airway epithelial wounding modelJ Clin Immunol, 2006376387'},{id:"B44",body:'ZhangSet alGrowth factors secreted by bronchial epithelial cells control myofibroblast proliferation: an in vitro co-culture model of airway remodeling in asthma.Lab Invest, 1999395405'},{id:"B45",body:'MorishimaYet alTriggering the induction of myofibroblast and fibrogenesis by airway epithelial shedding.Am J Respir Cell Mol Biol, 2001111'},{id:"B46",body:'DaviesD. EThe bronchial epithelium: translating gene and environment interactions in asthma.Curr Opin Allergy Clin Immunol, 20016771'},{id:"B47",body:'WoodleyDThe Molecular and Cellular Biology of Wound Repair. 2nd ed, ed. R.A.F. Clark1996New York: Plenum Publishing Corp. 339354'},{id:"B48",body:'SeilerW. Oet alImpaired migration of epidermal cells from decubitus ulcers in cell cultures. A cause of protracted wound healing?Am J Clin Pathol, 1989430434'},{id:"B49",body:'HannaCProliferation and migration of epithelial cells during corneal wound repair in the rabbit and the rat.Am J Ophthalmol, 19665563'},{id:"B50",body:'RidleyA. JRho family proteins: coordinating cell responses. Trends Cell Biol, 2001471477'},{id:"B51",body:'RidleyA. JRho GTPases and cell migration. J Cell Sci, 2001Pt 1527132722'},{id:"B52",body:'SchirmerJand KAktoriesLarge clostridial cytotoxins: cellular biology of Rho/Ras-glucosylating toxins.Biochim Biophys Acta, 20046674'},{id:"B53",body:'SanderE. Eand J. GCollardRho-like GTPases: their role in epithelial cell-cell adhesion and invasion.Eur J Cancer, 199913021308'},{id:"B54",body:'RidleyA. Jand AHallThe small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors.Cell1992389399'},{id:"B55",body:'RidleyA. Jet alThe small GTP-binding protein rac regulates growth factor-induced membrane ruffling.Cell1992401410'},{id:"B56",body:'KozmaRet alThe Ras-related protein Cdc42Hs and bradykinin promote formation of peripheral actin microspikes and filopodia in Swiss 3T3 fibroblasts.Mol Cell Biol, 199519421952'},{id:"B57",body:'SpurzemJ. Ret alActivation of protein kinase A accelerates bovine bronchial epithelial cell migration.Am J Physiol Lung Cell Mol Physiol, 2002L1108L1116'},{id:"B58",body:'DesaiL. Pet alRhoA and Rac1 are both required for efficient wound closure of airway epithelial cells.Am J Physiol Lung Cell Mol Physiol, 2004L1134L1144'},{id:"B59",body:'WangY. Pet alIQ domain GTPase-activating protein 1 mediates the process of injury and repair in bronchial epithelial cells.Sheng Li Xue Bao, 2008409418'},{id:"B60",body:'WangYet alIQGAP1 promotes cell proliferation and is involved in a phosphorylation-dependent manner in wound closure of bronchial epithelial cells.Int J Mol Med, 20087987'},{id:"B61",body:'JustIet alGlucosylation of Rho proteins by Clostridium difficile toxin B.Nature1995500503'},{id:"B62",body:'HerrmannCet alFunctional consequences of monoglucosylation of Ha-Ras at effector domain amino acid threonine 35J Biol Chem, 19981613416139'},{id:"B63",body:'SehrPet alGlucosylation and ADP ribosylation of rho proteins: effects on nucleotide binding, GTPase activity, and effector coupling.Biochemistry199852965304'},{id:"B64",body:'GerhardRet alGlucosylation of Rho GTPases by Clostridium difficile toxin A triggers apoptosis in intestinal epithelial cellsJ Med Microbiol, 2008Pt 6): 765770'},{id:"B65",body:'ZanettaJ. Pet alGlycoproteins and lectins in cell adhesion and cell recognition processes.Histochem J, 1992791804'},{id:"B66",body:'LisHand NSharonProtein glycosylation. Structural and functional aspects.Eur J Biochem, 1993127'},{id:"B67",body:'HoeM. Hand R. CHuntLoss of one asparagine-linked oligosaccharide from human transferrin receptors results in specific cleavage and association with the endoplasmic reticulum.J Biol Chem, 199249164923'},{id:"B68",body:'RandsEet alMutational analysis of beta-adrenergic receptor glycosylation.J Biol Chem, 19901075910764'},{id:"B69",body:'FeigeJ. Jand ABairdGlycosylation of the basic fibroblast growth factor receptor. The contribution of carbohydrate to receptor function.J Biol Chem, 19881402314029'},{id:"B70",body:'LeconteIet alN-linked oligosaccharide chains of the insulin receptor beta subunit are essential for transmembrane signaling.J Biol Chem, 19921741517423'},{id:"B71",body:'TsudaEet alThe role of carbohydrate in recombinant human erythropoietin.Eur J Biochem, 1990405411'},{id:"B72",body:'SchnaarR. LGlycosphingolipids in cell surface recognition.Glycobiology1991477485'},{id:"B73",body:'PhillipsM. Let alELAM-1 mediates cell adhesion by recognition of a carbohydrate ligand, sialyl-Lex.Science, 199011301132'},{id:"B74",body:'ChammasRet alFunctional hypotheses for aberrant glycosylation in tumor cellsBraz J Med Biol Res, 1994505507'},{id:"B75",body:'LoweJ. Bet alELAM-1--dependent cell adhesion to vascular endothelium determined by a transfected human fucosyltransferase cDNA.19901990475484'},{id:"B76",body:'MannP. LILopez-colbergand R. OKelleyCell surface oligosaccharide modulation during differentiation. I. Modulation of lectin binding.Mech Ageing Dev, 1987207217'},{id:"B77",body:'LisHand NSharonThe biochemistry of plant lectins (phytohemagglutinins).Annu Rev Biochem, 1973541574'},{id:"B78",body:'GipsonI. Kand R. AAndersonEffect of lectins on migration of the corneal epithelium.Invest Ophthalmol Vis Sci, 1980341349'},{id:"B79",body:'GipsonI. Kand T. CKiorpesEpithelial sheet movement: protein and glycoprotein synthesis.Dev Biol, 1982259262'},{id:"B80",body:'GipsonI. Ket alLectin binding to cell surfaces: comparisons between normal and migrating corneal epithelium.Dev Biol, 1983337345'},{id:"B81",body:'SweattA. JR. MDegiand R. MDavisCorneal wound-associated glycoconjugates analyzed by lectin histochemistryCurr Eye Res, 1999212218'},{id:"B82",body:'DorscheidD. Ret alCharacterization of cell surface lectin-binding patterns of human airway epithelium.Histochem J, 1999145151'},{id:"B83",body:'XiantangLet alGlycosylation profiles of airway epithelium after repair of mechanical injury in guinea pigs.Histochem J, 2000207216'},{id:"B84",body:'PlotkowskiM. Cet alDifferential adhesion of Pseudomonas aeruginosa to human respiratory epithelial cells in primary culture.J Clin Invest, 199120182028'},{id:"B85",body:'DorscheidD. Ret alRole of cell surface glycosylation in mediating repair of human airway epithelial cell monolayersAm J Physiol Lung Cell Mol Physiol, 2001L982L992'},{id:"B86",body:'AllahverdianSB. JPatchelland D. RDorscheidCarbohydrates and epithelial repair- more than just post-translational modification. Current Drug Targets, 2006597606'},{id:"B87",body:'AllahverdianSet alSialyl Lewis X modification of the epidermal growth factor receptor regulates receptor function during airway epithelial wound repairClin Exp Allergy, 2010607618'},{id:"B88",body:'DonaldsonD. Jand J. MMasonInhibition of epidermal cell migration by concanavalin A in skin wounds of the adult newt.J Exp Zool, 19775564'},{id:"B89",body:'PatchellB. Jand D. RDorscheidRepair of the injury to respiratory epithelial cells characteristic of asthma is stimulated by Allomyrina dichotoma agglutinin specific serum glycoproteinsClinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 2006585593'},{id:"B90",body:'Trinkaus-randallVet alCarbohydrate moieties of the basal lamina: their role in attachment and spreading of basal corneal epithelial cells.Cell Tissue Res, 1988315323'},{id:"B91",body:'AdamE. Cet alRole of carbohydrates in repair of human respiratory epithelium using an in vitro modelClin Exp Allergy, 200313981404'},{id:"B92",body:'SatoSand R. CHughesBinding specificity of a baby hamster kidney lectin for H type I and II chains, polylactosamine glycans, and appropriately glycosylated forms of laminin and fibronectin.J Biol Chem, 199269836990'},{id:"B93",body:'WooH. Jet alThe major non-integrin laminin binding protein of macrophages is identical to carbohydrate binding protein 35 (Mac-2).J Biol Chem, 199070977099'},{id:"B94",body:'WarfieldP. Ret alAdhesion of human breast carcinoma to extracellular matrix proteins is modulated by galectin-3.Invasion Metastasis, 1997101112'},{id:"B95",body:'MatarresePet alGalectin-3 overexpression protects from apoptosis by improving cell adhesion properties.Int J Cancer, 2000545554'},{id:"B96",body:'CaoZet alGalectin-7 as a potential mediator of corneal epithelial cell migration.Arch Ophthalmol, 20038286'},{id:"B97",body:'CaoZet alGalectins-3 and-7, but not galectin-1, play a role in re-epithelialization of wounds.J Biol Chem, 20024229942305'},{id:"B98",body:'HughesR. CSecretion of the galectin family of mammalian carbohydrate-binding proteins.Biochim Biophys Acta, 1999172185'},{id:"B99",body:'KojimaKet alAffinity purification and affinity characterization of carbohydrate-binding proteins in bovine kidney.J Chromatogr, 1992323330'},{id:"B100",body:'HajjarK. Aand C. MReynoldsalpha-Fucose-mediated binding and degradation of tissue-type plasminogen activator by HepG2 cells.J Clin Invest, 1994703710'},{id:"B101",body:'KimJand K. AHajjarAnnexinI. Ia plasminogen-plasminogen activator co-receptor. Front Biosci, 2002d341d348'},{id:"B102",body:'LiuJ. Wet alAnnexin II expression is reduced or lost in prostate cancer cells and its re-expression inhibits prostate cancer cell migration.Oncogene200314751485'},{id:"B103",body:'BalchCand J. RDedmanAnnexinsI. Iand V inhibit cell migration. Exp Cell Res, 1997259263'},{id:"B104",body:'MatsudaAet alIdentification and immunohistochemical localization of annexin II in rat cornea.Curr Eye Res, 1999368375'},{id:"B105",body:'RaynorC. Met alAnnexin II enhances cytomegalovirus binding and fusion to phospholipid membranes.Biochemistry199950895095'},{id:"B106",body:'ComptonTR. RNepomucenoand D. MNowlinHuman cytomegalovirus penetrates host cells by pH-independent fusion at the cell surface.Virology1992387395'},{id:"B107",body:'ComptonTD. MNowlinand N. RCooperInitiation of human cytomegalovirus infection requires initial interaction with cell surface heparan sulfateVirology1993834841'},{id:"B108",body:'MalhotraRet alIsolation and characterisation of potential respiratory syncytial virus receptor(s) on epithelial cells. Microbes Infect, 2003123133'},{id:"B109",body:'KotelkinAet alRespiratory syncytial virus infection sensitizes cells to apoptosis mediated by tumor necrosis factor-related apoptosis-inducing ligand.J Virol, 200391569172'},{id:"B110",body:'ChakrabortiSet alRegulation of matrix metalloproteinases: an overview.Mol Cell Biochem, 2003269285'},{id:"B111",body:'Van LintPand CLibertChemokine and cytokine processing by matrix metalloproteinases and its effect on leukocyte migration and inflammationJ Leukoc Biol, 200713751381'},{id:"B112",body:'GuedersM. Met alMatrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: potential implications in asthma and other lung diseasesEur J Pharmacol, 2006133144'},{id:"B113",body:'GreenleeK. JZWerband FKheradmandMatrix metalloproteinases in lung: multiple, multifarious, and multifaceted.Physiol Rev, 20076998'},{id:"B114",body:'TrifilieffAet alPharmacological profile of PKF242-484 and PKF241-466, novel dual inhibitors of TNF-alpha converting enzyme and matrix metalloproteinases, in models of airway inflammation.Br J Pharmacol, 200216551664'},{id:"B115",body:'LeeK. Set alDoxycycline reduces airway inflammation and hyperresponsiveness in a murine model of toluene diisocyanate-induced asthma.J Allergy Clin Immunol, 2004902909'},{id:"B116",body:'KumagaiKet alInhibition of matrix metalloproteinases prevents allergen-induced airway inflammation in a murine model of asthma.J Immunol, 199942124219'},{id:"B117",body:'DemedtsI. Ket alMatrix metalloproteinases in asthma and COPDCurr Opin Pharmacol, 2005257263'},{id:"B118",body:'RussellR. Eet alAlveolar macrophage-mediated elastolysis: roles of matrix metalloproteinases, cysteine, and serine proteases.Am J Physiol Lung Cell Mol Physiol, 2002L867L873'},{id:"B119",body:'BrackeKet alMatrix metalloproteinase-12 and cathepsin D expression in pulmonary macrophages and dendritic cells of cigarette smoke-exposed miceInt Arch Allergy Immunol, 2005169179'},{id:"B120",body:'MillerT. Let alExpression of matrix metalloproteinases 2, 7 and 9, and their tissue inhibitors 1 and 2, in developing rabbit tracheaeBiol Neonate, 2006236243'},{id:"B121",body:'PrikkKet alIn vivo collagenase-2 (MMP-8) expression by human bronchial epithelial cells and monocytes/macrophages in bronchiectasis.J Pathol, 2001232238'},{id:"B122",body:'Lopez-boadoY. SC. LWilsonand W. CParksRegulation of matrilysin expression in airway epithelial cells by Pseudomonas aeruginosa flagellin.J Biol Chem, 20014141741423'},{id:"B123",body:'PuchelleEet al[Regeneration of injured airway epithelium]Ann Pharm Fr, 2006107113'},{id:"B124",body:'ParksW. CY. SLopez-boadoand C. LWilsonMatrilysin in epithelial repair and defense.Chest2001Suppl): 36S41S'},{id:"B125",body:'CorauxCet alDifferential expression of matrix metalloproteinases and interleukin-8 during regeneration of human airway epithelium in vivo.J Pathol, 2005160169'},{id:"B126",body:'AdiseshaiahPet alA Fra-1-dependent, matrix metalloproteinase driven EGFR activation promotes human lung epithelial cell motility and invasionJ Cell Physiol, 2008405412'},{id:"B127",body:'GoswamiSet alDivergent functions for airway epithelial matrix metalloproteinase 7 and retinoic acid in experimental asthmaNat Immunol, 2009496503'},{id:"B128",body:'NabeshimaKet alEmmprin (basigin/CD147): matrix metalloproteinase modulator and multifunctional cell recognition molecule that plays a critical role in cancer progression. Pathol Int, 2006359367'},{id:"B129",body:'KadomatsuKand TMuramatsuRole of basigin, a glycoprotein belonging to the immunoglobulin superfamily, in the nervous system]. Tanpakushitsu Kakusan Koso, 2004Suppl): 24172424'},{id:"B130",body:'VignolaA. Met alHLA-DR and ICAM-1 expression on bronchial epithelial cells in asthma and chronic bronchitis.Am Rev Respir Dis, 1993689694'},{id:"B131",body:'LackieP. Met alExpression of CD44 isoforms is increased in the airway epithelium of asthmatic subjects.Am J Respir Cell Mol Biol, 19971422'},{id:"B132",body:'JouneauSet alEMMPRIN (CD147) regulation of MMP-9 in bronchial epithelial cells in COPD.Respirology, 2011705712'},{id:"B133",body:'CaudroySet alExpression of the extracellular matrix metalloproteinase inducer (EMMPRIN) and the matrix metalloproteinase-2 in bronchopulmonary and breast lesions.J Histochem Cytochem, 199915751580'},{id:"B134",body:'CaudroySet alEMMPRIN-mediated MMP regulation in tumor and endothelial cells.Clin Exp Metastasis, 2002697702'},{id:"B135",body:'HuetEet alRole of emmprin/CD147 in tissue remodelingConnect Tissue Res, 2008175179'},{id:"B136",body:'BetsuyakuTet alIncreased basigin in bleomycin-induced lung injury.Am J Respir Cell Mol Biol, 2003600606'},{id:"B137",body:'GuillotSet alIncreased extracellular matrix metalloproteinase inducer (EMMPRIN) expression in pulmonary fibrosis.Exp Lung Res, 20068197'},{id:"B138",body:'OdajimaNet alExtracellular matrix metalloproteinase inducer in interstitial pneumonias.Hum Pathol, 200610581065'},{id:"B139",body:'GwinnW. Met alNovel approach to inhibit asthma-mediated lung inflammation using anti-CD147 intervention.J Immunol, 200648704879'},{id:"B140",body:'LeirS. Het alIncreased CD44 expression in human bronchial epithelial repair after damage or plating at low cell densitiesAm J Physiol Lung Cell Mol Physiol, 2000L1129L1137'},{id:"B141",body:'YuW. Het alCD44 anchors the assembly of matrilysin/MMP-7 with heparin-binding epidermal growth factor precursor and ErbB4 and regulates female reproductive organ remodeling.Genes Dev, 2002307323'},{id:"B142",body:'PolosaRet alExpression of c-erbB receptors and ligands in the bronchial epithelium of asthmatic subjectsJ Allergy Clin Immunol, 20027581'},{id:"B143",body:'WhiteS. Ret alRole of very late adhesion integrins in mediating repair of human airway epithelial cell monolayers after mechanical injury.Am J Respir Cell Mol Biol, 1999787796'},{id:"B144",body:'BishayeeSRole of conformational alteration in the epidermal growth factor receptor (EGFR) function.Biochem Pharmacol, 200012171223'},{id:"B145",body:'StroopC. Jet alCharacterization of the carbohydrate chains of the secreted form of the human epidermal growth factor receptorGlycobiology, 2000901917'},{id:"B146",body:'SoderquistA. MGTodderudand GCarpenterThe role of carbohydrate as a post-translational modification of the receptor for epidermal growth factor.Adv Exp Med Biol, 1988569582'},{id:"B147",body:'WangX. Qet alEpidermal growth factor receptor glycosylation is required for ganglioside GM3 binding and GM3-mediated suppression [correction of suppresion] of activation.Glycobiology2001515522'},{id:"B148",body:'KonishiAand B. CBerkEpidermal growth factor receptor transactivation is regulated by glucose in vascular smooth muscle cells.J Biol Chem, 20033504935056Epub 2003 Jun 26.'},{id:"B149",body:'PartridgeE. Aet alRegulation of cytokine receptors by Golgi N-glycan processing and endocytosis.Science, 2004120124'},{id:"B150",body:'EisenmesserE. Zet alSolution structure of interleukin-13 and insights into receptor engagementJournal of Molecular Biology2001231241'},{id:"B151",body:'HersheyG. K. KI. LReceptorsand signaling pathways: An evolving web. Journal of Allergy and Clinical Immunology, 2003677690'},{id:"B152",body:'MintyAet alInterleukin-13 is a new human lymphokine regulating inflammatory and immune responses.Nature1993248250'},{id:"B153",body:'LiangHet alSUMF2 interacts with interleukin-13 and inhibits interleukin-13 secretion in bronchial smooth muscle cellsJournal of cellular biochemistry200910761083'},{id:"B154",body:'VladichF. Det alIL-13 R130Q, a common variant associated with allergy and asthma, enhances effector mechanisms essential for human allergic inflammationThe Journal of clinical investigation, 2005747754'},{id:"B155",body:'MckenzieA. Net alInterleukin 13, a T-cell-derived cytokine that regulates human monocyte and B-cell functionProceedings of the National Academy of Sciences of the United States of America199337353739'},{id:"B156",body:'Schmid-grendelmeierPet alEosinophils express functional IL-13 in eosinophilic inflammatory diseases.Journal of immunology (BaltimoreMd.: 1950), 200210211027'},{id:"B157",body:'Wills-karpMInterleukin-13 in asthma pathogenesisImmunological reviews, 2004Journal Article): 175190'},{id:"B158",body:'AllahverdianSet alSecretion of IL-13 by airway epithelial cells enhances epithelial repair via HB-EGFAm J Respir Cell Mol Biol, 2008153160'},{id:"B159",body:'ZurawskiGand J. EDe VriesInterleukin 13 elicits a subset of the activities of its close relative interleukin 4.Stem cells (DaytonOhio), 1994169174'},{id:"B160",body:'ZurawskiGand J. EDe VriesInterleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells.Immunology today19941926'},{id:"B161",body:'HartP. Het alPotential antiinflammatory effects of interleukin 4: suppression of human monocyte tumor necrosis factor alpha, interleukin 1, and prostaglandin E2.Proceedings of the National Academy of Sciences of the United States of America, 198938033807'},{id:"B162",body:'PopeS. Met alIL-13 induces eosinophil recruitment into the lung by an IL-5- and eotaxin-dependent mechanismThe Journal of allergy and clinical immunology2001594601'},{id:"B163",body:'LuttmannWet alActivation of human eosinophils by IL-13. Induction of CD69 surface antigen, its relationship to messenger RNA expression, and promotion of cellular viability.Journal of immunology (BaltimoreMd.: 1950), 199616781683'},{id:"B164",body:'BochnerB. Set alIL-13 selectively induces vascular cell adhesion molecule-1 expression in human endothelial cells.Journal of immunology (BaltimoreMd.: 1950), 1995799803'},{id:"B165",body:'GrunsteinM. Met alIL-13-dependent autocrine signaling mediates altered responsiveness of IgE-sensitized airway smooth muscle.American journal of physiologyLung cellular and molecular physiology, 2002L520L528'},{id:"B166",body:'AkihoHet alRole of IL-4, IL-13, and STAT6 in inflammation-induced hypercontractility of murine smooth muscle cells.American journal of physiologyGastrointestinal and liver physiology, 2002G226G232'},{id:"B167",body:'BoothB. Wet alInterleukin-13 induces proliferation of human airway epithelial cells in vitro via a mechanism mediated by transforming growth factor-alpha.American journal of respiratory cell and molecular biology2001739743'},{id:"B168",body:'Fichtner-feiglSet alIL-13 signaling through the IL-13alpha2 receptor is involved in induction of TGF-beta1 production and fibrosis.Nature medicine200699106'},{id:"B169",body:'LiLet alEffects of Th2 cytokines on chemokine expression in the lung: IL-13 potently induces eotaxin expression by airway epithelial cells.Journal of immunology (BaltimoreMd.: 1950), 199924772487'},{id:"B170",body:'LaoukiliJet alIL-13 alters mucociliary differentiation and ciliary beating of human respiratory epithelial cells.The Journal of clinical investigation200118171824'},{id:"B171",body:'ZhuZet alPulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin productionThe Journal of clinical investigation, 1999779788'},{id:"B172",body:'ShimJ. Jet alIL-13 induces mucin production by stimulating epidermal growth factor receptors and by activating neutrophils.American journal of physiologyLung cellular and molecular physiology, 2001L134L140'},{id:"B173",body:'LeonardW. Jand J. XLinCytokine receptor signaling pathways.The Journal of allergy and clinical immunology2000877888'},{id:"B174",body:'ArimaKet alCharacterization of the interaction between interleukin-13 and interleukin-13 receptors.The Journal of biological chemistry20052491524922'},{id:"B175",body:'GuoJet alChromosome mapping and expression of the human interleukin-13 receptor.Genomics1997141145'},{id:"B176",body:'AndrewsA. Let alKinetic analysis of the interleukin-13 receptor complex.The Journal of biological chemistry20024607346078'},{id:"B177",body:'MilouxBet alCloning of the human IL-13Rα1 chain and reconstitution with the IL-4Rα of a functional IL-4/IL-13 receptor complex. FEBS letters, 1997163166'},{id:"B178",body:'AmanM. Jet alcDNA cloning and characterization of the human interleukin 13 receptor alpha chain.The Journal of biological chemistry19962926529270'},{id:"B179",body:'WangI. Met alSTAT-1 is activated by IL-4 and IL-13 in multiple cell typesMolecular immunology2004873884'},{id:"B180",body:'HirstS. Jet alSelective induction of eotaxin release by interleukin-13 or interleukin-4 in human airway smooth muscle cells is synergistic with interleukin-1beta and is mediated by the interleukin-4 receptor alpha-chainAmerican journal of respiratory and critical care medicine, 200211611171'},{id:"B181",body:'YasuoMet alRelationship between calcium-activated chloride channel 1 and MUC5AC in goblet cell hyperplasia induced by interleukin-13 in human bronchial epithelial cellsRespirationinternational review of thoracic diseases, 2006347359'},{id:"B182",body:'WeiL. Het alIL-4 and IL-13 upregulate arginase I expression by cAMP and JAK/STAT6 pathways in vascular smooth muscle cells.American journal of physiologyCell physiology, 2000C248C256'},{id:"B183",body:'DainesM. Oand G. KHersheyA novel mechanism by which interferon-gamma can regulate interleukin (IL)-13 responses. Evidence for intracellular stores of IL-13 receptor alpha-2 and their rapid mobilization by interferon-gamma. The Journal of biological chemistry, 20021038710393'},{id:"B184",body:'DavidMet alInduction of the IL-13 receptor alpha2-chain by IL-4 and IL-13 in human keratinocytes: involvement of STAT6, ERK and 38MAPK pathways.Oncogene2001p. 6660-6668.'},{id:"B185",body:'CaputDet alCloning and characterization of a specific interleukin (IL)-13 binding protein structurally related to the IL-5 receptor alpha chain. The Journal of biological chemistry, 19961692116926'},{id:"B186",body:'LupardusP. JM. EBirnbaumand K. CGarciaMolecular basis for shared cytokine recognition revealed in the structure of an unusually high affinity complex between IL-13 and IL-13Ralpha2.Structure (LondonEngland : 1993332342'},{id:"B187",body:'KioiMSSeetharamand R. KPuriN-l. i. n. k. e. dGlycosylationOfI. LRAlphais essential for optimal IL-13 inhibitory activity. FASEB journal : official publication of the Federation of American Societies for Experimental Biology200623782380'},{id:"B188",body:'KonstantinidisA. Ket alCellular localization of interleukin 13 receptor alpha2 in human primary bronchial epithelial cells and fibroblasts.Journal of investigational allergology & clinical immunology : official organ of the International Association of Asthmology (INTERASMA) and Sociedad Latinoamericana de Alergia e Inmunologia, 2008174180'},{id:"B189",body:'AndrewsA. Let alIL-13 receptor alpha 2: a regulator of IL-13 and IL-4 signal transduction in primary human fibroblasts.The Journal of allergy and clinical immunology2006858865'},{id:"B190",body:'DonaldsonD. Det alThe Murine IL-13 Receptor {alpha}2: Molecular Cloning, Characterization, and Comparison with Murine IL-13 Receptor {alpha}The Journal of Immunology, 199823172324'},{id:"B191",body:'KawakamiKet alThe interleukin-13 receptor alpha2 chain: an essential component for binding and internalization but not for interleukin-13-induced signal transduction through the STAT6 pathway.Blood200126732679'},{id:"B192",body:'ZhangJ. Get alIdentification, purification, and characterization of a soluble interleukin (IL)-13-binding protein. Evidence that it is distinct from the cloned Il-13 receptor and Il-4 receptor alpha-chains. The Journal of biological chemistry, 199794749480'},{id:"B193",body:'WilsonM. Set alIL-13Ralpha2 and IL-10 coordinately suppress airway inflammation, airway-hyperreactivity, and fibrosis in mice.The Journal of clinical investigation200729412951'},{id:"B194",body:'SmirnovD. Vet alTandem arrangement of human genes for interleukin-4 and interleukin-13: resemblance in their organization.19951995277281'},{id:"B195",body:'HeinzmannAet alGenetic variants of IL-13 signalling and human asthma and atopy.Human molecular genetics2000549559'},{id:"B196",body:'HowardT. Det alGene-gene interaction in asthma: IL4RA and IL13 in a Dutch population with asthmaAmerican Journal of Human Genetics, 2002230236'},{id:"B197",body:'Tarazona-santosEand S. ATishkoffDivergent patterns of linkage disequilibrium and haplotype structure across global populations at the interleukin-13 (IL13) locus.Genes and immunity20055365'},{id:"B198",body:'MadhankumarA. BAMintzand WDebinskiAlanine-scanning mutagenesis of alpha-helix D segment of interleukin-13 reveals new functionally important residues of the cytokine.The Journal of biological chemistry20024319443205'},{id:"B199",body:'SemlaliAet alThymic stromal lymphopoietin-induced human asthmatic airway epithelial cell proliferation through an IL-13-dependent pathwayThe Journal of allergy and clinical immunology2010844850'},{id:"B200",body:'SingheraG. KRMacRedmond, and D.R. Dorscheid, Interleukin-9 and-13 inhibit spontaneous and corticosteroid induced apoptosis of normal airway epithelial cells. Experimental lung research, 2008579598'},{id:"B201",body:'WadsworthSDSinand DDorscheidClinical update on the use of biomarkers of airway inflammation in the management of asthmaJ Asthma Allergy, 20117786'},{id:"B202",body:'WatanabeTet alIncreased levels of HMGB-1 and endogenous secretory RAGE in induced sputum from asthmatic patientsRespir Med, 2011519525'},{id:"B203",body:'ReddelH. Ket alAn official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice.Am J Respir Crit Care Med, 20095999'},{id:"B204",body:'DAmicoA., et alAn investigation on electronic nose diagnosis of lung cancerD’Amico, A., et al., An investigation on electronic nose diagnosis of lung cancer. Lung Cancer, 2010. 68(2): p. 170-6.2010170176'},{id:"B205",body:'PayneD. Net alRelationship between exhaled nitric oxide and mucosal eosinophilic inflammation in children with difficult asthma, after treatment with oral prednisolone.Am J Respir Crit Care Med, 2001Pt 1): 13761381'},{id:"B206",body:'SchleichF. Net alExhaled nitric oxide thresholds associated with a sputum eosinophil count >/=in a cohort of unselected patients with asthma. Thorax, 201010391044'},{id:"B207",body:'JiangJet alNitric oxide gas phase release in human small airway epithelial cellsRespir Res, 20093\n\t\t\t'},{id:"B208",body:'KostikasKet alExhaled NO and exhaled breath condensate pH in the evaluation of asthma controlRespir Med, 2011526532'},{id:"B209",body:'GessnerCet alAngiogenic markers in breath condensate identify non-small cell lung cancerLung Cancer2010177184'},{id:"B210",body:'BloemenKet alA new approach to study exhaled proteins as potential biomarkers for asthmaClin Exp Allergy, 2011346356'},{id:"B211",body:'LessardAet alObesity and asthma: a specific phenotype? Chest, 2008317323'},{id:"B212",body:'SinD. Det alSerum PARC/CCL-18 Concentrations and Health Outcomes in Chronic Obstructive Pulmonary DiseaseAm J Respir Crit Care Med, 201111871192'},{id:"B213",body:'WedzichaJ. Aet alAcute exacerbations of chronic obstructive pulmonary disease are accompanied by elevations of plasma fibrinogen and serum IL-6 levels.Thromb Haemost, 2000210215'},{id:"B214",body:'ChangC. Let alBiochemical markers of cardiac dysfunction predict mortality in acute exacerbations of COPDThorax2011'},{id:"B215",body:'LowhagenOet alThe inflammatory marker serum eosinophil cationic protein (ECP) compared with PEF as a tool to decide inhaled corticosteroid dose in asthmatic patientsRespir Med, 200295101'},{id:"B216",body:'DosanjhAet alElevated Serum Eosinophil Cationic Protein Levels in Cystic Fibrosis, Pediatric Asthma, and BronchiolitisPediatric Asthma, Allergy & Immunology, 1996169173'},{id:"B217",body:'TrulsonAet alThe functional heterogeneity of eosinophil cationic protein is determined by a gene polymorphism and post-translational modifications. Clin Exp Allergy, 2007208218'},{id:"B218",body:'SekiyaTet alIncreased levels of a TH2-type CC chemokine thymus and activation-regulated chemokine (TARC) in serum and induced sputum of asthmaticsAllergy2002173177'},{id:"B219",body:'LeungT. Fet alPlasma concentration of thymus and activation-regulated chemokine is elevated in childhood asthmaJ Allergy Clin Immunol, 2002404409'},{id:"B220",body:'StephanVet alDetermination of N-methylhistamine in urine as an indicator of histamine release in immediate allergic reactions.J Allergy Clin Immunol, 1990Pt 1): 862868'},{id:"B221",body:'TakeiSet alUrinary N-methylhistamine in asthmatic children receiving azelastine hydrochloride.Ann Allergy Asthma Immunol, 1997492496'},{id:"B222",body:'SansukKet alGPCR proteomics: mass spectrometric and functional analysis of histamine H1 receptor after baculovirus-driven and in vitro cell free expression. J Proteome Res, 2008621629'},{id:"B223",body:'SaudeE. Jet alMetabolomic profiling of asthma: diagnostic utility of urine nuclear magnetic resonance spectroscopyJ Allergy Clin Immunol, 2011757764e1-6.'}],footnotes:[],contributors:[{corresp:null,contributorFullName:"S. Jasemine Yang",address:null,affiliation:'
'},{corresp:null,contributorFullName:"Delbert R. Dorscheid",address:null,affiliation:'
'},{corresp:"yes",contributorFullName:"Samuel J. Wadsworth",address:null,affiliation:'
'}],corrections:null},book:{id:"2323",title:"Carbohydrates",subtitle:"Comprehensive Studies on Glycobiology and Glycotechnology",fullTitle:"Carbohydrates - Comprehensive Studies on Glycobiology and Glycotechnology",slug:"carbohydrates-comprehensive-studies-on-glycobiology-and-glycotechnology",publishedDate:"November 21st 2012",bookSignature:"Chuan-Fa Chang",coverURL:"https://cdn.intechopen.com/books/images_new/2323.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",editors:[{id:"145728",title:"Prof.",name:"Chuan-Fa",middleName:null,surname:"Chang",slug:"chuan-fa-chang",fullName:"Chuan-Fa Chang"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"},chapters:[{id:"41124",title:"Carbohydrate Microarray",slug:"carbohydrate-microarray",totalDownloads:2778,totalCrossrefCites:1,signatures:"Chuan-Fa Chang",authors:[{id:"145728",title:"Prof.",name:"Chuan-Fa",middleName:null,surname:"Chang",fullName:"Chuan-Fa Chang",slug:"chuan-fa-chang"}]},{id:"41104",title:"Conversion of Carbohydrates Under Microwave Heating",slug:"conversion-of-carbohydrates-under-microwave-heating",totalDownloads:3615,totalCrossrefCites:4,signatures:"Aurore Richel and Michel Paquot",authors:[{id:"144442",title:"Prof.",name:"Aurore",middleName:null,surname:"Richel",fullName:"Aurore Richel",slug:"aurore-richel"}]},{id:"41107",title:"Boron-Carbohydrate Interactions",slug:"boron-carbohydrate-interactions",totalDownloads:7082,totalCrossrefCites:8,signatures:"Brighid Pappin, Milton J. Kiefel and Todd A. Houston",authors:[{id:"147209",title:"Dr.",name:"Todd",middleName:null,surname:"Houston",fullName:"Todd Houston",slug:"todd-houston"},{id:"156339",title:"Dr.",name:"Milton",middleName:null,surname:"Kiefel",fullName:"Milton Kiefel",slug:"milton-kiefel"},{id:"156340",title:"Ms.",name:"Brighid",middleName:null,surname:"Pappin",fullName:"Brighid Pappin",slug:"brighid-pappin"}]},{id:"41111",title:"Liquid Chromatography – Mass Spectrometry of Carbohydrates Derivatized with Biotinamidocaproyl Hydrazide",slug:"liquid-chromatography-mass-spectrometry-of-carbohydrates-derivatized-with-biotinamidocaproyl-hydrazi",totalDownloads:3605,totalCrossrefCites:0,signatures:"Stephanie Bank and Petra Kapkova",authors:[{id:"148596",title:"Dr.",name:"Petra",middleName:null,surname:"Kapkova",fullName:"Petra Kapkova",slug:"petra-kapkova"},{id:"148627",title:"Ms.",name:"Stephanie",middleName:null,surname:"Bank",fullName:"Stephanie Bank",slug:"stephanie-bank"}]},{id:"41103",title:"Investigation of Carbohydrates and Their Derivatives as Crystallization Modifiers",slug:"investigation-of-carbohydrates-and-their-derivatives-as-crystallization-modifiers",totalDownloads:3485,totalCrossrefCites:2,signatures:"Josef Jampílek and Jiří Dohnal",authors:[{id:"89487",title:"Prof.",name:"Josef",middleName:null,surname:"Jampílek",fullName:"Josef Jampílek",slug:"josef-jampilek"},{id:"155228",title:"Prof.",name:"Jiří",middleName:null,surname:"Dohnal",fullName:"Jiří Dohnal",slug:"jiri-dohnal"}]},{id:"41125",title:"Glycosidases – A Mechanistic Overview",slug:"glycosidases-a-mechanistic-overview",totalDownloads:2484,totalCrossrefCites:1,signatures:"Nuno Cerqueira, Natércia Brás, Maria João Ramos and Pedro Alexandrino Fernandes",authors:[{id:"144335",title:"Prof.",name:"Nuno",middleName:null,surname:"Cerqueira",fullName:"Nuno Cerqueira",slug:"nuno-cerqueira"},{id:"148943",title:"Dr.",name:"Natércia",middleName:null,surname:"Brás",fullName:"Natércia Brás",slug:"natercia-bras"},{id:"148956",title:"Prof.",name:"Maria João",middleName:null,surname:"Ramos",fullName:"Maria João Ramos",slug:"maria-joao-ramos"},{id:"148957",title:"Dr.",name:"Pedro Alexandrino",middleName:null,surname:"Fernandes",fullName:"Pedro Alexandrino Fernandes",slug:"pedro-alexandrino-fernandes"}]},{id:"41105",title:"DC-SIGN Antagonists – A Paradigm of C-Type Lectin Binding Inhibition",slug:"dc-sign-antagonists-a-paradigm-of-c-type-lectin-binding-inhibition",totalDownloads:2723,totalCrossrefCites:0,signatures:"Marko Anderluh",authors:[{id:"143196",title:"Prof.",name:"Marko",middleName:null,surname:"Anderluh",fullName:"Marko Anderluh",slug:"marko-anderluh"}]},{id:"41108",title:"Broad Antiviral Activity of Carbohydrate-Binding Agents Against Dengue Virus Infection",slug:"broad-antiviral-activity-of-carbohydrate-binding-agents-against-dengue-virus-infection",totalDownloads:2508,totalCrossrefCites:0,signatures:"Marijke Alen and Dominique Schols",authors:[{id:"148442",title:"Prof.",name:"Dominique",middleName:null,surname:"Schols",fullName:"Dominique Schols",slug:"dominique-schols"}]},{id:"41123",title:"IL-13, Asthma and Glycosylation in Airway Epithelial Repair",slug:"il-13-asthma-and-glycosylation-in-airway-epithelial-repair",totalDownloads:3578,totalCrossrefCites:0,signatures:"Samuel J. Wadsworth, S. Jasemine Yang and Delbert R. Dorscheid",authors:[{id:"141889",title:"Dr.",name:"Del",middleName:null,surname:"Dorscheid",fullName:"Del Dorscheid",slug:"del-dorscheid"},{id:"153539",title:"Dr.",name:"Samuel",middleName:null,surname:"Wadsworth",fullName:"Samuel Wadsworth",slug:"samuel-wadsworth"},{id:"154075",title:"Dr.",name:"Jasemine",middleName:null,surname:"Yang",fullName:"Jasemine Yang",slug:"jasemine-yang"}]},{id:"41106",title:"Metabolism of Carbochidrates in the Cell of Green Photosintesis Sulfur Bacteria",slug:"metabolism-of-carbochidrates-in-the-cell-of-green-photosintesis-sulfur-bacteria",totalDownloads:2621,totalCrossrefCites:0,signatures:"M. B. Gorishniy and S. P. Gudz",authors:[{id:"146009",title:"Dr.",name:"Muroslav",middleName:null,surname:"Gorishniy",fullName:"Muroslav Gorishniy",slug:"muroslav-gorishniy"}]},{id:"41118",title:"Digestion in Ruminants",slug:"digestion-in-ruminants",totalDownloads:6664,totalCrossrefCites:4,signatures:"Barbara Niwińska",authors:[{id:"144439",title:"Associate Prof.",name:"Barbara",middleName:"Włdysława",surname:"Niwińska",fullName:"Barbara Niwińska",slug:"barbara-niwinska"}]},{id:"41117",title:"Resistant Dextrins as Prebiotic",slug:"resistant-dextrins-as-prebiotic",totalDownloads:5416,totalCrossrefCites:3,signatures:"Katarzyna Śliżewska, Janusz Kapuśniak, Renata Barczyńska and Kamila Jochym",authors:[{id:"143518",title:"Dr.",name:"Katarzyna",middleName:null,surname:"Śliżewska",fullName:"Katarzyna Śliżewska",slug:"katarzyna-slizewska"}]},{id:"41122",title:"Food Structure and Carbohydrate Digestibility",slug:"food-structure-and-carbohydrate-digestibility",totalDownloads:7296,totalCrossrefCites:10,signatures:"Suman Mishra, Allan Hardacre and John Monro",authors:[{id:"143365",title:"Dr.",name:"Suman",middleName:null,surname:"Mishra",fullName:"Suman Mishra",slug:"suman-mishra"},{id:"146859",title:"Dr.",name:"John",middleName:null,surname:"Monro",fullName:"John Monro",slug:"john-monro"},{id:"163213",title:"Dr.",name:"Allan",middleName:null,surname:"Hardacre",fullName:"Allan Hardacre",slug:"allan-hardacre"}]},{id:"41110",title:"Carbohydrate Metabolism in Drosophila: Reliance on the Disaccharide Trehalose",slug:"carbohydrate-metabolism-in-drosophila-reliance-on-the-disaccharide-trehalose",totalDownloads:4872,totalCrossrefCites:8,signatures:"Alejandro Reyes-DelaTorre, María Teresa Peña-Rangel and Juan Rafael Riesgo-Escovar",authors:[{id:"148766",title:"Dr.",name:"Juan R.",middleName:null,surname:"Riesgo-Escovar",fullName:"Juan R. Riesgo-Escovar",slug:"juan-r.-riesgo-escovar"},{id:"148771",title:"Dr.",name:"María Teresa",middleName:null,surname:"Peña-Rangel",fullName:"María Teresa Peña-Rangel",slug:"maria-teresa-pena-rangel"},{id:"148772",title:"BSc.",name:"Alejandro",middleName:null,surname:"Reyes-Delatorre",fullName:"Alejandro Reyes-Delatorre",slug:"alejandro-reyes-delatorre"}]},{id:"41112",title:"Starvation Conditions Effects on Carbohydrate Metabolism of Marine Bacteria",slug:"starvation-conditions-effects-on-carbohydrate-metabolism-of-marine-bacteria",totalDownloads:2712,totalCrossrefCites:0,signatures:"Monia El Bour",authors:[{id:"142531",title:"Dr.",name:"Monia",middleName:null,surname:"El Bour",fullName:"Monia El Bour",slug:"monia-el-bour"}]},{id:"41114",title:"Adapting the Consumption of Carbohydrates for Diabetic Athletes",slug:"adapting-the-consumption-of-carbohydrates-for-diabetic-athletes",totalDownloads:3251,totalCrossrefCites:0,signatures:"Anna Novials and Serafín Murillo",authors:[{id:"103592",title:"Dr.",name:"Anna",middleName:null,surname:"Novials",fullName:"Anna Novials",slug:"anna-novials"},{id:"148487",title:"Dr.",name:"Serafin",middleName:null,surname:"Murillo",fullName:"Serafin Murillo",slug:"serafin-murillo"}]},{id:"41119",title:"Environmental and Genetic Variation for Water Soluble Carbohydrate Content in Cool Season Forage Grasses",slug:"environmental-and-genetic-variation-for-water-soluble-carbohydrate-content-in-cool-season-forage-gra",totalDownloads:2561,totalCrossrefCites:0,signatures:"Ali Ashraf Jafari",authors:[{id:"145334",title:"Prof.",name:"Ali Ashraf",middleName:null,surname:"Jafari",fullName:"Ali Ashraf Jafari",slug:"ali-ashraf-jafari"}]},{id:"41120",title:"Alterations in Root Morphology of Rootstock Peach Trees Caused by Mycorrhizal Fungi",slug:"alterations-in-root-morphology-of-rootstock-peach-trees-caused-by-mycorrhizal-fungi",totalDownloads:2556,totalCrossrefCites:0,signatures:"José Luis da Silva Nunes, Paulo Vitor Dutra de Souza, Gilmar Arduino Bettio Marodin, José Carlos Fachinello and Jorge Ernesto de Araújo Mariath",authors:[{id:"144373",title:"Dr.",name:"José Luis",middleName:null,surname:"Da Silva Nunes",fullName:"José Luis Da Silva Nunes",slug:"jose-luis-da-silva-nunes"}]},{id:"41113",title:"Plant Responses to Sugar Starvation",slug:"plant-responses-to-sugar-starvation",totalDownloads:3487,totalCrossrefCites:2,signatures:"Iwona Morkunas, Sławomir Borek, Magda Formela and Lech Ratajczak",authors:[{id:"144334",title:"Dr.",name:"Iwona",middleName:"Małgorzata",surname:"Morkunas",fullName:"Iwona Morkunas",slug:"iwona-morkunas"},{id:"145584",title:"Dr.",name:"Sławomir",middleName:null,surname:"Borek",fullName:"Sławomir Borek",slug:"slawomir-borek"},{id:"145585",title:"Prof.",name:"Lech",middleName:null,surname:"Ratajczak",fullName:"Lech Ratajczak",slug:"lech-ratajczak"},{id:"148592",title:"MSc.",name:"Magda",middleName:null,surname:"Formela",fullName:"Magda Formela",slug:"magda-formela"}]},{id:"41121",title:"Carbohydrates from Biomass: Sources and Transformation by Microbial Enzymes",slug:"carbohydrates-from-biomass-sources-and-transformation-by-microbial-enzymes",totalDownloads:3076,totalCrossrefCites:2,signatures:"Luis Henrique Souza Guimarães",authors:[{id:"148075",title:"Dr.",name:"Luis Henrique",middleName:"Souza",surname:"Guimaraes",fullName:"Luis Henrique Guimaraes",slug:"luis-henrique-guimaraes"}]},{id:"41115",title:"Starch and Microbial α-Amylases: From Concepts to Biotechnological Applications",slug:"starch-and-microbial-amylases-from-concepts-to-biotechnological-applications",totalDownloads:7410,totalCrossrefCites:8,signatures:"Amira El-Fallal, Mohammed Abou Dobara, Ahmed El-Sayed and Noha Omar",authors:[{id:"144675",title:"Dr.",name:"Noha",middleName:"Fathy",surname:"Omar",fullName:"Noha Omar",slug:"noha-omar"},{id:"148277",title:"Dr.",name:"Mohammed",middleName:null,surname:"Abou-Dobara",fullName:"Mohammed Abou-Dobara",slug:"mohammed-abou-dobara"},{id:"148278",title:"Dr.",name:"Ahmed",middleName:null,surname:"El-Sayed",fullName:"Ahmed El-Sayed",slug:"ahmed-el-sayed"},{id:"148279",title:"Prof.",name:"Amira",middleName:null,surname:"El-Fallal",fullName:"Amira El-Fallal",slug:"amira-el-fallal"}]},{id:"41116",title:"Algal Polysaccharides, Novel Applications and Outlook",slug:"algal-polysaccharides-novel-applications-and-outlook",totalDownloads:13455,totalCrossrefCites:50,signatures:"Stefan Kraan",authors:[{id:"142720",title:"Dr.",name:"Stefan",middleName:null,surname:"Kraan",fullName:"Stefan Kraan",slug:"stefan-kraan"}]},{id:"41109",title:"Biological Applications of Plants and Algae Lectins: An Overview",slug:"biological-applications-of-plants-and-algae-lectins-an-overview",totalDownloads:7090,totalCrossrefCites:2,signatures:"Edson Holanda Teixeira, Francisco Vassiliepe Sousa Arruda, Kyria Santiago do Nascimento, Victor Alves Carneiro, Celso Shiniti Nagano, Bruno Rocha da Silva, Alexandre Holanda Sampaio and Benildo Sousa Cavada",authors:[{id:"148792",title:"Prof.",name:"Edson",middleName:null,surname:"Teixeira",fullName:"Edson Teixeira",slug:"edson-teixeira"},{id:"156851",title:"Dr.",name:"Francisco V S",middleName:null,surname:"Arruda",fullName:"Francisco V S Arruda",slug:"francisco-v-s-arruda"},{id:"156852",title:"Prof.",name:"Kyria Santiago Do",middleName:null,surname:"Nascimento",fullName:"Kyria Santiago Do Nascimento",slug:"kyria-santiago-do-nascimento"},{id:"156857",title:"Dr.",name:"Victor Alves",middleName:null,surname:"Carneiro",fullName:"Victor Alves Carneiro",slug:"victor-alves-carneiro"},{id:"156858",title:"Prof.",name:"Celso Shiniti",middleName:null,surname:"Nagano",fullName:"Celso Shiniti Nagano",slug:"celso-shiniti-nagano"},{id:"156859",title:"Mr.",name:"Bruno Rocha Da",middleName:null,surname:"Silva",fullName:"Bruno Rocha Da Silva",slug:"bruno-rocha-da-silva"},{id:"156860",title:"Prof.",name:"Alexandre Holanda",middleName:null,surname:"Sampaio",fullName:"Alexandre Holanda Sampaio",slug:"alexandre-holanda-sampaio"},{id:"156861",title:"Prof.",name:"Benildo Sousa",middleName:null,surname:"Cavada",fullName:"Benildo Sousa Cavada",slug:"benildo-sousa-cavada"}]}]},relatedBooks:[{type:"book",id:"2553",title:"Lipid Peroxidation",subtitle:null,isOpenForSubmission:!1,hash:"b39734aa940b2d63ae5e8773d3dd5280",slug:"lipid-peroxidation",bookSignature:"Angel Catala",coverURL:"https://cdn.intechopen.com/books/images_new/2553.jpg",editedByType:"Edited by",editors:[{id:"196544",title:"Prof.",name:"Angel",surname:"Catala",slug:"angel-catala",fullName:"Angel Catala"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"},chapters:[{id:"38477",title:"Lipid Peroxidation: Chemical Mechanism, Biological Implications and Analytical Determination",slug:"lipid-peroxidation-chemical-mechanism-biological-implications-and-analytical-determination",signatures:"Marisa Repetto, Jimena Semprine and Alberto Boveris",authors:[{id:"36452",title:"Dr.",name:"Marisa",middleName:"Gabriela",surname:"Repetto",fullName:"Marisa Repetto",slug:"marisa-repetto"}]},{id:"38517",title:"Lipid Oxidation in Homogeneous and Micro-Heterogeneous Media in Presence of Prooxidants, Antioxidants and Surfactants",slug:"lipid-oxidation-in-homogeneous-and-micro-heterogeneous-media-in-presence-of-prooxidants-antioxidants",signatures:"Vessela D. Kancheva and Olga T. Kasaikina",authors:[{id:"139075",title:"Prof.",name:"Vessela",middleName:"Deneva",surname:"Kancheva",fullName:"Vessela Kancheva",slug:"vessela-kancheva"},{id:"142775",title:"Prof.",name:"Olga",middleName:null,surname:"Kasaikina",fullName:"Olga Kasaikina",slug:"olga-kasaikina"}]},{id:"38468",title:"Lipid Peroxidation End-Products as a Key of Oxidative Stress: Effect of Antioxidant on Their Production and Transfer of Free Radicals",slug:"lipid-peroxidation-end-products-as-a-key-of-oxidative-stress-effect-of-antioxidant-on-their-producti",signatures:"Hanaa Ali Hassan Mostafa Abd El-Aal",authors:[{id:"140134",title:"Prof.",name:"Hanaa",middleName:"Ali",surname:"Hassan",fullName:"Hanaa Hassan",slug:"hanaa-hassan"}]},{id:"38472",title:"Iron Overload and Lipid Peroxidation in Biological Systems",slug:"iron-overload-and-lipid-peroxidation-in-biological-systems",signatures:"Paula M. González, Natacha E. Piloni and Susana Puntarulo",authors:[{id:"36192",title:"Dr.",name:"Susana",middleName:null,surname:"Puntarulo",fullName:"Susana Puntarulo",slug:"susana-puntarulo"}]},{id:"38469",title:"Trends in the Evaluation of Lipid Peroxidation Processes",slug:"trends-in-the-evaluation-of-lipid-peroxidation-processes",signatures:"Mihaela Ilie and Denisa Margină",authors:[{id:"47029",title:"Dr.",name:"Denisa",middleName:null,surname:"Margina",fullName:"Denisa Margina",slug:"denisa-margina"},{id:"49035",title:"Dr.",name:"Mihaela",middleName:null,surname:"Ilie",fullName:"Mihaela Ilie",slug:"mihaela-ilie"}]},{id:"38473",title:"Automation of Methods for Determination of Lipid Peroxidation",slug:"automation-of-methods-for-determination-of-lipid-peroxidation",signatures:"Jiri Sochor, Branislav Ruttkay-Nedecky, Petr Babula, Vojtech Adam, Jaromir Hubalek and Rene Kizek",authors:[{id:"16205",title:"Dr.",name:"Rene",middleName:null,surname:"Kizek",fullName:"Rene Kizek",slug:"rene-kizek"},{id:"16208",title:"Dr.",name:"Petr",middleName:null,surname:"Babula",fullName:"Petr Babula",slug:"petr-babula"},{id:"30300",title:"Dr.",name:"Jaromír",middleName:null,surname:"Hubálek",fullName:"Jaromír Hubálek",slug:"jaromir-hubalek"},{id:"142669",title:"Dr.",name:"Jiri",middleName:null,surname:"Sochor",fullName:"Jiri Sochor",slug:"jiri-sochor"},{id:"142676",title:"Dr.",name:"Branislav",middleName:null,surname:"Ruttkay-Nedecky",fullName:"Branislav Ruttkay-Nedecky",slug:"branislav-ruttkay-nedecky"},{id:"142677",title:"Dr.",name:"Vojtech",middleName:null,surname:"Adam",fullName:"Vojtech Adam",slug:"vojtech-adam"}]},{id:"38478",title:"Liposomes as a Tool to Study Lipid Peroxidation",slug:"liposomes-as-a-tool-to-study-lipid-peroxidation",signatures:"Biljana Kaurinovic and Mira Popovic",authors:[{id:"139916",title:"Prof.",name:"Mira",middleName:null,surname:"Popovic",fullName:"Mira Popovic",slug:"mira-popovic"},{id:"142369",title:"Prof.",name:"Biljana",middleName:null,surname:"Kaurinovic",fullName:"Biljana Kaurinovic",slug:"biljana-kaurinovic"}]},{id:"38457",title:"Liposomes as a Tool to Study Lipid Peroxidation in Retina",slug:"liposomes-as-a-tool-to-study-lipid-peroxidation-in-retina",signatures:"Natalia Fagali and Angel Catalá",authors:[{id:"196544",title:"Prof.",name:"Angel",middleName:null,surname:"Catala",fullName:"Angel Catala",slug:"angel-catala"},{id:"139988",title:"Dr.",name:"Natalia",middleName:null,surname:"Fagali",fullName:"Natalia Fagali",slug:"natalia-fagali"}]},{id:"38461",title:"The Effect of Plant Secondary Metabolites on Lipid Peroxidation and Eicosanoid Pathway",slug:"the-effect-of-plant-secondary-metabolites-on-lipid-peroxidation-and-eicosanoid-pathway",signatures:"Neda Mimica-Dukić, Nataša Simin, Emilija Svirčev, Dejan Orčić, Ivana Beara, Marija Lesjak and Biljana Božin",authors:[{id:"78766",title:"Dr.",name:"Biljana",middleName:null,surname:"Bozin",fullName:"Biljana Bozin",slug:"biljana-bozin"},{id:"140273",title:"Prof.",name:"Neda",middleName:null,surname:"Mimica-Dukic",fullName:"Neda Mimica-Dukic",slug:"neda-mimica-dukic"},{id:"142754",title:"MSc.",name:"Natasa",middleName:null,surname:"Simin",fullName:"Natasa Simin",slug:"natasa-simin"},{id:"142756",title:"BSc.",name:"Emilija",middleName:null,surname:"Jovin",fullName:"Emilija Jovin",slug:"emilija-jovin"},{id:"142757",title:"Dr.",name:"Dejan",middleName:null,surname:"Orcic",fullName:"Dejan Orcic",slug:"dejan-orcic"},{id:"156386",title:"Dr.",name:"Ivana",middleName:null,surname:"Beara",fullName:"Ivana Beara",slug:"ivana-beara"},{id:"156387",title:"Dr.",name:"Marija",middleName:null,surname:"Lesjak",fullName:"Marija Lesjak",slug:"marija-lesjak"}]},{id:"38471",title:"Repeatedly Heated Vegetable Oils and Lipid Peroxidation",slug:"repeatedly-heated-vegetable-oils-and-lipid-peroxidation",signatures:"Kamsiah Jaarin and Yusof Kamisah",authors:[{id:"140497",title:"Dr.",name:"Kamsiah",middleName:null,surname:"Jaarin",fullName:"Kamsiah Jaarin",slug:"kamsiah-jaarin"},{id:"140500",title:"Associate Prof.",name:"Yusof",middleName:null,surname:"Kamisah",fullName:"Yusof Kamisah",slug:"yusof-kamisah"}]},{id:"38456",title:"Effects of Hydroperoxide in Lipid Peroxidation on Dough Fermentation",slug:"effects-of-hydroperoxide-in-lipid-peroxidation-on-dough-fermentation",signatures:"Toshiyuki Toyosaki",authors:[{id:"139920",title:"Prof.",name:"Toshiyuki",middleName:null,surname:"Toyosaki",fullName:"Toshiyuki Toyosaki",slug:"toshiyuki-toyosaki"}]},{id:"38460",title:"Modification of Fatty Acid Composition in Meat Through Diet: Effect on Lipid Peroxidation and Relationship to Nutritional Quality – A Review",slug:"modification-of-fatty-acid-composition-in-meat-through-diet-effect-on-lipid-peroxidation-and-relatio",signatures:"Gema Nieto and Gaspar Ros",authors:[{id:"141016",title:"Dr.",name:"Gema",middleName:null,surname:"Nieto",fullName:"Gema Nieto",slug:"gema-nieto"},{id:"141332",title:"Prof.",name:"Gaspar",middleName:null,surname:"Ros",fullName:"Gaspar Ros",slug:"gaspar-ros"}]},{id:"38458",title:"Lipid Peroxidation After Ionizing Irradiation Leads to Apoptosis and Autophagy",slug:"lipid-peroxidation-after-ionizing-irradiation-leads-to-apoptosis-and-autophagy",signatures:"Juliann G. Kiang, Risaku Fukumoto and Nikolai V. Gorbunov",authors:[{id:"157452",title:"Dr.",name:"Juliann",middleName:null,surname:"Kiang",fullName:"Juliann Kiang",slug:"juliann-kiang"},{id:"158709",title:"Dr.",name:"Risaku",middleName:null,surname:"Fukumoto",fullName:"Risaku Fukumoto",slug:"risaku-fukumoto"},{id:"158710",title:"Dr.",name:"Nikolai",middleName:null,surname:"Gorbunov",fullName:"Nikolai Gorbunov",slug:"nikolai-gorbunov"}]},{id:"38467",title:"Tissue Occurrence of Carbonyl Products of Lipid Peroxidation and Their Role in Inflammatory Disease",slug:"tissue-occurrence-of-carbonyl-products-of-lipid-peroxidation-and-their-role-in-inflammatory-disease",signatures:"Maria Armida Rossi",authors:[{id:"148504",title:"Prof.",name:"Maria",middleName:null,surname:"Rossi",fullName:"Maria Rossi",slug:"maria-rossi"}]},{id:"38465",title:"The Role of Physical Exercise on Lipid Peroxidation in Diabetic Complications",slug:"the-role-of-physical-exercise-on-lipid-peroxidation-in-diabetic-complications",signatures:"Yaşar Gül Özkaya",authors:[{id:"142843",title:"Dr.",name:"Y. Gul",middleName:null,surname:"Ozkaya",fullName:"Y. Gul Ozkaya",slug:"y.-gul-ozkaya"}]},{id:"38466",title:"Reactive Oxygen Species Act as Signaling Molecules in Liver Carcinogenesis",slug:"reactive-oxygen-species-act-as-signaling-molecules-in-liver-carcinogenesis",signatures:"María Cristina Carrillo, María de Luján Alvarez, Juan Pablo Parody, Ariel Darío Quiroga and María Paula Ceballos",authors:[{id:"142215",title:"PhD.",name:"Maria Cristina",middleName:null,surname:"Carrillo",fullName:"Maria Cristina Carrillo",slug:"maria-cristina-carrillo"},{id:"142855",title:"Dr.",name:"Maria De Luján",middleName:null,surname:"Alvarez",fullName:"Maria De Luján Alvarez",slug:"maria-de-lujan-alvarez"},{id:"142858",title:"BSc.",name:"Juan Pablo",middleName:null,surname:"Parody",fullName:"Juan Pablo Parody",slug:"juan-pablo-parody"},{id:"142859",title:"Dr.",name:"Ariel Darío",middleName:null,surname:"Quiroga",fullName:"Ariel Darío Quiroga",slug:"ariel-dario-quiroga"},{id:"142861",title:"BSc.",name:"Maria Paula",middleName:null,surname:"Ceballos",fullName:"Maria Paula Ceballos",slug:"maria-paula-ceballos"}]},{id:"38459",title:"Lipid Peroxidation and Antioxidants in Arterial Hypertension",slug:"lipid-peroxidation-and-antioxidants-in-arterial-hypertension",signatures:"Teresa Sousa, Joana Afonso, António Albino-Teixeira and Félix Carvalho",authors:[{id:"131252",title:"Prof.",name:"Félix",middleName:null,surname:"Carvalho",fullName:"Félix Carvalho",slug:"felix-carvalho"},{id:"140800",title:"Prof.",name:"António",middleName:null,surname:"Albino-Teixeira",fullName:"António Albino-Teixeira",slug:"antonio-albino-teixeira"},{id:"142410",title:"Prof.",name:"Teresa",middleName:null,surname:"Sousa",fullName:"Teresa Sousa",slug:"teresa-sousa"},{id:"142411",title:"MSc.",name:"Joana",middleName:null,surname:"Afonso",fullName:"Joana Afonso",slug:"joana-afonso"}]},{id:"38476",title:"Lipid Peroxidation and Reperfusion Injury in Hypertrophied Hearts",slug:"lipid-peroxidation-and-reperfusion-injury-in-hypertrophied-hearts",signatures:"Juliana C. Fantinelli, Ignacio A. Pérez Núñez, Luisa F. González Arbeláez and Susana M. Mosca",authors:[{id:"98613",title:"Dr.",name:"Susana",middleName:null,surname:"Mosca",fullName:"Susana Mosca",slug:"susana-mosca"}]},{id:"38455",title:"Lipid Peroxidation by-Products and the Metabolic Syndrome",slug:"lipid-peroxidation-by-products-and-the-metabolic-syndrome",signatures:"Nicolas J. Pillon and Christophe O. Soulage",authors:[{id:"139163",title:"Dr.",name:"Nicolas",middleName:"Jean",surname:"Pillon",fullName:"Nicolas Pillon",slug:"nicolas-pillon"},{id:"139829",title:"Dr.",name:"Christophe",middleName:null,surname:"Soulage",fullName:"Christophe Soulage",slug:"christophe-soulage"}]},{id:"38475",title:"Region Specific Vulnerability to Lipid Peroxidation in the Human Central Nervous System",slug:"region-specific-vulnerability-to-lipid-peroxidation-in-the-human-central-nervous-system",signatures:"Alba Naudí, Mariona Jové, Victòria Ayala, Omar Ramírez, Rosanna Cabré, Joan Prat, Manuel Portero-Otin, Isidre Ferrer and Reinald Pamplona",authors:[{id:"139955",title:"Prof.",name:"Reinald",middleName:null,surname:"Pamplona",fullName:"Reinald Pamplona",slug:"reinald-pamplona"}]},{id:"38474",title:"Role of Lipid Peroxidation in the Pathogenesis of Age-Related Cataract",slug:"role-of-lipid-peroxidation-in-the-pathogenesis-of-age-related-cataract",signatures:"Bojana Kisic, Dijana Miric, Lepsa Zoric and Aleksandra Ilic",authors:[{id:"139383",title:"Prof.",name:"Bojana",middleName:null,surname:"Kisic",fullName:"Bojana Kisic",slug:"bojana-kisic"},{id:"150937",title:"Prof.",name:"Dijana",middleName:null,surname:"Miric",fullName:"Dijana Miric",slug:"dijana-miric"},{id:"150938",title:"Prof.",name:"Lepsa",middleName:null,surname:"Zoric",fullName:"Lepsa Zoric",slug:"lepsa-zoric"},{id:"150939",title:"Dr.",name:"Aleksandra",middleName:null,surname:"Ilic",fullName:"Aleksandra Ilic",slug:"aleksandra-ilic"}]},{id:"38462",title:"Lipid Peroxidation in Hepatic Fibrosis",slug:"lipid-peroxidation-in-hepatic-fibrosis",signatures:"Ichiro Shimizu, Noriko Shimamoto, Katsumi Saiki, Mai Furujo and Keiko Osawa",authors:[{id:"142420",title:"Dr.",name:"Ichiro",middleName:null,surname:"Shimizu",fullName:"Ichiro Shimizu",slug:"ichiro-shimizu"}]},{id:"38463",title:"Use of CoA Biosynthesis Modulators and Selenoprotein Model Substance in Correction of Brain Ischemic and Reperfusion Injuries",slug:"use-of-coa-biosynthesis-modulators-and-selenoprotein-model-substance-in-correction-of-brain-ischemic",signatures:"Nina P. Kanunnikova, Natalya Z. Bashun and Andrey G. Moiseenok",authors:[{id:"142487",title:"Prof.",name:"Nina",middleName:null,surname:"Kanunnikova",fullName:"Nina Kanunnikova",slug:"nina-kanunnikova"},{id:"142491",title:"Dr.",name:"Natalya",middleName:null,surname:"Bashun",fullName:"Natalya Bashun",slug:"natalya-bashun"},{id:"142503",title:"Prof.",name:"Andrey",middleName:null,surname:"Moiseenok",fullName:"Andrey Moiseenok",slug:"andrey-moiseenok"}]},{id:"38464",title:"Lipid Peroxidation and Polybrominated Diphenyl Ethers – A Toxicological Perspective",slug:"lipid-peroxidation-and-polybrominated-diphenyl-ethers-a-toxicological-perspective",signatures:"Mary C. Vagula and Elisa M. Konieczko",authors:[{id:"141806",title:"Dr.",name:"Mary",middleName:null,surname:"Vagula",fullName:"Mary Vagula",slug:"mary-vagula"},{id:"150947",title:"Prof.",name:"Elisa",middleName:null,surname:"Konieczko",fullName:"Elisa Konieczko",slug:"elisa-konieczko"}]}]}]},onlineFirst:{chapter:{type:"chapter",id:"75030",title:"Cholesterol Recognition Motifs (CRAC) in the S Protein of Coronavirus: A Possible Target for Antiviral Therapy?",doi:"10.5772/intechopen.95977",slug:"cholesterol-recognition-motifs-crac-in-the-s-protein-of-coronavirus-a-possible-target-for-antiviral-",body:'
1. Introduction
The COVID-19 pandemic caused by the SARS-CoV2 coronavirus has resulted in almost hundred of millions of infections and about two millions of deaths in 2020 [1, 2]. According to the WHO data as of January 4, 2021, there have been 85 929 428 confirmed cases of COVID-19 reported to WHO, including 1 876 100 deaths [2]. It has been shown that in patients with laboratory-confirmed COVID-19, clinical results correlate with the presence of concomitant diseases, among which hypertension and diabetes mellitus, as well as old age, atherosclerosis, cardiovascular and cerebrovascular diseases worsening prognosis [3, 4, 5, 6, 7, 8, 9]. Notably, these factors are commonly associated with the impairments in the lipid/cholesterol metabolism and transport or are their direct consequence [3, 4, 5].
At present, a lot is known about the coronavirus SARS-CoV2. It is an enveloped single-stranded RNA virus belonging to the Betacoronavirus genus of the Coronaviridae family. The virus contains a 30 kb genome encoding four major viral structural proteins: spike (S), membrane (M), envelope (E), and nucleocapsid (N) proteins [9, 10]. According to modern concepts, the cellular receptor for S protein is angiotensin converting enzyme 2 (ACE2); binding of the S protein to this receptor allows the internalization of the virus and triggers the disease. Significant progress has been made in the development of vaccines against SARS-CoV2 and mass vaccination of people in different countries begins [11, 12]; this gives hope that the pandemic will stop. However, the issues of treating patients with various forms of COVID-19 and the development of drugs based on knowledge of the mechanisms underlying this pathology still need to be addressed. This chapter is mainly focused on the lipid aspects of the interactions of coronaviruses with host cells and, in particular, draws attention to the fact that interactions with host cells of many enveloped viruses, including coronaviruses SARS-CoV and SARS-CoV2, are cholesterol dependent. Moreover, these interactions lead to significant and potentially deleterious alterations in the cholesterol status of the infected cells. These cholesterol-dependent processes play a significant role both at the stage of the virus entry and during the development of severe respiratory syndrome (SARS) and other health problems caused by coronaviruses SARS-CoV and SARS-CoV2. Therefore, understanding this component is necessary for the development of additional approaches both to prevention and treatment of these diseases, and the attempts in this direction are being made (e.g., [13, 14, 15]). This review focuses on the fact that the coronavirus S protein, which is involved in cholesterol-dependent virus–cell interactions during entry and replication stages, contains the so-called cholesterol recognition amino-acid consensus (CRAC) motifs [16, 17] that can actually mediate these interactions. A hypothesis is put forward suggesting that binding of cell membrane cholesterol by CRAC-containing S protein (and possibly by other viral proteins) and subsequent removal of cholesterol from intracellular membranes by newly formed viral particles can affect normal functioning of cellular cholesterol-dependent proteins (receptors, ion channels, enzymes, etc.) and can eventually cause cell death due to destabilization and permeabilization of cell membranes. This deteriorating effect of CRAC-containing viral proteins can be counteracted by agents that prevent binding of membrane cholesterol to viral proteins and/or compensate for the membrane cholesterol depletion produced by the forming viral particles. It is possible that specially designed CRAC-containing peptides that specifically block interactions of S protein with cholesterol can expand the range of antiviral agents.
2. Some interactions of enveloped viruses with host cells are cholesterol-dependent
The viral life cycle includes four steps: entry, replication, assembly, and egress [18, 19, 20, 21] (Figure 1). At the entry step, an enveloped virus binds to a target receptor, the viral envelope fuses with the host cell membrane, and the viral nucleic acids are released into the cytoplasm. At the replication step, the nucleic acid is replicated in cytoplasmic replication organelles and viral proteins are synthesized. At the assembly step, viral proteins and nucleic acids are packed into a viral particle and the viral envelope is formed. At the egress step, mature viral particles leave the cell through the cellular membrane [18, 19, 20, 21].
Figure 1.
Life cycle of an enveloped virus as exemplified by coronavirus (based on [18, 19, 20, 21]). To enter a cell, virus binds via S protein to the receptors on the host cell and the viral envelope fuses with plasma membrane or membrane of endolysosome (EL) and releases the genomic nucleic acid into the cell cytoplasm. Viral membrane is shaded. Note that viral envelope remains in cell plasma membrane both after direct fusion and after endosomal membrane recycling (MR). At the replication stage, replication–transcription complex is formed and viral proteins and copies of RNA are produced. At the assembly stage, viral particles are formed from nucleocapsid (genomic RNA and N protein) and intracellular cell membranes (endopasmic reticulum (ER) and/or ER-to-Golgi intermediate compartment (ERGIC)), containing viral membrane-associated proteins (S, M, and E). During the assembly process, double-membrane vesicles (DMV) are formed. At the exit stage, viral particles are released by secretory pathway.
Some interactions of enveloped viruses with the cell in the course of penetration and during assembly, budding, and exit of the virus from the cell are known to depend on the presence of cholesterol and lipid rafts in the membranes of the host cells [21, 22, 23, 24, 25, 26]. This has been shown for immunodeficiency viruses (HIV) [27, 28, 29, 30, 31], influenza [32, 33, 34, 35, 36, 37], herpes [38], Newcastle disease virus [39], and rotavirus [40], as well as hepatitis C virus (HCV) [41, 42, 43] and some other viruses of the Flaviviridae family (Yellow fever virus, Zika virus, Dengue virus, West Nile virus [44, 45]). For example, the vital need of cholesterol for replication of hepatitis C virus (HCV) was shown by different methods in [41, 43]. Lipid withdrawal from the medium considerably suppressed the virus replication, which was restored to normal levels upon addition of exogenous LDL. Moreover, virus replication was suppressed by knockdown or pharmacological inhibition of Niemann–Pick type C1 protein (NPC1) – cell protein mediating the endosomal cholesterol transport [41, 43].
The cholesterol dependence of virus–cell interactions has also been demonstrated for various coronaviruses [14, 15, 46, 47, 48, 49, 50, 51, 52], including SARS-CoV and SARS-CoV2 [50, 51, 52]. Li et al. 2007 [50] reported that the production of SARS-CoV particles released from the infected Vero E6 is notably suppressed following cholesterol depletion by cell pretreatment with methyl-β-cyclodextrin (mβCD), and the addition of cholesterol to the culture medium reversed this effect. Later, Glende et al. 2008 [51] showed that the removal of cholesterol from cell membranes using mβCD reduces the efficiency of infection of cells not only with the SARS-CoV but also with a non-replicating pseudotype of vesicular stomatitis virus containing the surface glycoprotein S of the SARS-CoV virus (VSV-ΔG-S), which confirms the key role of the S protein in the virus entry. The authors also reported that the cellular receptor of the SARS-CoV virus, angiotensin-converting enzyme (ACE2), is co-localized with Flotilin2 and LAMP2, the protein markers of the detergent-resistant membrane domains (rafts) [51].
The issues concerning the importance of the host cell membrane lipids, rafts, and cholesterol at different stages of the virus life cycle have been addressed in numerous comprehensive reviews, and the dependence of the viral life cycle on cellular cholesterol, as well as the impact produced by viruses on cellular lipids and cholesterol in particular is regarded as a basis for antiviral therapy [15, 30, 31, 45, 53]. For example, cholesterol-lowering treatments are considered as a possible prophylactic or preventive measures [45, 54]. However, alterations in the cell lipid status produced by viruses that have entered a cell impose more complex requirements on potential medicines.
3. Virus-induced modulations of the lipid composition of cell membranes. Formation of viral envelope can result in a hazardous decrease in the cholesterol content in cell membranes
Viruses not only depend on cholesterol but also significantly modulate the lipid composition of cell membranes [53, 55, 56, 57, 58, 59, 60, 61, 62, 63]. This occurs both at the stage of virus internalization and during the synthesis of viral proteins and intracellular assembly of new viral particles. The consequences of these changes can determine the clinical course and severity of the disease. The release of the gene material of many enveloped viruses into the cytoplasm of the cell occurs by fusion of the viral envelope with plasma membrane or with membranes of late endosomes (endolysosomes) formed during receptor-mediated endocytosis [18, 19, 20, 21, 64, 65, 66, 67, 68, 69, 70]. The inclusion of viral envelopes into the host cell membrane (either after direct fusion of after endosomal membrane recycling) should change both the lipid and protein composition of the cell membrane and cause rearrangements in the lipidic milieu and antigenic profile of the host cell membrane (Figure 1). Further, at the stage of the assembly of new viral particles, their envelopes are formed from cellular membranes [14, 15, 45, 55, 57, 58, 59, 60, 61, 62, 63, 64, 65, 67, 68]. Some viruses bud from the plasma membrane (e.g., togaviruses, rhabdoviruses, paramyxoviruses, orthmyxoviruses, and retroviruses, including HIV), others use the endoplasmic reticulum (ER) (coronaviruses and flaviviruses) or/and a Golgi complex (bunyaviruses), some (e.g., herpes virus) have more complicated budding scenario [59, 60, 61, 62]. The formation of the viral envelopes can involve lipid sorting and, in particular, accumulation in the viral envelope of cholesterol and sphingolipids that are acquired from the host cell membranes [33, 61, 62, 63, 64, 65, 69, 70]. For example, HIV-1 selectively buds from membrane domains enriched in cholesterol and sphingolipids (rafts); as a result, host cell rafts become a viral coat and the level of cholesterol and sphingolipids and the cholesterol/phospholipids ratio in the viral envelope is higher than in the plasma membrane where they originate, and also notably higher than in the intracellular membranes [53, 61, 62, 65]. Another example – bovine viral diarrhea virus (BVDV) of the Flaviviridae family budding from the endoplasmic reticulum (ER): the content of cholesterol, sphingomyelin, and hexosyl-ceramide in the BVDV particles was shown to be more than twofold higher than in the infected cells [69]. As the cholesterol concentration in the ER is significantly (several times) lower than in the plasma membrane [71, 72, 73, 74], the loss of cholesterol due to the formation of viral envelopes can be destructive for the ER membranes.
For lipid sorting necessary for the virus envelope formation, various mechanisms are used to manipulate synthesis, metabolism, and transport of host lipids, cholesterol in particular, and lead to significant changes in the lipid status of the host cell. HIV-1 infection is known to induce various alteration of cellular lipids, including increased cholesterol synthesis and uptake [75], suppressed cholesterol efflux [76], as well as a shift in phospholipid synthesis to neutral lipids and peroxidation of polyunsaturated fatty acid [53, 65, 75, 76]. Hepatitis C virus (HCV) also causes massive rearrangements of intracellular membranes leading to the formation of double-membrane vesicles (DMVs) enriched with cholesterol. As was shown in [41], HCV ‘usurps’ cholesterol transporter proteins, such as NPC1, in order to deliver cholesterol to the viral replication organelle where cholesterol is needed, and blockage of this transporter suppresses the virus replication. Coronaviruses, like Flaviviruses, are assembled and bud from the membranes of Golgi complex and ER [41, 60] and also form double-membrane vesicles [77]. At the same number of newly formed viral particles, the consequences of removing cholesterol from ER membranes by double-membrane vesicles can be more severe than in the case of single membrane vesicles; a quantitative assessment of this process is necessary.
A possible mechanism stimulating the delivery of cholesterol to ER from plasma membrane during coronavirus replication was demonstrated by Wang et al. 2020 [78]. The authors reported that SARS-CoV2 activates the host cell gene encoding cholesterol 25-hydroxylase and induces the formation of 25-hydroxycholesterol, which increases cholesterol availability [79] and triggers its delivery from the plasma membrane to the endoplasmic reticulum, where cholesterol is required for the viral envelope formation. Although, as is known [14, 23, 24, 25, 26, 27, 28, 29, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55], the depletion of cholesterol in the plasma membrane suppresses the virus entry into the cell, the observed trafficking of cholesterol into the ER (normally the flow goes in the opposite direction [71, 72]) can reflect an increased uptake of cholesterol for the formation of envelopes of new viruses. After the release of newly formed viruses, this depleted cell will not be susceptible to new infection.
Thus, the formation and release of viral particles from the cell cannot but affect the composition of the host cell membranes. It can be expected that after a full replication cycle of viruses with high envelope cholesterol, the level of cholesterol in the membranes of the host cell will be reduced, and this depletion of cholesterol can lead to a significant deregulation of cholesterol-dependent processes, including intracellular signaling and metabolic pathways. At a high rate of assembly of a large number of viruses, infected cells may not be able to compensate for the loss of cholesterol in their membranes, and this can lead to cell death due to destabilization and permeabilization of cell membranes. Indeed, ample evidence indicates that lowered membrane cholesterol is associated with altered mechanical properties and increased permeability of the membrane [80, 81, 82, 83]. Some viral and bacterial proteins trigger apoptosis through lysosomal membrane permeabilization leading to release of cathepsins [81]. The human immunodeficiency virus type 1 (HIV-1) protein Nef is one of such proteins: when entering mammalian cells, it causes permeabilization of the lysosomal membrane [81]. It seems appropriate at this point to recall that permeabilization of intracellular membranes due to cholesterol depletion underlies the cytotoxic effect of some anticancer drugs [81, 84, 85, 86, 87]. As was shown by Appelqvist et al. 2011 [84], the mechanism of action of cisplatin and some other lysosomotropic drugs at least partially is based on the permeabilization of lysosomal membranes leading to cell death; cholesterol accumulation in lysosomal membranes caused by inhibition of cholesterol transporting protein NPC1 prevented the lysosome-dependent cell death [84]. Note that in the case of virus infection, inhibition of the NPC1-dependent cholesterol transport suppressed the virus replication [41] and rescued the infected cells. When NPC1 functions normally and cholesterol is delivered from lysosomal compartment to ER for the formation of viral envelopes, lysosomal membranes lose cholesterol and become leaky; in a way, virus acts like a lysosomotropic drug. Cholesterol supplementation was also shown to reverse a strong cytotoxic effect on colon cancer cells caused by a low molecular weight compound TASIN-1 producing cholesterol-dependent ER stress triggering oxidative stress and JNK-dependent apoptosis [85].
Thus, virus–cell interactions lead to significant modulations in the lipid composition of cell membranes. A decrease in cholesterol in cell membranes owing to the formation of viral envelopes can be one of the most dangerous consequences of the virus particle assembly, as the amount of cholesterol removed from the cell membranes by newly formed viruses can exceed the compensatory resources of the cell. If the delivery of cholesterol to the cells is insufficient, deregulation of cholesterol-dependent processes can lead to massive cell death, which manifests itself in the clinical course of the disease and a poor prognosis. In this connection, it should be noted that in patients infected with COVID-19, a significant decrease (several fold) in total cholesterol and low-density lipoprotein (LDL) cholesterol levels was recorded [13, 88], and cholesterol-lowering treatments (such as statins) may not be advisable for patients with life-threatening COVID-19 infection, at least until they recover from the infection [88]. Such a drop of the LDL cholesterol level in COVID-19 patients may reflect an enhanced recruitment of circulating cholesterol by the cells to compensate for its loss associated with virus reproduction. Perhaps the clinical prognosis depends on the timely and successful delivery of cholesterol required for cell membrane repair. Another direction in the development of drugs for the treatment of the disease is the search for agents that interfere with the interactions of viral proteins with cholesterol, and this search should be based on an understanding of the mechanisms of these interactions. So far, the only drugs for which clinically significant results have been demonstrated against COVID-19, are dexamethasone and some other corticosteroids [89, 90, 91]; secosteroids (vitamin D) are shown to help, too [92]. The use of dexamethasone led to a reduction in mortality to one third of hospitalized patients with severe respiratory complications from COVID-19. It seems possible that the action of steroids may be associated with the repair of a cell membrane damaged by virus-induced depletion of cholesterol.
How does the virus manage to bind and remove cholesterol from cell membranes?
4. Cholesterol recognition/interaction amino acid consensus (CRAC) motifs in viral proteins. Possible uses of CRAC-containing peptides
As was shown earlier [16, 17, 93], some proteins involved in cholesterol-dependent cell functions possess the so-called cholesterol recognition/interaction amino acid consensus (CRAC) motifs – small regions with a specific set of amino acid residues involving a branched apolar aminoacid residue (Val (V), Leu (L), or Ile (I)), aromatic residue (Tyr (Y)), and cationic aminoacid residue (Arg (R) or Lys (K)); these motif-forming amino acids are separated by short segments of any 1–5 amino acid residues. In subsequent discussions, more candidates of aromatic amino acid residues were proposed, and the general formula for the CRAC motifs presumably involved in the interaction of protein with cholesterol presently appears as follows: V/L/I–X(1–5)–W/Y/F–(X)(1–5)–R/K, where X stands for any amino acid residue [94, 95, 96, 97, 98, 99, 100]. Although the predictive value of this formula has been questioned [95, 96, 97], the presence of this motif in many proteins and its participation in the protein–cholesterol interactions has been confirmed by different methods [16, 17, 93, 94, 95]. The formula of the CRAC motif can be further developed [94]; important is the very concept of a motif mediating the interactions of cholesterol-dependent proteins with cholesterol.
CRAC motifs are found in many viral proteins, and their role in cholesterol-dependent virus–cell interactions have been demonstrated. For example, CRAC motifs are present in the HIV matrix protein р17, which was shown to participate in virus entry through the raft domains of the cell membranes [27, 101]. The α-helical domain of the hepatitis C virus nonstructural protein NS5A, which is anchored at the cytoplasmic leaflet of the endoplasmic reticulum and is involved in replication hepatitis C virus, also contains CRAC motif [102]. Importantly, peptides derived from this domain were shown to exhibit a broad-spectrum anti-viral activity. Cheng et al. 2008 [103] reported that peptide C5A containing amino acid residues 3–20 of the amphipathic α-helical N-terminal domain of hepatitis A virus protein NS5A suppressed the virus replication by more than 5 orders of magnitude. The authors did not mention the CRAC concept; however, the active peptide C5A (SWLRDIWDWICEVLSDFK) clearly contains the CRAC motif: RDIWDWICEV. Later, the antiviral activity of this peptide C5A against HIV was also demonstrated [104]. It is possible that peptide C5A, owing to the presence of the CRAC motif, binds cholesterol and competes for cholesterol binding with viral protein and thus inhibits the formation of the viral particle.
CRAC motifs are found in alpha-helices of matrix protein M1 of influenza A virus [105, 106, 107]. An important role of these CRAC motifs in the organization of the raft structure of the virion membrane was substantiated by using the method of directed point mutations in the CRAC-containing α-helices in the M1 protein [106, 107]. Further studies revealed that M1-derived peptides containing CRAC motifs LEVLMEWLKTR, NNMDKAVKLYRKLK, GLKNDLLENLQAYQKR, corresponding to α-helixes 3 (aa 39–49), 6 (aa 91–105) and 13 (aa 228–243), respectively, to a different extent modulate cholesterol-dependent interactions of cultured macrophages with 2-μm particles that mimic bacteria (phagocytic index). Of the three peptides, NNMDKAVKLYRKLK was most potent and stimulated the cell activity by 50–60% at 35 μΜ [108]. Peptide RTKLWEMLVELGNMDKAVKLWRKLKR obtained by combining two of these short peptides and containing two CRAC motifs produced much stronger and more complex effect: in a narrow range of low concentrations (1–5 μM) the peptide exerted a stimulatory effect and at 50 μM the peptide was cytotoxic [109]. Reducing the cholesterol content in the cells with methyl-β-cyclodextrin (mβCD) abolished the stimulatory component and lowered the peptide concentration required for the toxic effect. Substitution of the motif-forming amino acids abolished these effects [110]. The cytotoxic effect of the M1-derived peptide RTKLWEMLVELGNMDKAVKLWRKLKR can be explained by the binding (sequestration) of membrane cholesterol by the peptide; this can imitate removal of cholesterol from cell membranes, which occurs during the formation of the viral envelope.
S proteins of coronaviruses SARS-CoV and SARS-CoV2 also contain CRAC motifs [51, 109, 110]. For example, in the case of the S protein of coronavirus SARS-CoV, the CRAC motif YIKWPWYVW is located in the “aromatic” region of the transmembrane domain of the S-protein; this highly conserved region of the S-protein was shown to be necessary for the infection of cells with coronavirus [111, 112].
If the assumption about the essential role of sequestration and removal of membrane cholesterol by viral CRAC-containing proteins in the COVID-19 parthenogenesis is correct, then in order to prevent this destructive action for the cell, it is necessary to maintain a safe level of cholesterol in the plasma membrane. A significant decrease in total cholesterol and low-density lipoprotein (LDL) cholesterol levels in COVID-19 patients [13, 88] may be indicative of the critical loss of cholesterol by cells, and an efficient cholesterol delivery to the cholesterol-depleted cells may be helpful. Cyclodextrins are possible candidates as non-toxic cholesterol transporters [113, 114, 115, 116], which can redistribute cholesterol from endogenous and/or exogenous sources. The use of cyclodextrins increased the lifespan of NPC1−/− experimental mice [117] and improved the condition of patients with Nieman–Pick disease [118]. Another alternative is to prevent viral proteins from interacting with membrane cholesterol. At least some of the drugs that are currently tested – for example, polyphenolic substances like quercetin and saponin glycyrrhizin [119, 120] – can act at the protein/cholesterol interface and hinder cholesterol binding by the CRAC motif of the viral S protein and thus inhibit the assembly of new viral particles. Glycyrrhizin, an active component of liquorice roots, was shown to inhibit SARS-CV replication in Vero cells and replication of SARS-associated coronavirus [121, 122]. However, such agents are not very selective and can affect other cholesterol-dependent proteins and therefore cause side effects. Perhaps specially designed CRAC-peptides specifically blocking the interactions of S-protein with cholesterol will prevent the cellular cholesterol loss leading to permeabilization of membranes, oxidative stress, and cell death. The ability of CRAC-containing peptides to regulate cholesterol-dependent cell functions has been demonstrated in a number of works [17, 109, 122, 123], and studies of the antiviral activity of these peptides may be useful and promising.
5. Conclusions
The SARS-CoV2 pandemic has sparked a brainstorming session over the underlying mechanisms of viral diseases. Many assumptions have been made. This chapter considers possible consequences of cholesterol depletion in the membranes of infected cells due to the formation of cholesterol-rich viral envelopes. At a high viral load and high replication rate the reduction in the cholesterol level in the cell membranes can lead to their permeabilization and subsequent cell death, and this can be one of the factors in pathogenesis of diseases induced by SARS-CoV2. Cholesterol-recognition/interaction (CRAC) motifs in viral proteins may represent a mechanism for the binding of the viral protein with cholesterol. Substances preventing these interactions of viral proteins with cholesterol can suppress the formation of the viral envelope and therefore can be studied as possible antiviral drugs. Peptides containing CRAC motifs from viral proteins may be among these substances.
Acknowledgments
The work was partially supported by the Russian Foundation for Basic Research (project no. 18-04-01363).
Conflict of interest
The author declares that there is no conflict of interest.
\n',keywords:"peptides, cholesterol-recognition motif (CRAC), CRAC-containing peptides, coronavirus, S-protein, SARS-CoV2, COVID-19",chapterPDFUrl:"https://cdn.intechopen.com/pdfs/75030.pdf",chapterXML:"https://mts.intechopen.com/source/xml/75030.xml",downloadPdfUrl:"/chapter/pdf-download/75030",previewPdfUrl:"/chapter/pdf-preview/75030",totalDownloads:13,totalViews:0,totalCrossrefCites:0,dateSubmitted:"October 30th 2020",dateReviewed:"January 12th 2021",datePrePublished:"February 1st 2021",datePublished:null,dateFinished:"February 1st 2021",readingETA:"0",abstract:"Some interactions of enveloped viruses with the host cell membrane have a cholesterol-dependent component, which may account for clinical manifestations of the infectious disease and can be used for the development of antiviral drugs. These cholesterol-dependent interactions can be mediated by cholesterol-recognition amino-acid consensus (CRAC) motifs present in viral proteins. The S protein of the SARS-CoV and SARS-CoV2 coronaviruses contains CRAC motifs that can be involved in the process of virus entry into the cell. Besides, during viral envelope formation, CRAC motifs can be responsible for binding of cell membrane cholesterol, leading to depletion of cell membrane cholesterol and subsequent malfunctioning of cellular cholesterol-dependent proteins, destabilization and permeabilization of cell membranes and, ultimately, to the death of infected cells. Understanding the mechanisms of cholesterol-dependent virus–cell interactions and the role of CRAC-containing viral proteins in the pathogenesis of the disease can serve as the basis for the development of new drugs that prevent both coronavirus entry into the cell and the damage of the infected cell during the viral morphogenesis. The target for such drugs can be the S-protein/cholesterol interface. CRAC-containing peptides derived from viral proteins may be among these agents. These peptides can also be used as experimental tools to study cholesterol-dependent virus–cell interactions.",reviewType:"peer-reviewed",bibtexUrl:"/chapter/bibtex/75030",risUrl:"/chapter/ris/75030",signatures:"Antonina Dunina-Barkovskaya",book:{id:"9496",title:"Dyslipidemia",subtitle:null,fullTitle:"Dyslipidemia",slug:null,publishedDate:null,bookSignature:"Dr. Wilbert S. Aronow",coverURL:"https://cdn.intechopen.com/books/images_new/9496.jpg",licenceType:"CC BY 3.0",editedByType:null,editors:[{id:"164597",title:"Dr.",name:"Wilbert S.",middleName:null,surname:"Aronow",slug:"wilbert-s.-aronow",fullName:"Wilbert S. Aronow"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}},authors:[{id:"116265",title:"Dr.",name:"Antonina",middleName:null,surname:"Dunina-Barkovskaya",fullName:"Antonina Dunina-Barkovskaya",slug:"antonina-dunina-barkovskaya",email:"dunina@belozersky.msu.ru",position:null,institution:null}],sections:[{id:"sec_1",title:"1. Introduction",level:"1"},{id:"sec_2",title:"2. Some interactions of enveloped viruses with host cells are cholesterol-dependent",level:"1"},{id:"sec_3",title:"3. Virus-induced modulations of the lipid composition of cell membranes. Formation of viral envelope can result in a hazardous decrease in the cholesterol content in cell membranes",level:"1"},{id:"sec_4",title:"4. Cholesterol recognition/interaction amino acid consensus (CRAC) motifs in viral proteins. Possible uses of CRAC-containing peptides",level:"1"},{id:"sec_5",title:"5. Conclusions",level:"1"},{id:"sec_6",title:"Acknowledgments",level:"1"},{id:"sec_9",title:"Conflict of interest",level:"1"}],chapterReferences:[{id:"B1",body:'Zhou P, Yang X-L, Wang X-G, Hu B, Zhang L, Zhang W. et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270-273 DOI: 10.1038/s41586-020-2012-7'},{id:"B2",body:'WHO Coronavirus Disease (COVID-19) Dashboard, Data last updated: 2021/1/7. Available from: https://covid19.who.int/ Accessed: 2021-01-07]'},{id:"B3",body:'Guan WJ, Liang WH, Zhao Y, et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: A nationwide analysis. Eur Respir J. 2020;55:2000547. DOI: 10.1183/13993003.00547-2020'},{id:"B4",body:'Vinciguerra M, Romiti S, Fattouch K, De Bellis A, Greco E. Atherosclerosis as pathogenetic substrate for SARS-Cov2 cytokine storm. J Clin Med. 2020;9(7):2095. DOI:10.3390/jcm9072095'},{id:"B5",body:'Dodek P. Diabetes and other comorbidities were associated with a poor outcome in the severe acute respiratory syndrome. ACP J Club. 2004;140(1):19. DOI: 10.1001/jama.289.21.JOC30885'},{id:"B6",body:'Scully EP, Haverfield J, Ursin RL, Tannenbaum C, Klein SL. Considering how biological sex impacts immune responses and COVID-19 outcomes. Nat Rev Immunol. 2020;20:442-447. DOI: 10.1038/s41577-020-0348-8'},{id:"B7",body:'Dudley JP, Lee NT. Disparities in age-specific morbidity and mortality from SARS-CoV-2 in China and the Republic of Korea. Clinical Infectious Diseases. 2020; 71(15):863-865. DOI: 10.1093/cid/ciaa354'},{id:"B8",body:'Potluri T, Fink AL, Sylvia KE, Dhakal S, Vermillion MS, Vom Steeg L, Deshpande S, Narasimhan H, Klein SL. Age-associated changes in the impact of sex steroids on influenza vaccine responses in males and females. NPJ Vaccines. 2019;4:29. DOI: 10.1038/s41541-019-0124-6. Erratum in: NPJ Vaccines. 2019;4:35.'},{id:"B9",body:'Huang C, Wang Y, Li X, Ren L, Zhao J., Hu Y, Zhang L, Fan G, Xu J, Gu X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497-506. DOI: 10.1016/S0140-6736(20)30183-54'},{id:"B10",body:'Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, Wang W, Song H, Huang B., Zhu N., et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding. Lancet. 2020;395:565-574. DOI: 10.1016/S0140-6736(20)30251-8'},{id:"B11",body:'Wu SC. Progress and concept for COVID-19 vaccine development. Biotechnol J. 2020;15(6):e2000147. DOI:10.1002/biot.202000147'},{id:"B12",body:'Ledford H. Moderna COVID vaccine becomes second to get US authorization. Two RNA vaccines will be useful as US infections surge, but the speedy authorizations complicate clinical trials. Nature NEWS. 2020. 18 December 2020. Update 19 December 2020. Available from: https://doi.org/10.1038/d41586-020-03593-7 [Accessed: 2021-01-07]'},{id:"B13",body:'Radenkovic D, Chawla S, Pirro M, Sahebkar A, Banach M. Cholesterol in relation to COVID-19: Should we care about it? J Clin Med. 2020;9:1909. DOI: 10.3390/jcm9061909'},{id:"B14",body:'Kočar E, Režen T, Rozman D. Cholesterol, lipoproteins, and COVID-19: Basic concepts and clinical applications. Biochim Biophys Acta Mol Cell Biol Lipids. 2020;1866(2):158849. DOI: 10.1016/j.bbalip.2020.158849'},{id:"B15",body:'Abu-Farha M, Thanaraj TA, Qaddoumi MG, Hashem A, Abubaker J, Al-Mulla ad Fahd.The role of lipid metabolism in COVID-19 virus infection and as a drug target. Int J Mol Sci. 2020;21:3544. DOI:10.3390/ijms21103544 www.mdpi'},{id:"B16",body:'Li H, Papadopoulos V. Peripheral–type benzodiazepine receptor function in cholesterol transport. Identification of a putative cholesterol recognition/interaction amino acid sequence and consensus pattern. Endocrinology. 1998;139:4991-4997. DOI: 10.1016/s0039-128x(96)00154-7'},{id:"B17",body:'Li H, Yao Z, Degenhardt B, Teper, G, Papadopoulos V. Cholesterol binding at the cholesterol recognition/interaction amino acid consensus (CRAC) of the peripheral–type benzodiazepine receptor and inhibition of steroidogenesis by an HIV TAT–CRAC peptide. Proc Natl Acad Sci USA. 2001;98:1267-1272. DOI: 10.1073/pnas.031461598'},{id:"B18",body:'Jones JE, Le Sage V., Lakdawala SS. Viral and host heterogeneity and their effects on the viral life cycle. Nat Rev Microbiol. 2020;Oct 6:1-11. DOI: 10.1038/s41579-020-00449-9'},{id:"B19",body:'V\'kovski P, Kratzel A, Steiner S, Stalder H, Thiel V. Coronavirus biology and replication: Implications for SARS-CoV-2. Nat Rev Microbiol. 2020;28:1-16. DOI: 10.1038/s41579-020-00468-6'},{id:"B20",body:'de Haan CAM, Rottier PJM. Molecular interactions in the assembly of coronaviruses. Adv Virus Res. 2005;64:165-230. DOI: 10.1016/S0065-3527(05)64006-7'},{id:"B21",body:'Chazal N, Gerlier D. Virus entry, assembly, budding, and membrane rafts. Microbiol Mol Biol Rev. 2003;67:226-237. DOI: 10.1128/mmbr.67.2.226-237.2003'},{id:"B22",body:'Nayak DP, Hui EK. The role of lipid microdomains in virus biology. Subcell Biochem. 2004;37:443-491. DOI: 10.1007/978-1-4757-5806-1_14'},{id:"B23",body:'Rawat SS, Viard M, Gallo SA, Rein A, Blumenthal R, Puri A. Modulation of entry of enveloped viruses by cholesterol and sphingolipids (Review). Mol Membr Biol. 2003;20(3):243-254. DOI: 10.1080/0968768031000104944'},{id:"B24",body:'Sezgin E, Levental I, Mayor S, Eggeling C. The mystery of membrane organization: Composition, regulation and roles of lipid rafts. Nat Rev Mol Cell Biol. 2017;18:361-374. DOI: 10.1038/nrm.2017.16'},{id:"B25",body:'Brown DA, London E. Structure and origin of ordered lipid domains in biological membranes. J Membr Biol. 1998;164:103-114. DOI: 10.1007/s002329900397'},{id:"B26",body:'Harder T, Scheiffele P, Verkade P, Simons K. Lipid domain structure of the plasma membrane revealed by patching of membrane components. J Cell Biol. 1998;141:929-942. DOI: 10.1083/jcb.141.4.929'},{id:"B27",body:'Carter GC, Bernstone L, Sangani D, Bee JW, Harder T, James W. HIV entry in macrophages is dependent on intact lipid rafts. Virology. 2009;386(1):192-202. DOI: 10.1016/j.virol.2008.12.031'},{id:"B28",body:'Campbell SM, Crowe SM, Mak J. Virion-associated cholesterol is critical for the maintenance of HIV-1 structure and infectivity. AIDS. 2002;16:2253-2261. DOI: 10.1097/00002030-200211220-00004'},{id:"B29",body:'Graham DR, Chertova E, Hilburn JM, Arthur LO, Hildreth JE. Cholesterol depletion of human immunodeficiency virus type 1 and simian immunodeficiency virus with b-cyclodextrin inactivates and permeabilizes the virions: evidence for virion-associated lipid rafts. J Virol. 2003;77:8237-8248. DOI: 10.1128/jvi.77.15.8237-8248.2003'},{id:"B30",body:'Sviridov D, Mukhamedova N, Makarov AA, Adzhubei A, Bukrinsky M. Comorbidities of HIV infection: Role of Nef-induced impairment of cholesterol metabolism and lipid raft functionality. AIDS. 2020;34:1-13. DOI: 10.1097/QAD.0000000000002385'},{id:"B31",body:'Sung-Tae Y, Kiessling V, Simmons JA, et al. HIV gp41-mediated membrane fusion occurs at edges of cholesterol-rich lipid domains. Nat Chem Biol. 2015;11:424-431. DOI: 10.1038/nchembio.1800'},{id:"B32",body:'Keller P, Simons K. Cholesterol is required for surface transport of influenza virus hemagglutinin. J Cell Biol. 1998;140(6):1357-1367. DOI: 10.1083/jcb.140.6.1357'},{id:"B33",body:'Gerl MJ, Sampaio JL, Urban S, Kalvodova L, Verbavatz JM, Binnington B, Lindemann D, Lingwood CA, Shevchenko A, Schroeder C, Simons K. Quantitative analysis of the lipidomes of the influenza virus envelope and MDCK cell apical membrane. J Cell Biol. 2012;196(2):213-221. DOI: 10.1083/jcb.201108175'},{id:"B34",body:'Nayak DP, Hui EK-W, Barman S. Assembly and budding of influenza virus. Virus Res. 2004;106:147-165. DOI: 10.1016/j.virusres.2004.08.012'},{id:"B35",body:'Zhang J, Pekosz A, Lamb RA. Influenza virus assembly and lipid raft microdomains: A role for the cytoplasmic tails of the spike glycoproteins. J Virol. 2000;74:4634-4644. DOI: 10.1128/jvi.74.10.4634-4644.2000'},{id:"B36",body:'Veit M, Thaa B. Association of influenza virus proteins with membrane rafts. Adv Virol. 2011;2011:Article ID 370606. DOI: 10.1155/2011/370606'},{id:"B37",body:'Ali A, Avalos RT, Ponimaskin E, Nayak DP. Influenza virus assembly: Effect of influenza virus glycoproteins on the membrane association of M1 protein. J Virol. 2000;74:8709-8719. DOI: 10.1128/jvi.74.18.8709-8719.2000'},{id:"B38",body:'Bender FC, Whitbeck JC, Ponce de Leon M, Lou H, Eisenberg RJ, Cohen GH. Specific association of glycoprotein B with lipid rafts during herpes simplex virus entry. J Virol. 2003;77:9542-9552. DOI: 10.1128/jvi.77.17.9542-9552.2003'},{id:"B39",body:'Laliberte JP, McGinnes LW, Morrison TG, Incorporation of functional HN-F glycoprotein-containing complexes into Newcastle disease virus is dependent on cholesterol and membrane lipid integrity. J Virol. 2007;81:10636-10648. DOI: 10.1128/JVI.01119-07'},{id:"B40",body:'Dou X, Li Y, Han J, Zarlenga DS, Zhu W, Ren X, Dong N, Li X, Li G. Cholesterol of lipid rafts is a key determinant for entry and post-entry control of porcine rotavirus infection. BMC Vet Res. 2018;14(1):45. DOI: 10.1186/s12917-018-1366-7'},{id:"B41",body:'Stoeck IK, Lee J-Y, Tabata K, Romero-Brey I, Paul D, Schult P, Lohmann V, Kaderali L, Bartenschlager R. Hepatitis C virus replication depends on endosomal cholesterol homeostasis. J Virol. 2018;92:e01196-17. DOI: 10.1128/JVI.01196-17'},{id:"B42",body:'Paul D, Hoppe S, Saher G, Krijnse-Locker J, Bartenschlager R. Morphological and biochemical characterization of the membranous hepatitis C virus replication compartment. J Virol. 2013;87(19):10612-10627. DOI:10.1128/JVI.01370-13'},{id:"B43",body:'Elgner F, Ren H, Medvedev R, Ploen D, Himmelsbach K, Boller K, Hildt E. The intracellular cholesterol transport inhibitor U18666A inhibits the exosome-dependent release of mature hepatitis C virus. J Virol. 2016;90:11181-11196. DOI: 10.1128/JVI.01053-16'},{id:"B44",body:'Leier HC, Messer WB, Tafesse FG. Lipids and pathogenic flaviviruses: An intimate union. PloS Pathogens. 2018;14(5):e1006952. DOI: 10.1371/journal.ppat. 1006952'},{id:"B45",body:'Osuna-Ramos JF, Reyes-Ruiz JM, Del Angel RM. The role of host cholesterol during flavivirus infection. Front Cell Infect Microbiol. 2018;8:388. DOI: 10.3389/fcimb.2018.00388'},{id:"B46",body:'Cervin M, Anderson R. Modulation of coronavirus-mediated cell fusion by homeostatic control of cholesterol and fatty acid metabolism. J Med Virol. 1991;35:142-149. DOI: 10.1002/jmv.1890350213'},{id:"B47",body:'Thorp EB, Gallagher TM. Requirements for CEACAMs and cholesterol during murine coronavirus cell entry. J Virol. 2004;78(6):2682-2692. DOI: 10.1128/jvi.78.6.2682-2692.2004'},{id:"B48",body:'Choi KS., Aizaki H, Lai MMC. Murine coronavirus requires lipid rafts for virus entry and cell-cell fusion but not for virus release. J Virol. 2005;79(15):9862-9871. DOI: 10.1128/JVI.79.15.9862-9871.2005'},{id:"B49",body:'Pratelli A, Colao V. Role of the lipid rafts in the life cycle of canine coronavirus. J Gen Virol. 2015;96(Pt 2):331-337. DOI: 10.1099/vir.0.070870-0'},{id:"B50",body:'Li G-M, Li Y-G, Yamate M, Li S-M, Ikuta K. Lipid rafts play an important role in the early stage of severe acute respiratory syndrome-coronavirus life cycle. Microbes and Infection. 2007;9:96-102. DOI: 10.1016/j.micinf.2006.10.015'},{id:"B51",body:'Glende J, Schwegmann-Wessels C, Al-Falah M, Pfefferle S, Qu X, Deng H, Drosten C, Naim HY, Herrler G. Importance of cholesterol-rich membrane microdomains in the interaction of the S protein of SARS-coronavirus with the cellular receptor angiotensin-converting enzyme 2. Virology. 2008;381(2):215-221. DOI: 10.1016/j.virol.2008.08.026'},{id:"B52",body:'Lee W, Ahn JH, Park HH, Kim HN, Kim H, Yoo Y, Shin H, Hong KS, Jang JG, Park CG, Choi EY, Bae J, Seo Y. COVID-19-activated SREBP2 disturbs cholesterol biosynthesis and leads to cytokine storm. Signal Transduct Target Ther. 2020;5. DOI: 10.1038/s41392-020-00292-7.'},{id:"B53",body:'Raulin J. Human immunodeficiency virus and host cell lipids. Interesting pathways in research for a new HIV therapy. Prog Lipid Res. 2002;41(1):27-65. DOI: 10.1016/s0163-7827(01)00019-4'},{id:"B54",body:'Wang S, Li W, Hui H, Tiwari SK, Zhang Q, Croker BA, Rawlings S, Smith D, Carlin AF, Rana TM. Cholesterol 25-Hydroxylase inhibits SARS-CoV-2 and other coronaviruses by depleting membrane cholesterol. EMBO J. 2020;39(21):e106057. DOI: 10.15252/embj.2020106057'},{id:"B55",body:'Veterinary Virology. Academic Press, 1987. Chapter 1, Structure and Composition of Viruses. DOI: https://doi.org/10.1016/C2013-0-10647-2'},{id:"B56",body:'Nguyen DH, Hildreth JE. Evidence for budding of human immunodeficiency virus type 1 selectively from glycolipid-enriched membrane lipid rafts. J Virol. 2000;74(7):3264-3272. DOI: 10.1128/jvi.74.7.3264-3272.2000'},{id:"B57",body:'Chazal N, Gerlier D. Virus entry, assembly, budding, and membrane rafts. Microbiol Mol Biol Rev. 2003;67(2):226-237. DOI: 10.1128/mmbr.67.2.226-237.2003'},{id:"B58",body:'Wilflingseder D, Stoiber H. Float on: Lipid rafts in the lifecycle of HIV. Front Biosci. 2007;12:2124-2135. DOI: 10.2741/2216.'},{id:"B59",body:'Navaratnarajah CK, Warrier R, Kuhn RJ. Assembly of Viruses: Enveloped Particles. Encyclopedia of Virology. 2008;193-200. DOI: 10.1016/B978-012374410-4.00667-1'},{id:"B60",body:'Miller S, Krijnse-Locker J. Modification of intracellular membrane structures for virus replication. Nat Rev Microbiol. 2008;6:363-374. DOI: 10.1038/nrmicro1890'},{id:"B61",body:'Lorizate M, Kräusslich HG. Role of lipids in virus replication. Cold Spring Harb Perspect Biol. 2011;3(10):a004820. DOI:10.1101/cshperspect.a004820.'},{id:"B62",body:'Welsch S, Müller B, Kräusslich HG. More than one door – Budding of enveloped viruses through cellular membranes. FEBS Lett. 2007;581(11):2089-2097. DOI: 10.1016/j.febslet.2007.03.060'},{id:"B63",body:'Pagliari F, Marafioti MG, Genard G, Candeloro P, Viglietto G, Seco J, Tirinato L. ssRNA virus and host lipid rearrangements: Is there a role for lipid droplets in SARS-CoV-2 infection? Front Mol Biosci. 2020;7:578964. DOI: 10.3389/fmolb.2020.578964'},{id:"B64",body:'Sung-Tae Y, Kiessling V, Simmons JA, et al. HIV gp41-mediated membrane fusion occurs at edges of cholesterol-rich lipid domains. Nat Chem Biol. 2015;11:424-431. DOI: 10.1038/nchembio.1800'},{id:"B65",body:'Zhang Z, He G, Filipowicz NA, Randall G, Belov GA, Kopek BG, Wang X. Host lipids in positive-strand RNA virus genome replication. Front Microbiol. 2019;10:286. DOI: 10.3389/fmicb.2019.00286'},{id:"B66",body:'Bender SJ, Phillips JM, Scott EP, Weiss SR. Murine coronavirus receptors are differentially expressed in the central nervous system and play virus strain-dependent roles in neuronal spread. J Virology. 2010;84(21):11030-11044; DOI: 10.1128/JVI.02688-09'},{id:"B67",body:'Lu YE, Cassese T, Kielian M. The cholesterol requirement for Sindbis virus entry and exit and characterization of a spike protein region involved in cholesterol dependence. J Virology. 1999;73(5):4272-4278. DOI: 10.1128/JVI.73.5.4272-4278.1999'},{id:"B68",body:'DeTulleo L, Kirchhausen T. The clathrin endocytic pathway in viral infection. EMBO J. 1998;17(16):4585-4593. DOI:10.1093/emboj/17.16.4585'},{id:"B69",body:'Callens N, Brügger B, Bonnafous P, Drobecq H, Gerl MJ, Krey T, et al. Morphology and molecular composition of purified bovine viral diarrhea virus envelope. PLoS Pathog. 2016;12(3):e1005476. DOI: 10.1371/journal.ppat.1005476'},{id:"B70",body:'Laliberte JP, McGinnes LW, Morrison TG. Incorporation of functional HN-F glycoprotein-containing complexes into Newcastle disease virus is dependent on cholesterol and membrane lipid integrity. J Virol. 2007;81:10636-10648. DOI: 10.1128/JVI.01119-07'},{id:"B71",body:'Wattenberg BW, Silbert DF. Sterol partitioning among intracellular membranes. Testing a model for cellular sterol distribution. J Biol Chem. 1983;258(4):2284-2289.'},{id:"B72",body:'Kaplan MR, Simoni RD. Transport of cholesterol from the endoplasmic reticulum to the plasma membrane. J Cell Biol. 1985;101(2):446-453. DOI: 10.1083/jcb.101.2.446'},{id:"B73",body:'Lange Y, Swaisgood MH, Ramos BV, Steck TL. Plasma membranes contain half the phospholipid and 90% of the cholesterol and sphingomyelin in cultured human fibroblasts. J Biol Chem. 1989;264(7):3786-3793.'},{id:"B74",body:'Litvinov DY, Savushkin EV, & Dergunov AD. Intracellular and plasma membrane events in cholesterol transport and homeostasis. J Lipids. 2018;2018:3965054. DOI: 10.1155/2018/3965054'},{id:"B75",body:'van\'t Wout AB, Swain JV, Schindler M, Rao U, Pathmajeyan MS, Mullins JI, Kirchhoff F. Nef induces multiple genes involved in cholesterol synthesis and uptake in human immunodeficiency virus type 1-infected T cells. J Virology. 2005;79(15):10053-10058. DOI: 10.1128/JVI.79.15.10053-10058.2005'},{id:"B76",body:'Jennelle L, Hunegnaw R, Dubrovsky L, Pushkarsky T, Fitzgerald ML, Sviridov D, Popratiloff A, Brichacek B, Bukrinsky M. HIV-1 protein Nef inhibits activity of ATP-binding cassette transporter A1 by targeting endoplasmic reticulum chaperone calnexin. J Biol Chem. 2014;289(42):28870-28884. DOI: 10.1074/jbc.M114.583591'},{id:"B77",body:'Stertz S, Reichelt M, Spiegel M, Kuri T, Martínez-Sobrido L, García-Sastre A, Weber F, Kochs G. The intracellular sites of early replication and budding of SARS-coronavirus. Virology. 2007;361:304-315. DOI: 10.1016/j.virol.2006.11.027'},{id:"B78",body:'Wang S, Li W, Hui H, Tiwari SK, Zhang Q, Croker BA, Rawlings S, Smith D, Carlin AF, Rana TM. Cholesterol 25-Hydroxylase inhibits SARS-CoV-2 and other coronaviruses by depleting membrane cholesterol. EMBO J. 2020;39(21):e106057. DOI: 10.15252/embj.2020106057'},{id:"B79",body:'Olsen BN, Schlesinger PH, Ory DS, Baker NA. 25-Hydroxycholesterol increases the availability of cholesterol in phospholipid membranes. Biophys J. 2011;100(4):948-956. DOI: 10.1016/j.bpj.2010.12.3728'},{id:"B80",body:'Ikonen E. Cellular cholesterol trafficking and compartmentalization. Nat. Rev. Mol. Cell Biol. 2008;9(2):125-138. DOI: 10.1038/nrm2336'},{id:"B81",body:'Johansson AC, Appelqvist H, Nilsson C, Kågedal K, Roberg K, Ollinger K. Regulation of apoptosis-associated lysosomal membrane permeabilization. Apoptosis. 2010;15(5):527-540. DOI: 10.1007/s10495-009-0452-5'},{id:"B82",body:'Khatibzadeh N, Spector AA, Brownell WE, Anvari B. Effects of plasma membrane cholesterol level and cytoskeleton F-actin on cell protrusion mechanics. PLoS ONE. 2013;8(2): e57147. DOI: 10.1371/journal.pone.0057147'},{id:"B83",body:'Biswas A, Kashyap P, Datta S, Sengupta T, Sinha B. Cholesterol depletion by mβCD enhances cell membrane tension and its variations-reducing integrity. Biophys J. 2019;116(8):1456-1468. DOI: 10.1016/j.bpj.2019.03.016'},{id:"B84",body:'Appelqvist H, Nilsson C, Garner B, Brown AJ, Kågedal K, Ollinger K. Attenuation of the lysosomal death pathway by lysosomal cholesterol accumulation. Am J Pathol. 2011;178(2):629-639. DOI: 10.1016/j.ajpath.2010.10.030'},{id:"B85",body:'Zhang L, Kim SB, Luitel K, Shay JW. Cholesterol depletion by TASIN-1 induces apoptotic cell death through the ER stress/ROS/JNK signaling in colon cancer cells. Mol Cancer Ther. 2018;17(5):943-951. DOI: 10.1158/1535-7163'},{id:"B86",body:'Hsu SPC, Kuo JS, Chiang HC, Wang HE, Wang YS, Huang CC, Huang YC, Chi MS, Mehta MP, Chi KH. Temozolomide, sirolimus and chloroquine is a new therapeutic combination that synergizes to disrupt lysosomal function and cholesterol homeostasis in GBM cells. Oncotarget. 2018;9(6):6883-6896. DOI: 10.18632/oncotarget.23855'},{id:"B87",body:'King MA, Ganley IG, Flemington V. Inhibition of cholesterol metabolism underlies synergy between mTOR pathway inhibition and chloroquine in bladder cancer cells. Oncogene. 2016;35(34):4518-4528. DOI: 10.1038/onc.2015.511'},{id:"B88",body:'Hu X, Chen D, Wu L, He G, Ye W. Declined serum high density lipoprotein cholesterol is associated with the severity of COVID-19 infection. Clin Chim Acta. 2020;510:105-110. DOI: 10.1016/j.cca.2020.07.015'},{id:"B89",body:'Coronavirus breakthrough: Dexamethasone is first drug shown to save lives. Nature. 2020;582:469. DOI: 10.1038/d41586-020-01824-5'},{id:"B90",body:'RECOVERY Collaborative Group, Horby P, Lim WS, Emberson JR, Mafham M, et al. Effect of dexamethasone in hospitalized patients with COVID-19. Preliminary report. N Engl J Med. 2020 Jul 17:NEJMoa2021436.DOI: 10.1056/NEJMoa2021436'},{id:"B91",body:'Gozzo L, Longo L, Vitale DC, Drago F. Dexamethasone treatment for Covid-19, a curious precedent highlighting a regulatory gap. Frontiers in Pharmacol. 2020;11:621934. DOI: https://doi.org/10.3389/fphar.2020.621934'},{id:"B92",body:'Weir EK, Thenappan T, Bhargava M, Chen Y. Does vitamin D deficiency increase the severity of COVID-19? Clin Med (Lond). 2020;20(4):e107-e108. DOI: 10.7861/clinmed.2020-0301'},{id:"B93",body:'Jamin N, Neumann JM, Ostuni MA, Vu TK, Yao ZX, Murail S, Robert JC, Giatzakis C, Papadopoulos V, Lacapère JJ. Characterization of the cholesterol recognition amino acid consensus sequence of the peripheral-type benzodiazepine receptor. Mol Endocrinol. 2005;19(3):588-594. DOI: 10.1210/me.2004-0308'},{id:"B94",body:'Listowski MA, Leluk J, Kraszewski S, Sikorski AF. Cholesterol interaction with the MAGUK protein family member, MPP1, via CRAC and CRAC-like motifs: An in silico docking analysis. PLoS One. 2015;10(7):e0133141. DOI:10.1371/journal. Pone.0133141'},{id:"B95",body:'Fantini J, Epand RM, Barrantes FJ. Cholesterol-recognition motifs in membrane proteins. In: Direct mechanisms in cholesterol modulation of protein function. Eds Rosenhouse-Dantsker A., Bukiya A.N. Series Advances in experimental medicine and biology, 2019. vol. 1135. Cham: Springer, p. 3-25. DOI: 10.1007/978-3-030-14265-0_1'},{id:"B96",body:'Epand RM. Cholesterol and the interaction of proteins with membrane domains. Prog Lipid Res. 2006;45:279-294. DOI: 10.1016/j.plipres.2006.02.001'},{id:"B97",body:'Palmer M. Cholesterol and the activity of bacterial toxins. FEMS Microbiol Lett. 2004;238:281-289. DOI: 10.1016/j.femsle.2004.07.059'},{id:"B98",body:'Epand RF, Thomas A., Brasseur R., Vishwanathan SA, Hunter E, Epand RM. Juxtamembrane protein segments that contribute to recruitment of cholesterol into domains. Biochemistry. 2006;45:6105-6114. DOI: 10.1021/bi060245+'},{id:"B99",body:'Miller CM, Brown AC, Mittal J. Disorder in cholesterol-binding functionality of CRAC peptides: A molecular dynamics study. J Phys Chem B. 2014;118:13169-13174. DOI: 10.1021/jp5106423'},{id:"B100",body:'Song Y, Kenworthy AK, Sanders CR. Cholesterol as a co-solvent and a ligand for membrane proteins. Protein Science. 2014;23:1-22. DOI: 10.1002/pro.2385'},{id:"B101",body:'He W, Mazzuca P, Yuan W, Varney K, Bugatti A, Cagnotto A, Giagulli C, Rusnati M, Marsico S, Diomede L, Salmona M, Caruso A, Lu W, Caccuri F. Identification of amino acid residues critical for the B cell growth-promoting activity of HIV-1 matrix protein p17 variants. Biochim. Biophys Acta Gen Subj. 2019;1863(1):13-24. DOI: 10.1016/j.bbagen.2018.09.016'},{id:"B102",body:'Hanson JM, Gettel DL, Tabaei SR, Jackman J, Kim MC, Sasaki DY, Groves JT, Liedberg B, Cho N-J, Parikh AN. Cholesterol-enriched domain formation induced by viral-encoded, membrane-active amphipathic peptide. Biophys J. 2016;110:176-187. DOI: 10.1016/j.bpj.2015.11.032'},{id:"B103",body:'Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV. A virocidal amphipathic α-helical peptide that inhibits hepatitis C virus infection in vitro. Proc Natl Acad Sci USA. 2008;105:3088-3093. DOI: 10.1073/pnas.0712380105'},{id:"B104",body:'Gallay PA, Chatterji U, Kirchhoff A, Gandarilla A, Pyles RB, Baum MM, Moss JA. Protection efficacy of C5A against vaginal and rectal HIV challenges in humanized mice. Open Virol J. 2018;12:1-13. DOI: 10.2174/1874357901812010001'},{id:"B105",body:'Schroeder C. Cholesterol-binding viral proteins in virus entry and morphogenesis. Subcell Biochem. 2010;51:77-108. DOI: 10.1007/978-90-481-8622-8_3'},{id:"B106",body:'Tsfasman T, Kost V, Markushin S, Lotte V, Koptiaeva I, Bogacheva E, Baratova L, Radyukhin V. Amphipathic alpha–helices and putative cholesterol binding domains of the influenza virus matrix M1 protein are crucial for virion structure organization. Virus Res. 2015;210:114-118. DOI: 10.1016/j.virusres.2015.07.017'},{id:"B107",body:'Radyukhin VA, Dadinova LA, Orlov IA, Baratova LA. Amphipathic secondary structure elements and putative cholesterol recognizing amino acid consensus (CRAC) motifs as governing factors of highly specific matrix protein interactions with raft–type membranes in enveloped viruses. J Biomol Str Dynam. 2018;36:1351-1359. DOI: 10.1080/07391102.2017.1323012'},{id:"B108",body:'Dunina-Barkovskaya AY, Vishnyakova KS, Golovko AO, Arutyunyan AM, Baratova LA, Batishchev OV, Radyukhin VA. Amphipathic CRAC-containing peptides derived from the influenza virus A M1 protein modulate cholesterol-dependent activity of cultured IC-21 macrophages. Biochemistry (Moscow). 2018;83(8):982-991. DOI: https://doi.org/10.1134/S0006297918080096'},{id:"B109",body:'Dunina-Barkovskaya AY, Vishnyakova KS, Baratova LA, Radyukhin VA. Modulation of cholesterol-dependent activity of macrophages IC-21 by a peptide containing two CRAC-motifs from protein M1 of influenza virus. Biochemistry (Moscow) Suppl Series A Membr Cell Biol. 2019;13(3): 268-276. DOI: https://doi.org/10.1134/S1990747819030139'},{id:"B110",body:'Dunina-Barkovskaya AY, Vishnyakova KS. Modulation of the cholesterol-dependent activity of macrophages IC-21 by CRAC peptides with substituted motif-forming amino acids. Biochemistry (Moscow) Suppl Series A Membr Cell Biol. 2020;14(4):331-343. DOI: https://doi.org/10.1134/S1990747820040054'},{id:"B111",body:'Corver J, Broer R, van Kasteren P, Spaan W. Mutagenesis of the transmembrane domain of the SARS coronavirus spike glycoprotein: Refinement of the requirements for SARS coronavirus cell entry. Virol J. 2009;6:230. DOI: 10.1186/1743-422X- 6-230'},{id:"B112",body:'Liu Z, Xiao X, Wei X, et al. Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS-CoV-2. J Med Virol. 2020;1-7. DOI: 10.1002/jmv.25726'},{id:"B113",body:'Baglivo M, Baronio M, Natalini G, Beccari T, Chiurazzi P, Fulcheri E, Petralia PP, Michelini S, Fiorentini G, Miggiano GA, Morresi A, Tonini G, Bertelli M. Natural small molecules as inhibitors of coronavirus lipid-dependent attachment to host cells: a possible strategy for reducing SARS-COV-2 infectivity? Acta Biomed. 2020;91(1):161-164. DOI: 10.23750/abm.v91i1.9402.'},{id:"B114",body:'Zidovetzki R, Levitan I. Use of cyclodextrins to manipulate plasma membrane cholesterol content: Evidence, misconceptions and control strategies. Biochim Biophys Acta. 2007;1768:1311-1324. DOI: 10.1016/j.bbamem.2007.03.026'},{id:"B115",body:'Kurkov SV, Loftsson T. Cyclodextrins. Int J Pharm. 2013;453(1):167-80. DOI: 10.1016/j.ijpharm.2012.06.055'},{id:"B116",body:'Leclercq L. 2016. Interactions between cyclodextrins and cellular components: Towards greener medical applications? Beilstein J Org Chem. 12, 2644-2662.DOI: 10.3762/bjoc.12.261'},{id:"B117",body:'Taylor A M, Liu B, Mari Y, Liu B, Repa JJ. Cyclodextrin mediates rapid changes in lipid balance in Npc1−/− mice without carrying cholesterol through the bloodstream. J Lipid Res. 2012;53(11):2331-2342. DOI: 10.1194/jlr.M028241'},{id:"B118",body:'Matsuo M, Togawa M, Hirabaru K, Mochinaga S, Narita A, Adachi M, Egashira M, Irie T, Ohno K. Effects of cyclodextrin in two patients with Niemann-Pick Type C disease. Mol Genet Metab. 2013;108(1):76-81. DOI: 10.1016/j.ymgme.2012.11.005.'},{id:"B119",body:'Glinsky GV. Tripartite combination of candidate pandemic mitigation agents: Vitamin D, quercetin, and estradiol manifest properties of medicinal agents for targeted mitigation of the COVID-19 pandemic defined by genomics-guided tracing of SARS-CoV-2 targets in human cells. Biomedicines. 2020;8(5):129. DOI: 10.3390/biomedicines8050129'},{id:"B120",body:'Cinatl J, Morgenstern B, Bauer G, Chandra P, Rabenau H, Doerr HW. Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. Lancet. 2003;361:2045-2046. DOI: 10.1016/s0140-6736(03)13615-x'},{id:"B121",body:'Bailly C, Vergoten G. Glycyrrhizin: An alternative drug for the treatment of COVID-19 infection and the associated respiratory syndrome? Pharmacol Therapeutics. 2020;214:107618. DOI: 10.1016/j.pharmthera.2020.107618'},{id:"B122",body:'Brown AC, Koufos E, Balashova NV, Boesze-Battaglia K, Lally ET. Inhibition of LtxA toxicity by blocking cholesterol binding with peptides. Molecular Oral Microbiology. 2016;31(1):94-105. DOI: 10.1111/omi.12133'},{id:"B123",body:'Lecanu L, Yao ZX, McCourty A, Sidahmed el-K, Orellana ME, Burnier MN, Papadopoulos V. Control of hypercholesterolemia and atherosclerosis using the cholesterol recognition/interaction amino acid sequence of the translocator protein TSPO. Steroids. 2013;78(2):137-146. DOI: 10.1016/j.steroids.2012.10.018'}],footnotes:[],contributors:[{corresp:"yes",contributorFullName:"Antonina Dunina-Barkovskaya",address:"dunina@belozersky.msu.ru",affiliation:'
Belozersky Institute of Physico-Chemical Biology, Moscow Lomonosov State University, Moscow, Russia
'}],corrections:null},book:{id:"9496",title:"Dyslipidemia",subtitle:null,fullTitle:"Dyslipidemia",slug:null,publishedDate:null,bookSignature:"Dr. Wilbert S. Aronow",coverURL:"https://cdn.intechopen.com/books/images_new/9496.jpg",licenceType:"CC BY 3.0",editedByType:null,editors:[{id:"164597",title:"Dr.",name:"Wilbert S.",middleName:null,surname:"Aronow",slug:"wilbert-s.-aronow",fullName:"Wilbert S. Aronow"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}}},profile:{item:{id:"304543",title:"Prof.",name:"Luis",middleName:null,surname:"De La Maza",email:"lmdelama@uci.edu",fullName:"Luis De La Maza",slug:"luis-de-la-maza",position:null,biography:null,institutionString:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",totalCites:0,totalChapterViews:"0",outsideEditionCount:0,totalAuthoredChapters:"1",totalEditedBooks:"0",personalWebsiteURL:null,twitterURL:null,linkedinURL:null,institution:null},booksEdited:[],chaptersAuthored:[{title:"A Noninvasive, Orally Stable, Mucosa-Penetrating Polyvalent Vaccine Platform Based on Hepatitis E Virus Nanoparticle",slug:"a-noninvasive-orally-stable-mucosa-penetrating-polyvalent-vaccine-platform-based-on-hepatitis-e-viru",abstract:"Hepatitis E virus nanoparticle (HEVNP) is an orally stable, mucosa-penetrating delivery platform for noninvasive, targeted delivery of therapeutic and diagnostic agents. HEVNP does not carry HEV genomic RNA and is incapable of replication. The key characteristics that make HEVNP an ideal and unique vehicle for diagnostic and therapeutic delivery include surface plasticity, resistance to the harsh environment of the gastrointestinal (GI) tract, significant payload capacity, platform sustainability, and safety. Furthermore, HEVNP is easily produced using currently available expression/purification technologies; can be easily formulated as a liquid, powder, or solid; and can be distributed (and stored) without the need for a temperature-controlled supply chain.",signatures:"Shizuo G. Kamita, Mo A. Baikoghli, Luis M. de la Maza and R. Holland Cheng",authors:[{id:"242476",title:"Distinguished Prof.",name:"R. Holland",surname:"Cheng",fullName:"R. Holland Cheng",slug:"r.-holland-cheng",email:"rhch@ucdavis.edu"},{id:"258461",title:"Dr.",name:"Mo",surname:"Baikoghli",fullName:"Mo Baikoghli",slug:"mo-baikoghli",email:"mab@pioms.org"},{id:"304542",title:"Dr.",name:"Shizuo",surname:"Kamita",fullName:"Shizuo Kamita",slug:"shizuo-kamita",email:"sgkamita@ucdavis.edu"},{id:"304543",title:"Prof.",name:"Luis",surname:"De La Maza",fullName:"Luis De La Maza",slug:"luis-de-la-maza",email:"lmdelama@uci.edu"}],book:{title:"Synthetic Biology",slug:"synthetic-biology-new-interdisciplinary-science",productType:{id:"1",title:"Edited Volume"}}}],collaborators:[{id:"58980",title:"Dr.",name:"Marjanca",surname:"Starčič Erjavec",slug:"marjanca-starcic-erjavec",fullName:"Marjanca Starčič Erjavec",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/58980/images/system/58980.jpeg",biography:"Marjanca Starčič Erjavec, PhD, is a professor of Molecular Biology at the Department of Biology, Biotechnical faculty, University of Ljubljana, Slovenia, EU. She studied biology (undergraduate course) and biochemistry and molecular biology (graduate course) at the University of Ljubljana, Slovenia. She defended her PhD thesis in the field of bacterial molecular genetics at the University of Utrecht, Netherlands. She was a visiting professor at University of Maribor, Slovenia, University of Graz, Austria, University of Modena, Italy, Duke University, Durham, USA and at the Institute of Ecology and Genetics of Microorganisms, Perm, Russia. At the University of Ljubljana, she is involved in teaching different subjects for students of microbiology and molecular and functional biology. She conducts research on horizontal gene transfer, including plasmids, natural and clinical E. coli strains.",institutionString:"University of Ljubljana",institution:{name:"University of Ljubljana",institutionURL:null,country:{name:"Slovenia"}}},{id:"77013",title:"Prof.",name:"Rajendra",surname:"Bera",slug:"rajendra-bera",fullName:"Rajendra Bera",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"International Institute of Information Technology",institutionURL:null,country:{name:"India"}}},{id:"242476",title:"Distinguished Prof.",name:"R. Holland",surname:"Cheng",slug:"r.-holland-cheng",fullName:"R. Holland Cheng",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"258461",title:"Dr.",name:"Mo",surname:"Baikoghli",slug:"mo-baikoghli",fullName:"Mo Baikoghli",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"282969",title:"Ph.D.",name:"Danielle",surname:"Zauli",slug:"danielle-zauli",fullName:"Danielle Zauli",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"284957",title:"Prof.",name:"Bianca",surname:"Mendes Maciel",slug:"bianca-mendes-maciel",fullName:"Bianca Mendes Maciel",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"284958",title:"MSc.",name:"Amanda",surname:"Teixeira Sampaio Lopes",slug:"amanda-teixeira-sampaio-lopes",fullName:"Amanda Teixeira Sampaio Lopes",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"290766",title:"Dr.",name:"Kadri",surname:"Karim",slug:"kadri-karim",fullName:"Kadri Karim",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"299083",title:"Prof.",name:"Xiangyuan",surname:"Wan",slug:"xiangyuan-wan",fullName:"Xiangyuan Wan",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"304542",title:"Dr.",name:"Shizuo",surname:"Kamita",slug:"shizuo-kamita",fullName:"Shizuo Kamita",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null}]},generic:{page:{slug:"horizon-2020-compliance",title:"Horizon 2020 Compliance",intro:'
General requirements for Open Access to Horizon 2020 research project outputs are found within Guidelines on Open Access to Scientific Publication and Research Data in Horizon 2020. The guidelines, in their simplest form, state that if you are a Horizon 2020 recipient, you must ensure open access to your scientific publications by enabling them to be downloaded, printed and read online. Additionally, said publications must be peer reviewed.
',metaTitle:"Horizon 2020 Compliance",metaDescription:"General requirements for Open Access to Horizon 2020 research project outputs are found within Guidelines on Open Access to Scientific Publication and Research Data in Horizon 2020. The guidelines, in their simplest form, state that if you are a Horizon 2020 recipient, you must ensure open access to your scientific publications by enabling them to be downloaded, printed and read online. Additionally, said publications must be peer reviewed. ",metaKeywords:null,canonicalURL:null,contentRaw:'[{"type":"htmlEditorComponent","content":"
Publishing with IntechOpen means that your scientific publications already meet these basic requirements. It also means that through our utilization of open licensing, our publications are also able to be copied, shared, searched, linked, crawled, and mined for text and data, optimizing our authors' compliance as suggested by the European Commission.
\\n\\n
Metadata for all publications is also automatically deposited in IntechOpen's OAI repository, making them available through the Open Access Infrastructure for Research in Europe's (OpenAIRE) search interface further establishing our compliance.
\\n\\n
In other words, publishing with IntechOpen guarantees compliance.
When choosing a publication, Horizon 2020 grant recipients are encouraged to provide open access to various types of scientific publications including monographs, edited books and conference proceedings.
\\n\\n
IntechOpen publishes all of the aforementioned formats in compliance with the requirements and criteria established by the European Commission for the Horizon 2020 Program.
\\n\\n
Authors requiring additional information are welcome to send their inquiries to funders@intechopen.com
Publishing with IntechOpen means that your scientific publications already meet these basic requirements. It also means that through our utilization of open licensing, our publications are also able to be copied, shared, searched, linked, crawled, and mined for text and data, optimizing our authors' compliance as suggested by the European Commission.
\n\n
Metadata for all publications is also automatically deposited in IntechOpen's OAI repository, making them available through the Open Access Infrastructure for Research in Europe's (OpenAIRE) search interface further establishing our compliance.
\n\n
In other words, publishing with IntechOpen guarantees compliance.
When choosing a publication, Horizon 2020 grant recipients are encouraged to provide open access to various types of scientific publications including monographs, edited books and conference proceedings.
\n\n
IntechOpen publishes all of the aforementioned formats in compliance with the requirements and criteria established by the European Commission for the Horizon 2020 Program.
\n\n
Authors requiring additional information are welcome to send their inquiries to funders@intechopen.com
\n'}]},successStories:{items:[]},authorsAndEditors:{filterParams:{sort:"featured,name"},profiles:[{id:"6700",title:"Dr.",name:"Abbass A.",middleName:null,surname:"Hashim",slug:"abbass-a.-hashim",fullName:"Abbass A. Hashim",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/6700/images/1864_n.jpg",biography:"Currently I am carrying out research in several areas of interest, mainly covering work on chemical and bio-sensors, semiconductor thin film device fabrication and characterisation.\nAt the moment I have very strong interest in radiation environmental pollution and bacteriology treatment. The teams of researchers are working very hard to bring novel results in this field. I am also a member of the team in charge for the supervision of Ph.D. students in the fields of development of silicon based planar waveguide sensor devices, study of inelastic electron tunnelling in planar tunnelling nanostructures for sensing applications and development of organotellurium(IV) compounds for semiconductor applications. I am a specialist in data analysis techniques and nanosurface structure. I have served as the editor for many books, been a member of the editorial board in science journals, have published many papers and hold many patents.",institutionString:null,institution:{name:"Sheffield Hallam University",country:{name:"United Kingdom"}}},{id:"54525",title:"Prof.",name:"Abdul Latif",middleName:null,surname:"Ahmad",slug:"abdul-latif-ahmad",fullName:"Abdul Latif Ahmad",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"20567",title:"Prof.",name:"Ado",middleName:null,surname:"Jorio",slug:"ado-jorio",fullName:"Ado Jorio",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Universidade Federal de Minas Gerais",country:{name:"Brazil"}}},{id:"47940",title:"Dr.",name:"Alberto",middleName:null,surname:"Mantovani",slug:"alberto-mantovani",fullName:"Alberto Mantovani",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"12392",title:"Mr.",name:"Alex",middleName:null,surname:"Lazinica",slug:"alex-lazinica",fullName:"Alex Lazinica",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/12392/images/7282_n.png",biography:"Alex Lazinica is the founder and CEO of IntechOpen. After obtaining a Master's degree in Mechanical Engineering, he continued his PhD studies in Robotics at the Vienna University of Technology. Here he worked as a robotic researcher with the university's Intelligent Manufacturing Systems Group as well as a guest researcher at various European universities, including the Swiss Federal Institute of Technology Lausanne (EPFL). During this time he published more than 20 scientific papers, gave presentations, served as a reviewer for major robotic journals and conferences and most importantly he co-founded and built the International Journal of Advanced Robotic Systems- world's first Open Access journal in the field of robotics. Starting this journal was a pivotal point in his career, since it was a pathway to founding IntechOpen - Open Access publisher focused on addressing academic researchers needs. Alex is a personification of IntechOpen key values being trusted, open and entrepreneurial. Today his focus is on defining the growth and development strategy for the company.",institutionString:null,institution:{name:"TU Wien",country:{name:"Austria"}}},{id:"19816",title:"Prof.",name:"Alexander",middleName:null,surname:"Kokorin",slug:"alexander-kokorin",fullName:"Alexander Kokorin",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/19816/images/1607_n.jpg",biography:"Alexander I. Kokorin: born: 1947, Moscow; DSc., PhD; Principal Research Fellow (Research Professor) of Department of Kinetics and Catalysis, N. Semenov Institute of Chemical Physics, Russian Academy of Sciences, Moscow.\r\nArea of research interests: physical chemistry of complex-organized molecular and nanosized systems, including polymer-metal complexes; the surface of doped oxide semiconductors. He is an expert in structural, absorptive, catalytic and photocatalytic properties, in structural organization and dynamic features of ionic liquids, in magnetic interactions between paramagnetic centers. The author or co-author of 3 books, over 200 articles and reviews in scientific journals and books. He is an actual member of the International EPR/ESR Society, European Society on Quantum Solar Energy Conversion, Moscow House of Scientists, of the Board of Moscow Physical Society.",institutionString:null,institution:{name:"Semenov Institute of Chemical Physics",country:{name:"Russia"}}},{id:"62389",title:"PhD.",name:"Ali Demir",middleName:null,surname:"Sezer",slug:"ali-demir-sezer",fullName:"Ali Demir Sezer",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/62389/images/3413_n.jpg",biography:"Dr. Ali Demir Sezer has a Ph.D. from Pharmaceutical Biotechnology at the Faculty of Pharmacy, University of Marmara (Turkey). He is the member of many Pharmaceutical Associations and acts as a reviewer of scientific journals and European projects under different research areas such as: drug delivery systems, nanotechnology and pharmaceutical biotechnology. Dr. Sezer is the author of many scientific publications in peer-reviewed journals and poster communications. Focus of his research activity is drug delivery, physico-chemical characterization and biological evaluation of biopolymers micro and nanoparticles as modified drug delivery system, and colloidal drug carriers (liposomes, nanoparticles etc.).",institutionString:null,institution:{name:"Marmara University",country:{name:"Turkey"}}},{id:"61051",title:"Prof.",name:"Andrea",middleName:null,surname:"Natale",slug:"andrea-natale",fullName:"Andrea Natale",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"100762",title:"Prof.",name:"Andrea",middleName:null,surname:"Natale",slug:"andrea-natale",fullName:"Andrea Natale",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"St David's Medical Center",country:{name:"United States of America"}}},{id:"107416",title:"Dr.",name:"Andrea",middleName:null,surname:"Natale",slug:"andrea-natale",fullName:"Andrea Natale",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Texas Cardiac Arrhythmia",country:{name:"United States of America"}}},{id:"64434",title:"Dr.",name:"Angkoon",middleName:null,surname:"Phinyomark",slug:"angkoon-phinyomark",fullName:"Angkoon Phinyomark",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/64434/images/2619_n.jpg",biography:"My name is Angkoon Phinyomark. I received a B.Eng. degree in Computer Engineering with First Class Honors in 2008 from Prince of Songkla University, Songkhla, Thailand, where I received a Ph.D. degree in Electrical Engineering. My research interests are primarily in the area of biomedical signal processing and classification notably EMG (electromyography signal), EOG (electrooculography signal), and EEG (electroencephalography signal), image analysis notably breast cancer analysis and optical coherence tomography, and rehabilitation engineering. I became a student member of IEEE in 2008. During October 2011-March 2012, I had worked at School of Computer Science and Electronic Engineering, University of Essex, Colchester, Essex, United Kingdom. In addition, during a B.Eng. I had been a visiting research student at Faculty of Computer Science, University of Murcia, Murcia, Spain for three months.\n\nI have published over 40 papers during 5 years in refereed journals, books, and conference proceedings in the areas of electro-physiological signals processing and classification, notably EMG and EOG signals, fractal analysis, wavelet analysis, texture analysis, feature extraction and machine learning algorithms, and assistive and rehabilitative devices. I have several computer programming language certificates, i.e. Sun Certified Programmer for the Java 2 Platform 1.4 (SCJP), Microsoft Certified Professional Developer, Web Developer (MCPD), Microsoft Certified Technology Specialist, .NET Framework 2.0 Web (MCTS). I am a Reviewer for several refereed journals and international conferences, such as IEEE Transactions on Biomedical Engineering, IEEE Transactions on Industrial Electronics, Optic Letters, Measurement Science Review, and also a member of the International Advisory Committee for 2012 IEEE Business Engineering and Industrial Applications and 2012 IEEE Symposium on Business, Engineering and Industrial Applications.",institutionString:null,institution:{name:"Joseph Fourier University",country:{name:"France"}}},{id:"55578",title:"Dr.",name:"Antonio",middleName:null,surname:"Jurado-Navas",slug:"antonio-jurado-navas",fullName:"Antonio Jurado-Navas",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/55578/images/4574_n.png",biography:"Antonio Jurado-Navas received the M.S. degree (2002) and the Ph.D. degree (2009) in Telecommunication Engineering, both from the University of Málaga (Spain). He first worked as a consultant at Vodafone-Spain. From 2004 to 2011, he was a Research Assistant with the Communications Engineering Department at the University of Málaga. In 2011, he became an Assistant Professor in the same department. From 2012 to 2015, he was with Ericsson Spain, where he was working on geo-location\ntools for third generation mobile networks. Since 2015, he is a Marie-Curie fellow at the Denmark Technical University. His current research interests include the areas of mobile communication systems and channel modeling in addition to atmospheric optical communications, adaptive optics and statistics",institutionString:null,institution:{name:"University of Malaga",country:{name:"Spain"}}}],filtersByRegion:[{group:"region",caption:"North America",value:1,count:5766},{group:"region",caption:"Middle and South America",value:2,count:5228},{group:"region",caption:"Africa",value:3,count:1717},{group:"region",caption:"Asia",value:4,count:10370},{group:"region",caption:"Australia and Oceania",value:5,count:897},{group:"region",caption:"Europe",value:6,count:15791}],offset:12,limit:12,total:118192},chapterEmbeded:{data:{}},editorApplication:{success:null,errors:{}},ofsBooks:{filterParams:{hasNoEditors:"0",sort:"ebgfFaeGuveeFgfcChcyvfu"},books:[],filtersByTopic:[{group:"topic",caption:"Agricultural and Biological Sciences",value:5,count:16},{group:"topic",caption:"Biochemistry, Genetics and Molecular Biology",value:6,count:4},{group:"topic",caption:"Business, Management and Economics",value:7,count:2},{group:"topic",caption:"Chemistry",value:8,count:8},{group:"topic",caption:"Computer and Information Science",value:9,count:6},{group:"topic",caption:"Earth and Planetary Sciences",value:10,count:7},{group:"topic",caption:"Engineering",value:11,count:19},{group:"topic",caption:"Environmental Sciences",value:12,count:2},{group:"topic",caption:"Immunology and Microbiology",value:13,count:3},{group:"topic",caption:"Materials Science",value:14,count:5},{group:"topic",caption:"Mathematics",value:15,count:1},{group:"topic",caption:"Medicine",value:16,count:24},{group:"topic",caption:"Neuroscience",value:18,count:2},{group:"topic",caption:"Pharmacology, Toxicology and Pharmaceutical Science",value:19,count:3},{group:"topic",caption:"Physics",value:20,count:3},{group:"topic",caption:"Psychology",value:21,count:4},{group:"topic",caption:"Robotics",value:22,count:1},{group:"topic",caption:"Social Sciences",value:23,count:3},{group:"topic",caption:"Technology",value:24,count:1},{group:"topic",caption:"Veterinary Medicine and Science",value:25,count:1}],offset:0,limit:12,total:null},popularBooks:{featuredBooks:[{type:"book",id:"9385",title:"Renewable Energy",subtitle:"Technologies and Applications",isOpenForSubmission:!1,hash:"a6b446d19166f17f313008e6c056f3d8",slug:"renewable-energy-technologies-and-applications",bookSignature:"Tolga Taner, Archana Tiwari and Taha Selim Ustun",coverURL:"https://cdn.intechopen.com/books/images_new/9385.jpg",editors:[{id:"197240",title:"Associate Prof.",name:"Tolga",middleName:null,surname:"Taner",slug:"tolga-taner",fullName:"Tolga Taner"}],equalEditorOne:{id:"186791",title:"Dr.",name:"Archana",middleName:null,surname:"Tiwari",slug:"archana-tiwari",fullName:"Archana Tiwari",profilePictureURL:"https://mts.intechopen.com/storage/users/186791/images/system/186791.jpg",biography:"Dr. Archana Tiwari is Associate Professor at Amity University, India. Her research interests include renewable sources of energy from microalgae and further utilizing the residual biomass for the generation of value-added products, bioremediation through microalgae and microbial consortium, antioxidative enzymes and stress, and nutraceuticals from microalgae. She has been working on algal biotechnology for the last two decades. She has published her research in many international journals and has authored many books and chapters with renowned publishing houses. She has also delivered talks as an invited speaker at many national and international conferences. Dr. Tiwari is the recipient of several awards including Researcher of the Year and Distinguished Scientist.",institutionString:"Amity University",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"3",totalChapterViews:"0",totalEditedBooks:"1",institution:{name:"Amity University",institutionURL:null,country:{name:"India"}}},equalEditorTwo:{id:"197609",title:"Prof.",name:"Taha Selim",middleName:null,surname:"Ustun",slug:"taha-selim-ustun",fullName:"Taha Selim Ustun",profilePictureURL:"https://mts.intechopen.com/storage/users/197609/images/system/197609.jpeg",biography:"Dr. Taha Selim Ustun received a Ph.D. in Electrical Engineering from Victoria University, Melbourne, Australia. He is a researcher with the Fukushima Renewable Energy Institute, AIST (FREA), where he leads the Smart Grid Cybersecurity Laboratory. Prior to that, he was a faculty member with the School of Electrical and Computer Engineering, Carnegie Mellon University, Pittsburgh, PA, USA. His current research interests include power systems protection, communication in power networks, distributed generation, microgrids, electric vehicle integration, and cybersecurity in smart grids. He serves on the editorial boards of IEEE Access, IEEE Transactions on Industrial Informatics, Energies, Electronics, Electricity, World Electric Vehicle and Information journals. Dr. Ustun is a member of the IEEE 2004 and 2800, IEC Renewable Energy Management WG 8, and IEC TC 57 WG17. He has been invited to run specialist courses in Africa, India, and China. He has delivered talks for the Qatar Foundation, the World Energy Council, the Waterloo Global Science Initiative, and the European Union Energy Initiative (EUEI). His research has attracted funding from prestigious programs in Japan, Australia, the European Union, and North America.",institutionString:"Fukushima Renewable Energy Institute, AIST (FREA)",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"1",totalChapterViews:"0",totalEditedBooks:"0",institution:{name:"National Institute of Advanced Industrial Science and Technology",institutionURL:null,country:{name:"Japan"}}},equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10065",title:"Wavelet Theory",subtitle:null,isOpenForSubmission:!1,hash:"d8868e332169597ba2182d9b004d60de",slug:"wavelet-theory",bookSignature:"Somayeh Mohammady",coverURL:"https://cdn.intechopen.com/books/images_new/10065.jpg",editors:[{id:"109280",title:"Dr.",name:"Somayeh",middleName:null,surname:"Mohammady",slug:"somayeh-mohammady",fullName:"Somayeh Mohammady"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9644",title:"Glaciers and the Polar Environment",subtitle:null,isOpenForSubmission:!1,hash:"e8cfdc161794e3753ced54e6ff30873b",slug:"glaciers-and-the-polar-environment",bookSignature:"Masaki Kanao, Danilo Godone and Niccolò Dematteis",coverURL:"https://cdn.intechopen.com/books/images_new/9644.jpg",editors:[{id:"51959",title:"Dr.",name:"Masaki",middleName:null,surname:"Kanao",slug:"masaki-kanao",fullName:"Masaki Kanao"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"8985",title:"Natural Resources Management and Biological Sciences",subtitle:null,isOpenForSubmission:!1,hash:"5c2e219a6c021a40b5a20c041dea88c4",slug:"natural-resources-management-and-biological-sciences",bookSignature:"Edward R. Rhodes and Humood Naser",coverURL:"https://cdn.intechopen.com/books/images_new/8985.jpg",editors:[{id:"280886",title:"Prof.",name:"Edward R",middleName:null,surname:"Rhodes",slug:"edward-r-rhodes",fullName:"Edward R Rhodes"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9671",title:"Macrophages",subtitle:null,isOpenForSubmission:!1,hash:"03b00fdc5f24b71d1ecdfd75076bfde6",slug:"macrophages",bookSignature:"Hridayesh Prakash",coverURL:"https://cdn.intechopen.com/books/images_new/9671.jpg",editors:[{id:"287184",title:"Dr.",name:"Hridayesh",middleName:null,surname:"Prakash",slug:"hridayesh-prakash",fullName:"Hridayesh Prakash"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9313",title:"Clay Science and Technology",subtitle:null,isOpenForSubmission:!1,hash:"6fa7e70396ff10620e032bb6cfa6fb72",slug:"clay-science-and-technology",bookSignature:"Gustavo Morari Do Nascimento",coverURL:"https://cdn.intechopen.com/books/images_new/9313.jpg",editors:[{id:"7153",title:"Prof.",name:"Gustavo",middleName:null,surname:"Morari Do Nascimento",slug:"gustavo-morari-do-nascimento",fullName:"Gustavo Morari Do Nascimento"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9888",title:"Nuclear Power Plants",subtitle:"The Processes from the Cradle to the Grave",isOpenForSubmission:!1,hash:"c2c8773e586f62155ab8221ebb72a849",slug:"nuclear-power-plants-the-processes-from-the-cradle-to-the-grave",bookSignature:"Nasser Awwad",coverURL:"https://cdn.intechopen.com/books/images_new/9888.jpg",editors:[{id:"145209",title:"Prof.",name:"Nasser",middleName:"S",surname:"Awwad",slug:"nasser-awwad",fullName:"Nasser Awwad"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9027",title:"Human Blood Group Systems and Haemoglobinopathies",subtitle:null,isOpenForSubmission:!1,hash:"d00d8e40b11cfb2547d1122866531c7e",slug:"human-blood-group-systems-and-haemoglobinopathies",bookSignature:"Osaro Erhabor and Anjana Munshi",coverURL:"https://cdn.intechopen.com/books/images_new/9027.jpg",editors:[{id:"35140",title:null,name:"Osaro",middleName:null,surname:"Erhabor",slug:"osaro-erhabor",fullName:"Osaro Erhabor"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"7841",title:"New Insights Into Metabolic Syndrome",subtitle:null,isOpenForSubmission:!1,hash:"ef5accfac9772b9e2c9eff884f085510",slug:"new-insights-into-metabolic-syndrome",bookSignature:"Akikazu Takada",coverURL:"https://cdn.intechopen.com/books/images_new/7841.jpg",editors:[{id:"248459",title:"Dr.",name:"Akikazu",middleName:null,surname:"Takada",slug:"akikazu-takada",fullName:"Akikazu Takada"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"8558",title:"Aerodynamics",subtitle:null,isOpenForSubmission:!1,hash:"db7263fc198dfb539073ba0260a7f1aa",slug:"aerodynamics",bookSignature:"Mofid Gorji-Bandpy and Aly-Mousaad Aly",coverURL:"https://cdn.intechopen.com/books/images_new/8558.jpg",editors:[{id:"35542",title:"Prof.",name:"Mofid",middleName:null,surname:"Gorji-Bandpy",slug:"mofid-gorji-bandpy",fullName:"Mofid Gorji-Bandpy"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"7847",title:"Medical Toxicology",subtitle:null,isOpenForSubmission:!1,hash:"db9b65bea093de17a0855a1b27046247",slug:"medical-toxicology",bookSignature:"Pınar Erkekoglu and Tomohisa Ogawa",coverURL:"https://cdn.intechopen.com/books/images_new/7847.jpg",editors:[{id:"109978",title:"Prof.",name:"Pınar",middleName:null,surname:"Erkekoglu",slug:"pinar-erkekoglu",fullName:"Pınar Erkekoglu"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10432",title:"Casting Processes and Modelling of Metallic Materials",subtitle:null,isOpenForSubmission:!1,hash:"2c5c9df938666bf5d1797727db203a6d",slug:"casting-processes-and-modelling-of-metallic-materials",bookSignature:"Zakaria Abdallah and Nada Aldoumani",coverURL:"https://cdn.intechopen.com/books/images_new/10432.jpg",editors:[{id:"201670",title:"Dr.",name:"Zak",middleName:null,surname:"Abdallah",slug:"zak-abdallah",fullName:"Zak Abdallah"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}}],offset:12,limit:12,total:5240},hotBookTopics:{hotBooks:[],offset:0,limit:12,total:null},publish:{},publishingProposal:{success:null,errors:{}},books:{featuredBooks:[{type:"book",id:"10065",title:"Wavelet Theory",subtitle:null,isOpenForSubmission:!1,hash:"d8868e332169597ba2182d9b004d60de",slug:"wavelet-theory",bookSignature:"Somayeh Mohammady",coverURL:"https://cdn.intechopen.com/books/images_new/10065.jpg",editors:[{id:"109280",title:"Dr.",name:"Somayeh",middleName:null,surname:"Mohammady",slug:"somayeh-mohammady",fullName:"Somayeh Mohammady"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9644",title:"Glaciers and the Polar Environment",subtitle:null,isOpenForSubmission:!1,hash:"e8cfdc161794e3753ced54e6ff30873b",slug:"glaciers-and-the-polar-environment",bookSignature:"Masaki Kanao, Danilo Godone and Niccolò Dematteis",coverURL:"https://cdn.intechopen.com/books/images_new/9644.jpg",editors:[{id:"51959",title:"Dr.",name:"Masaki",middleName:null,surname:"Kanao",slug:"masaki-kanao",fullName:"Masaki Kanao"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9385",title:"Renewable Energy",subtitle:"Technologies and Applications",isOpenForSubmission:!1,hash:"a6b446d19166f17f313008e6c056f3d8",slug:"renewable-energy-technologies-and-applications",bookSignature:"Tolga Taner, Archana Tiwari and Taha Selim Ustun",coverURL:"https://cdn.intechopen.com/books/images_new/9385.jpg",editors:[{id:"197240",title:"Associate Prof.",name:"Tolga",middleName:null,surname:"Taner",slug:"tolga-taner",fullName:"Tolga Taner"}],equalEditorOne:{id:"186791",title:"Dr.",name:"Archana",middleName:null,surname:"Tiwari",slug:"archana-tiwari",fullName:"Archana Tiwari",profilePictureURL:"https://mts.intechopen.com/storage/users/186791/images/system/186791.jpg",biography:"Dr. Archana Tiwari is Associate Professor at Amity University, India. Her research interests include renewable sources of energy from microalgae and further utilizing the residual biomass for the generation of value-added products, bioremediation through microalgae and microbial consortium, antioxidative enzymes and stress, and nutraceuticals from microalgae. She has been working on algal biotechnology for the last two decades. She has published her research in many international journals and has authored many books and chapters with renowned publishing houses. She has also delivered talks as an invited speaker at many national and international conferences. Dr. Tiwari is the recipient of several awards including Researcher of the Year and Distinguished Scientist.",institutionString:"Amity University",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"3",totalChapterViews:"0",totalEditedBooks:"1",institution:{name:"Amity University",institutionURL:null,country:{name:"India"}}},equalEditorTwo:{id:"197609",title:"Prof.",name:"Taha Selim",middleName:null,surname:"Ustun",slug:"taha-selim-ustun",fullName:"Taha Selim Ustun",profilePictureURL:"https://mts.intechopen.com/storage/users/197609/images/system/197609.jpeg",biography:"Dr. Taha Selim Ustun received a Ph.D. in Electrical Engineering from Victoria University, Melbourne, Australia. He is a researcher with the Fukushima Renewable Energy Institute, AIST (FREA), where he leads the Smart Grid Cybersecurity Laboratory. Prior to that, he was a faculty member with the School of Electrical and Computer Engineering, Carnegie Mellon University, Pittsburgh, PA, USA. His current research interests include power systems protection, communication in power networks, distributed generation, microgrids, electric vehicle integration, and cybersecurity in smart grids. He serves on the editorial boards of IEEE Access, IEEE Transactions on Industrial Informatics, Energies, Electronics, Electricity, World Electric Vehicle and Information journals. Dr. Ustun is a member of the IEEE 2004 and 2800, IEC Renewable Energy Management WG 8, and IEC TC 57 WG17. He has been invited to run specialist courses in Africa, India, and China. He has delivered talks for the Qatar Foundation, the World Energy Council, the Waterloo Global Science Initiative, and the European Union Energy Initiative (EUEI). His research has attracted funding from prestigious programs in Japan, Australia, the European Union, and North America.",institutionString:"Fukushima Renewable Energy Institute, AIST (FREA)",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"1",totalChapterViews:"0",totalEditedBooks:"0",institution:{name:"National Institute of Advanced Industrial Science and Technology",institutionURL:null,country:{name:"Japan"}}},equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"8985",title:"Natural Resources Management and Biological Sciences",subtitle:null,isOpenForSubmission:!1,hash:"5c2e219a6c021a40b5a20c041dea88c4",slug:"natural-resources-management-and-biological-sciences",bookSignature:"Edward R. Rhodes and Humood Naser",coverURL:"https://cdn.intechopen.com/books/images_new/8985.jpg",editors:[{id:"280886",title:"Prof.",name:"Edward R",middleName:null,surname:"Rhodes",slug:"edward-r-rhodes",fullName:"Edward R Rhodes"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9671",title:"Macrophages",subtitle:null,isOpenForSubmission:!1,hash:"03b00fdc5f24b71d1ecdfd75076bfde6",slug:"macrophages",bookSignature:"Hridayesh Prakash",coverURL:"https://cdn.intechopen.com/books/images_new/9671.jpg",editors:[{id:"287184",title:"Dr.",name:"Hridayesh",middleName:null,surname:"Prakash",slug:"hridayesh-prakash",fullName:"Hridayesh Prakash"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9313",title:"Clay Science and Technology",subtitle:null,isOpenForSubmission:!1,hash:"6fa7e70396ff10620e032bb6cfa6fb72",slug:"clay-science-and-technology",bookSignature:"Gustavo Morari Do Nascimento",coverURL:"https://cdn.intechopen.com/books/images_new/9313.jpg",editors:[{id:"7153",title:"Prof.",name:"Gustavo",middleName:null,surname:"Morari Do Nascimento",slug:"gustavo-morari-do-nascimento",fullName:"Gustavo Morari Do Nascimento"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9888",title:"Nuclear Power Plants",subtitle:"The Processes from the Cradle to the Grave",isOpenForSubmission:!1,hash:"c2c8773e586f62155ab8221ebb72a849",slug:"nuclear-power-plants-the-processes-from-the-cradle-to-the-grave",bookSignature:"Nasser Awwad",coverURL:"https://cdn.intechopen.com/books/images_new/9888.jpg",editors:[{id:"145209",title:"Prof.",name:"Nasser",middleName:"S",surname:"Awwad",slug:"nasser-awwad",fullName:"Nasser Awwad"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9027",title:"Human Blood Group Systems and Haemoglobinopathies",subtitle:null,isOpenForSubmission:!1,hash:"d00d8e40b11cfb2547d1122866531c7e",slug:"human-blood-group-systems-and-haemoglobinopathies",bookSignature:"Osaro Erhabor and Anjana Munshi",coverURL:"https://cdn.intechopen.com/books/images_new/9027.jpg",editors:[{id:"35140",title:null,name:"Osaro",middleName:null,surname:"Erhabor",slug:"osaro-erhabor",fullName:"Osaro Erhabor"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10432",title:"Casting Processes and Modelling of Metallic Materials",subtitle:null,isOpenForSubmission:!1,hash:"2c5c9df938666bf5d1797727db203a6d",slug:"casting-processes-and-modelling-of-metallic-materials",bookSignature:"Zakaria Abdallah and Nada Aldoumani",coverURL:"https://cdn.intechopen.com/books/images_new/10432.jpg",editors:[{id:"201670",title:"Dr.",name:"Zak",middleName:null,surname:"Abdallah",slug:"zak-abdallah",fullName:"Zak Abdallah"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"7841",title:"New Insights Into Metabolic Syndrome",subtitle:null,isOpenForSubmission:!1,hash:"ef5accfac9772b9e2c9eff884f085510",slug:"new-insights-into-metabolic-syndrome",bookSignature:"Akikazu Takada",coverURL:"https://cdn.intechopen.com/books/images_new/7841.jpg",editors:[{id:"248459",title:"Dr.",name:"Akikazu",middleName:null,surname:"Takada",slug:"akikazu-takada",fullName:"Akikazu Takada"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}}],latestBooks:[{type:"book",id:"9243",title:"Coastal Environments",subtitle:null,isOpenForSubmission:!1,hash:"8e05e5f631e935eef366980f2e28295d",slug:"coastal-environments",bookSignature:"Yuanzhi Zhang and X. San Liang",coverURL:"https://cdn.intechopen.com/books/images_new/9243.jpg",editedByType:"Edited by",editors:[{id:"77597",title:"Prof.",name:"Yuanzhi",middleName:null,surname:"Zhang",slug:"yuanzhi-zhang",fullName:"Yuanzhi Zhang"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10020",title:"Operations Management",subtitle:"Emerging Trend in the Digital Era",isOpenForSubmission:!1,hash:"526f0dbdc7e4d85b82ce8383ab894b4c",slug:"operations-management-emerging-trend-in-the-digital-era",bookSignature:"Antonella Petrillo, Fabio De Felice, Germano Lambert-Torres and Erik Bonaldi",coverURL:"https://cdn.intechopen.com/books/images_new/10020.jpg",editedByType:"Edited by",editors:[{id:"181603",title:"Dr.",name:"Antonella",middleName:null,surname:"Petrillo",slug:"antonella-petrillo",fullName:"Antonella Petrillo"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9521",title:"Antimicrobial Resistance",subtitle:"A One Health Perspective",isOpenForSubmission:!1,hash:"30949e78832e1afba5606634b52056ab",slug:"antimicrobial-resistance-a-one-health-perspective",bookSignature:"Mihai Mareș, Swee Hua Erin Lim, Kok-Song Lai and Romeo-Teodor Cristina",coverURL:"https://cdn.intechopen.com/books/images_new/9521.jpg",editedByType:"Edited by",editors:[{id:"88785",title:"Prof.",name:"Mihai",middleName:null,surname:"Mares",slug:"mihai-mares",fullName:"Mihai Mares"}],equalEditorOne:{id:"190224",title:"Dr.",name:"Swee Hua Erin",middleName:null,surname:"Lim",slug:"swee-hua-erin-lim",fullName:"Swee Hua Erin Lim",profilePictureURL:"https://mts.intechopen.com/storage/users/190224/images/system/190224.png",biography:"Dr. Erin Lim is presently working as an Assistant Professor in the Division of Health Sciences, Abu Dhabi Women\\'s College, Higher Colleges of Technology in Abu Dhabi, United Arab Emirates and is affiliated as an Associate Professor to Perdana University-Royal College of Surgeons in Ireland, Selangor, Malaysia. She obtained her Ph.D. from Universiti Putra Malaysia in 2010 with a National Science Fellowship awarded from the Ministry of Science, Technology and Innovation Malaysia and has been actively involved in research ever since. Her main research interests include analysis of carriage and transmission of multidrug resistant bacteria in non-conventional settings, besides an interest in natural products for antimicrobial testing. She is heavily involved in the elucidation of mechanisms of reversal of resistance in bacteria in addition to investigating the immunological analyses of diseases, development of vaccination and treatment models in animals. She hopes her work will support the discovery of therapeutics in the clinical setting and assist in the combat against the burden of antibiotic resistance.",institutionString:"Abu Dhabi Women’s College",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"3",totalChapterViews:"0",totalEditedBooks:"0",institution:{name:"Perdana University",institutionURL:null,country:{name:"Malaysia"}}},equalEditorTwo:{id:"221544",title:"Dr.",name:"Kok-Song",middleName:null,surname:"Lai",slug:"kok-song-lai",fullName:"Kok-Song Lai",profilePictureURL:"https://mts.intechopen.com/storage/users/221544/images/system/221544.jpeg",biography:"Dr. Lai Kok Song is an Assistant Professor in the Division of Health Sciences, Abu Dhabi Women\\'s College, Higher Colleges of Technology in Abu Dhabi, United Arab Emirates. He obtained his Ph.D. in Biological Sciences from Nara Institute of Science and Technology, Japan in 2012. Prior to his academic appointment, Dr. Lai worked as a Senior Scientist at the Ministry of Science, Technology and Innovation, Malaysia. His current research areas include antimicrobial resistance and plant-pathogen interaction. His particular interest lies in the study of the antimicrobial mechanism via membrane disruption of essential oils against multi-drug resistance bacteria through various biochemical, molecular and proteomic approaches. Ultimately, he hopes to uncover and determine novel biomarkers related to antibiotic resistance that can be developed into new therapeutic strategies.",institutionString:"Higher Colleges of Technology",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"8",totalChapterViews:"0",totalEditedBooks:"0",institution:{name:"Higher Colleges of Technology",institutionURL:null,country:{name:"United Arab Emirates"}}},equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9560",title:"Creativity",subtitle:"A Force to Innovation",isOpenForSubmission:!1,hash:"58f740bc17807d5d88d647c525857b11",slug:"creativity-a-force-to-innovation",bookSignature:"Pooja Jain",coverURL:"https://cdn.intechopen.com/books/images_new/9560.jpg",editedByType:"Edited by",editors:[{id:"316765",title:"Dr.",name:"Pooja",middleName:null,surname:"Jain",slug:"pooja-jain",fullName:"Pooja Jain"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9669",title:"Recent Advances in Rice Research",subtitle:null,isOpenForSubmission:!1,hash:"12b06cc73e89af1e104399321cc16a75",slug:"recent-advances-in-rice-research",bookSignature:"Mahmood-ur- Rahman Ansari",coverURL:"https://cdn.intechopen.com/books/images_new/9669.jpg",editedByType:"Edited by",editors:[{id:"185476",title:"Dr.",name:"Mahmood-Ur-",middleName:null,surname:"Rahman Ansari",slug:"mahmood-ur-rahman-ansari",fullName:"Mahmood-Ur- Rahman Ansari"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10192",title:"Background and Management of Muscular Atrophy",subtitle:null,isOpenForSubmission:!1,hash:"eca24028d89912b5efea56e179dff089",slug:"background-and-management-of-muscular-atrophy",bookSignature:"Julianna Cseri",coverURL:"https://cdn.intechopen.com/books/images_new/10192.jpg",editedByType:"Edited by",editors:[{id:"135579",title:"Dr.",name:"Julianna",middleName:null,surname:"Cseri",slug:"julianna-cseri",fullName:"Julianna Cseri"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9550",title:"Entrepreneurship",subtitle:"Contemporary Issues",isOpenForSubmission:!1,hash:"9b4ac1ee5b743abf6f88495452b1e5e7",slug:"entrepreneurship-contemporary-issues",bookSignature:"Mladen Turuk",coverURL:"https://cdn.intechopen.com/books/images_new/9550.jpg",editedByType:"Edited by",editors:[{id:"319755",title:"Prof.",name:"Mladen",middleName:null,surname:"Turuk",slug:"mladen-turuk",fullName:"Mladen Turuk"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10065",title:"Wavelet Theory",subtitle:null,isOpenForSubmission:!1,hash:"d8868e332169597ba2182d9b004d60de",slug:"wavelet-theory",bookSignature:"Somayeh Mohammady",coverURL:"https://cdn.intechopen.com/books/images_new/10065.jpg",editedByType:"Edited by",editors:[{id:"109280",title:"Dr.",name:"Somayeh",middleName:null,surname:"Mohammady",slug:"somayeh-mohammady",fullName:"Somayeh Mohammady"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9313",title:"Clay Science and Technology",subtitle:null,isOpenForSubmission:!1,hash:"6fa7e70396ff10620e032bb6cfa6fb72",slug:"clay-science-and-technology",bookSignature:"Gustavo Morari Do Nascimento",coverURL:"https://cdn.intechopen.com/books/images_new/9313.jpg",editedByType:"Edited by",editors:[{id:"7153",title:"Prof.",name:"Gustavo",middleName:null,surname:"Morari Do Nascimento",slug:"gustavo-morari-do-nascimento",fullName:"Gustavo Morari Do Nascimento"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9888",title:"Nuclear Power Plants",subtitle:"The Processes from the Cradle to the Grave",isOpenForSubmission:!1,hash:"c2c8773e586f62155ab8221ebb72a849",slug:"nuclear-power-plants-the-processes-from-the-cradle-to-the-grave",bookSignature:"Nasser Awwad",coverURL:"https://cdn.intechopen.com/books/images_new/9888.jpg",editedByType:"Edited by",editors:[{id:"145209",title:"Prof.",name:"Nasser",middleName:"S",surname:"Awwad",slug:"nasser-awwad",fullName:"Nasser Awwad"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}]},subject:{topic:{id:"285",title:"Design Engineering",slug:"technology-design-engineering",parent:{title:"Technology",slug:"technology"},numberOfBooks:5,numberOfAuthorsAndEditors:201,numberOfWosCitations:155,numberOfCrossrefCitations:86,numberOfDimensionsCitations:210,videoUrl:null,fallbackUrl:null,description:null},booksByTopicFilter:{topicSlug:"technology-design-engineering",sort:"-publishedDate",limit:12,offset:0},booksByTopicCollection:[{type:"book",id:"8374",title:"New Innovations in Engineering Education and Naval Engineering",subtitle:null,isOpenForSubmission:!1,hash:"4019cba8abf5c1688f512dd73a1e79aa",slug:"new-innovations-in-engineering-education-and-naval-engineering",bookSignature:"Nur Md. Sayeed Hassan and Sérgio António Neves Lousada",coverURL:"https://cdn.intechopen.com/books/images_new/8374.jpg",editedByType:"Edited by",editors:[{id:"143363",title:"Dr.",name:"Nur Md. Sayeed",middleName:null,surname:"Hassan",slug:"nur-md.-sayeed-hassan",fullName:"Nur Md. Sayeed Hassan"}],equalEditorOne:{id:"248645",title:"Dr.",name:"Sérgio António",middleName:null,surname:"Neves Lousada",slug:"sergio-antonio-neves-lousada",fullName:"Sérgio António Neves Lousada",profilePictureURL:"https://mts.intechopen.com/storage/users/248645/images/system/248645.jpeg",biography:"Sérgio António Neves Lousada is a Civil Engineer with a PhD\nin civil engineering and his area of knowledge is in hydraulics.\nHe teaches at the University of Madeira, Faculty of Exact Sciences and Engineering, in the Civil Engineering course, with a\nmajor field of hydraulics, environment and water resources and\nsecondary field of construction. Currently he is course director\nof the First Cycle in Civil Engineering, according to the statement of the Scientific Council of the Faculty of Exact Sciences and Engineering at\nthe University of Madeira. Since 2012, he has been researching hydraulic sciences,\nparticularly in the areas of hydraulics, urban hydraulics and marine and fluvial construction. He has published several articles and books and has participated in events\nmainly in the areas of hydraulics, urban planning, and land management.",institutionString:"University of Madeira",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"5",totalChapterViews:"0",totalEditedBooks:"0",institution:{name:"University of Madeira",institutionURL:null,country:{name:"Portugal"}}},equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"7249",title:"3D Printing",subtitle:null,isOpenForSubmission:!1,hash:"bd92f056fb3bb4793bf7f07413747568",slug:"3d-printing",bookSignature:"Dragan Cvetković",coverURL:"https://cdn.intechopen.com/books/images_new/7249.jpg",editedByType:"Edited by",editors:[{id:"101330",title:"Dr.",name:"Dragan",middleName:"Mladen",surname:"Cvetković",slug:"dragan-cvetkovic",fullName:"Dragan Cvetković"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1942",title:"Applied Measurement Systems",subtitle:null,isOpenForSubmission:!1,hash:"64893485e869fc18f5520846648ea70c",slug:"applied-measurement-systems",bookSignature:"Md. Zahurul Haq",coverURL:"https://cdn.intechopen.com/books/images_new/1942.jpg",editedByType:"Edited by",editors:[{id:"104292",title:"Prof.",name:"Md. Zahurul",middleName:null,surname:"Haq",slug:"md.-zahurul-haq",fullName:"Md. Zahurul Haq"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"307",title:"Rapid Prototyping Technology",subtitle:"Principles and Functional Requirements",isOpenForSubmission:!1,hash:"aa39f8a56e606bbc2935e87620674425",slug:"rapid-prototyping-technology-principles-and-functional-requirements",bookSignature:"Muhammad Enamul Hoque",coverURL:"https://cdn.intechopen.com/books/images_new/307.jpg",editedByType:"Edited by",editors:[{id:"39279",title:"Prof.",name:"Md Enamul",middleName:"Enamul",surname:"Hoque",slug:"md-enamul-hoque",fullName:"Md Enamul Hoque"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"930",title:"Advanced Applications of Rapid Prototyping Technology in Modern Engineering",subtitle:null,isOpenForSubmission:!1,hash:"3775beff84516a387ab64fe05390fbea",slug:"advanced-applications-of-rapid-prototyping-technology-in-modern-engineering",bookSignature:"Muhammad Enamul Hoque",coverURL:"https://cdn.intechopen.com/books/images_new/930.jpg",editedByType:"Edited by",editors:[{id:"39279",title:"Prof.",name:"Md Enamul",middleName:"Enamul",surname:"Hoque",slug:"md-enamul-hoque",fullName:"Md Enamul Hoque"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],booksByTopicTotal:5,mostCitedChapters:[{id:"20723",doi:"10.5772/24994",title:"Rapid Prototyping of Hybrid, Plastic-Quartz 3D-Chips for Battery-Operated Microplasmas",slug:"rapid-prototyping-of-hybrid-plastic-quartz-3d-chips-for-battery-operated-microplasmas",totalDownloads:2411,totalCrossrefCites:1,totalDimensionsCites:23,book:{slug:"rapid-prototyping-technology-principles-and-functional-requirements",title:"Rapid Prototyping Technology",fullTitle:"Rapid Prototyping Technology - Principles and Functional Requirements"},signatures:"Weagant S., Li L. and Karanassios V.",authors:[{id:"60925",title:"Prof.",name:"Vassili",middleName:null,surname:"Karanassios",slug:"vassili-karanassios",fullName:"Vassili Karanassios"},{id:"96647",title:"Mr.",name:"Scott",middleName:null,surname:"Weagant",slug:"scott-weagant",fullName:"Scott Weagant"},{id:"96648",title:"Ms.",name:"Lu",middleName:null,surname:"Li",slug:"lu-li",fullName:"Lu Li"}]},{id:"29364",doi:"10.5772/36302",title:"Planar Microwave Sensors for Complex Permittivity Characterization of Materials and Their Applications",slug:"planar-microwave-sensors-for-complex-permittivity-characterization-of-materials-and-their-applicatio",totalDownloads:4463,totalCrossrefCites:13,totalDimensionsCites:21,book:{slug:"applied-measurement-systems",title:"Applied Measurement Systems",fullTitle:"Applied Measurement Systems"},signatures:"Kashif Saeed, Muhammad F. Shafique, Matthew B. Byrne and Ian C. Hunter",authors:[{id:"107789",title:"Dr.",name:"Kashif",middleName:null,surname:"Saeed",slug:"kashif-saeed",fullName:"Kashif Saeed"},{id:"108133",title:"Dr.",name:"Muhammad",middleName:"Farhan",surname:"Shafique",slug:"muhammad-shafique",fullName:"Muhammad Shafique"},{id:"112179",title:"Dr.",name:"Matthew",middleName:null,surname:"Byrne",slug:"matthew-byrne",fullName:"Matthew Byrne"},{id:"148470",title:"Dr.",name:"Ian C.",middleName:null,surname:"Hunter",slug:"ian-c.-hunter",fullName:"Ian C. Hunter"}]},{id:"20719",doi:"10.5772/20174",title:"Hyperelastic Modeling of Rubber-Like Photopolymers for Additive Manufacturing Processes",slug:"hyperelastic-modeling-of-rubber-like-photopolymers-for-additive-manufacturing-processes",totalDownloads:11036,totalCrossrefCites:6,totalDimensionsCites:13,book:{slug:"rapid-prototyping-technology-principles-and-functional-requirements",title:"Rapid Prototyping Technology",fullTitle:"Rapid Prototyping Technology - Principles and Functional Requirements"},signatures:"Giovanni Berselli, Rocco Vertechy, Marcello Pellicciari and Gabriele Vassura",authors:[{id:"5972",title:"PhD",name:"Giovanni",middleName:null,surname:"Berselli",slug:"giovanni-berselli",fullName:"Giovanni Berselli"},{id:"100163",title:"Dr.",name:"Marcello",middleName:null,surname:"Pellicciari",slug:"marcello-pellicciari",fullName:"Marcello Pellicciari"},{id:"124391",title:"Prof.",name:"Gabriele",middleName:null,surname:"Vassura",slug:"gabriele-vassura",fullName:"Gabriele Vassura"},{id:"133521",title:"Prof.",name:"Rocco",middleName:null,surname:"Vertechy",slug:"rocco-vertechy",fullName:"Rocco Vertechy"}]}],mostDownloadedChaptersLast30Days:[{id:"61731",title:"3D Printing of Scaffolds for Tissue Engineering",slug:"3d-printing-of-scaffolds-for-tissue-engineering",totalDownloads:1757,totalCrossrefCites:2,totalDimensionsCites:8,book:{slug:"3d-printing",title:"3D Printing",fullTitle:"3D Printing"},signatures:"Jingyu Liu and Cheng Yan",authors:[{id:"139494",title:"Prof.",name:"Cheng",middleName:null,surname:"Yan",slug:"cheng-yan",fullName:"Cheng Yan"},{id:"246713",title:"MSc.",name:"Jingyu",middleName:null,surname:"Liu",slug:"jingyu-liu",fullName:"Jingyu Liu"}]},{id:"61889",title:"Stereolithography",slug:"stereolithography",totalDownloads:1608,totalCrossrefCites:3,totalDimensionsCites:10,book:{slug:"3d-printing",title:"3D Printing",fullTitle:"3D Printing"},signatures:"Christina Schmidleithner and Deepak M. Kalaskar",authors:[{id:"247897",title:"Dr.",name:"Deepak",middleName:null,surname:"Kalaskar",slug:"deepak-kalaskar",fullName:"Deepak Kalaskar"}]},{id:"63501",title:"Patient-Specific 3D Printed Models for Education, Research and Surgical Simulation",slug:"patient-specific-3d-printed-models-for-education-research-and-surgical-simulation",totalDownloads:1001,totalCrossrefCites:2,totalDimensionsCites:3,book:{slug:"3d-printing",title:"3D Printing",fullTitle:"3D Printing"},signatures:"Daniil I. Nikitichev, Premal Patel, James Avery, Louis J. Robertson,\nThore M. Bucking, Kirill Y. Aristovich, Efthymios Maneas, Adrien E.\nDesjardins and Tom Vercauteren",authors:[{id:"165411",title:"Dr.",name:"Adrien",middleName:null,surname:"Desjardins",slug:"adrien-desjardins",fullName:"Adrien Desjardins"},{id:"244280",title:"Dr.",name:"Daniil",middleName:null,surname:"Nikitichev",slug:"daniil-nikitichev",fullName:"Daniil Nikitichev"},{id:"262721",title:"Dr.",name:"Premal",middleName:"A",surname:"Patel",slug:"premal-patel",fullName:"Premal Patel"},{id:"262722",title:"Dr.",name:"James",middleName:null,surname:"Avery",slug:"james-avery",fullName:"James Avery"},{id:"262725",title:"Dr.",name:"Louis",middleName:null,surname:"Robertson",slug:"louis-robertson",fullName:"Louis Robertson"},{id:"262728",title:"MSc.",name:"Thore",middleName:null,surname:"Bucking",slug:"thore-bucking",fullName:"Thore Bucking"},{id:"262731",title:"Dr.",name:"Kirill",middleName:null,surname:"Aristovich",slug:"kirill-aristovich",fullName:"Kirill Aristovich"},{id:"262732",title:"MSc.",name:"Efthymios",middleName:null,surname:"Maneas",slug:"efthymios-maneas",fullName:"Efthymios Maneas"},{id:"262734",title:"Prof.",name:"Tom",middleName:null,surname:"Vercauteren",slug:"tom-vercauteren",fullName:"Tom Vercauteren"}]},{id:"62221",title:"Production Management Fundamentals for Additive Manufacturing",slug:"production-management-fundamentals-for-additive-manufacturing",totalDownloads:633,totalCrossrefCites:2,totalDimensionsCites:3,book:{slug:"3d-printing",title:"3D Printing",fullTitle:"3D Printing"},signatures:"Marcello Fera, Roberto Macchiaroli, Fabio Fruggiero and Alfredo\nLambiase",authors:[{id:"163046",title:"Dr.",name:"Fabio",middleName:null,surname:"Fruggiero",slug:"fabio-fruggiero",fullName:"Fabio Fruggiero"},{id:"168518",title:"Prof.",name:"Alfredo",middleName:null,surname:"Lambiase",slug:"alfredo-lambiase",fullName:"Alfredo Lambiase"},{id:"168731",title:"Ph.D.",name:"Marcello",middleName:null,surname:"Fera",slug:"marcello-fera",fullName:"Marcello Fera"},{id:"245678",title:"Prof.",name:"Roberto",middleName:null,surname:"Macchiaroli",slug:"roberto-macchiaroli",fullName:"Roberto Macchiaroli"}]},{id:"62278",title:"3D Printing Planning Stereotactic Radiosurgery in Uveal Melanoma Patients",slug:"3d-printing-planning-stereotactic-radiosurgery-in-uveal-melanoma-patients",totalDownloads:545,totalCrossrefCites:4,totalDimensionsCites:5,book:{slug:"3d-printing",title:"3D Printing",fullTitle:"3D Printing"},signatures:"Alena Furdova, Adriana Furdova, Miron Sramka, Robert Furda and\nGabriel Kralik",authors:[{id:"244211",title:"Associate Prof.",name:"Alena",middleName:null,surname:"Furdova",slug:"alena-furdova",fullName:"Alena Furdova"},{id:"244212",title:"Ms.",name:"Adriana",middleName:null,surname:"Furdova",slug:"adriana-furdova",fullName:"Adriana Furdova"},{id:"244213",title:"Prof.",name:"Miron",middleName:null,surname:"Sramka",slug:"miron-sramka",fullName:"Miron Sramka"},{id:"244511",title:"Mr.",name:"Robert",middleName:null,surname:"Furda",slug:"robert-furda",fullName:"Robert Furda"},{id:"244514",title:"Dr.",name:"Gabriel",middleName:null,surname:"Kralik",slug:"gabriel-kralik",fullName:"Gabriel Kralik"}]},{id:"61745",title:"High-Resolution Electric-Field-Driven Jet 3D Printing and Applications",slug:"high-resolution-electric-field-driven-jet-3d-printing-and-applications",totalDownloads:863,totalCrossrefCites:1,totalDimensionsCites:1,book:{slug:"3d-printing",title:"3D Printing",fullTitle:"3D Printing"},signatures:"Guangming Zhang, Lei Qian, Jiawei Zhao, Hefei Zhou and Hongbo\nLan",authors:[{id:"6642",title:"Prof.",name:"Hongbo",middleName:null,surname:"Lan",slug:"hongbo-lan",fullName:"Hongbo Lan"}]},{id:"20116",title:"Medical Applications of Rapid Prototyping - A New Horizon",slug:"medical-applications-of-rapid-prototyping-a-new-horizon",totalDownloads:7593,totalCrossrefCites:5,totalDimensionsCites:7,book:{slug:"advanced-applications-of-rapid-prototyping-technology-in-modern-engineering",title:"Advanced Applications of Rapid Prototyping Technology in Modern Engineering",fullTitle:"Advanced Applications of Rapid Prototyping Technology in Modern Engineering"},signatures:"Vaibhav Bagaria, Darshana Rasalkar, Shalini Jain Bagaria and Jami Ilyas",authors:[{id:"37266",title:"Dr.",name:"Vaibhav",middleName:null,surname:"Bagaria",slug:"vaibhav-bagaria",fullName:"Vaibhav Bagaria"},{id:"54766",title:"Dr.",name:"Darshana",middleName:null,surname:"Rasalkar",slug:"darshana-rasalkar",fullName:"Darshana Rasalkar"},{id:"62768",title:"Dr.",name:"Jami",middleName:null,surname:"Ilyas",slug:"jami-ilyas",fullName:"Jami Ilyas"},{id:"70915",title:"Prof.",name:"Shalini",middleName:null,surname:"Jain",slug:"shalini-jain",fullName:"Shalini Jain"}]},{id:"20723",title:"Rapid Prototyping of Hybrid, Plastic-Quartz 3D-Chips for Battery-Operated Microplasmas",slug:"rapid-prototyping-of-hybrid-plastic-quartz-3d-chips-for-battery-operated-microplasmas",totalDownloads:2415,totalCrossrefCites:1,totalDimensionsCites:23,book:{slug:"rapid-prototyping-technology-principles-and-functional-requirements",title:"Rapid Prototyping Technology",fullTitle:"Rapid Prototyping Technology - Principles and Functional Requirements"},signatures:"Weagant S., Li L. and Karanassios V.",authors:[{id:"60925",title:"Prof.",name:"Vassili",middleName:null,surname:"Karanassios",slug:"vassili-karanassios",fullName:"Vassili Karanassios"},{id:"96647",title:"Mr.",name:"Scott",middleName:null,surname:"Weagant",slug:"scott-weagant",fullName:"Scott Weagant"},{id:"96648",title:"Ms.",name:"Lu",middleName:null,surname:"Li",slug:"lu-li",fullName:"Lu Li"}]},{id:"62318",title:"Three-Dimensional Printing and Navigation in Bone Tumor Resection",slug:"three-dimensional-printing-and-navigation-in-bone-tumor-resection",totalDownloads:432,totalCrossrefCites:0,totalDimensionsCites:0,book:{slug:"3d-printing",title:"3D Printing",fullTitle:"3D Printing"},signatures:"Lucas E. Ritacco, Candelaria Mosquera, Ignacio Albergo, Domingo L.\nMuscolo, German L. Farfalli, Miguel A. Ayerza, Luis A. Aponte-Tinao\nand Axel V. Mancino",authors:[{id:"254210",title:"M.D.",name:"Lucas",middleName:null,surname:"Ritacco",slug:"lucas-ritacco",fullName:"Lucas Ritacco"},{id:"259783",title:"Mrs.",name:"Candelaria",middleName:null,surname:"Mosquera",slug:"candelaria-mosquera",fullName:"Candelaria Mosquera"},{id:"259784",title:"Dr.",name:"Germán",middleName:null,surname:"Farfalli",slug:"german-farfalli",fullName:"Germán Farfalli"},{id:"260100",title:"Dr.",name:"Domingo L.",middleName:null,surname:"Muscolo",slug:"domingo-l.-muscolo",fullName:"Domingo L. Muscolo"},{id:"260101",title:"Dr.",name:"Miguel A.",middleName:null,surname:"Ayerza",slug:"miguel-a.-ayerza",fullName:"Miguel A. Ayerza"},{id:"260109",title:"Dr.",name:"Luis A.",middleName:null,surname:"Aponte-Tinao",slug:"luis-a.-aponte-tinao",fullName:"Luis A. Aponte-Tinao"},{id:"260110",title:"Dr.",name:"Ignacio",middleName:null,surname:"Albergo",slug:"ignacio-albergo",fullName:"Ignacio Albergo"},{id:"260111",title:"Mr.",name:"Axel",middleName:null,surname:"Mancino",slug:"axel-mancino",fullName:"Axel Mancino"}]},{id:"66449",title:"Personalizing Course Design, Build and Delivery Using PLErify",slug:"personalizing-course-design-build-and-delivery-using-plerify",totalDownloads:381,totalCrossrefCites:0,totalDimensionsCites:0,book:{slug:"new-innovations-in-engineering-education-and-naval-engineering",title:"New Innovations in Engineering Education and Naval Engineering",fullTitle:"New Innovations in Engineering Education and Naval Engineering"},signatures:"Maria Lorna A. Kunnath",authors:[{id:"280683",title:"Dr.",name:"Maria Lorna",middleName:"Azul",surname:"Kunnath",slug:"maria-lorna-kunnath",fullName:"Maria Lorna Kunnath"}]}],onlineFirstChaptersFilter:{topicSlug:"technology-design-engineering",limit:3,offset:0},onlineFirstChaptersCollection:[],onlineFirstChaptersTotal:0},preDownload:{success:null,errors:{}},aboutIntechopen:{},privacyPolicy:{},peerReviewing:{},howOpenAccessPublishingWithIntechopenWorks:{},sponsorshipBooks:{sponsorshipBooks:[{type:"book",id:"10176",title:"Microgrids and Local Energy Systems",subtitle:null,isOpenForSubmission:!0,hash:"c32b4a5351a88f263074b0d0ca813a9c",slug:null,bookSignature:"Prof. Nick Jenkins",coverURL:"https://cdn.intechopen.com/books/images_new/10176.jpg",editedByType:null,editors:[{id:"55219",title:"Prof.",name:"Nick",middleName:null,surname:"Jenkins",slug:"nick-jenkins",fullName:"Nick Jenkins"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}}],offset:8,limit:8,total:1},route:{name:"profile.detail",path:"/profiles/304543/luis-de-la-maza",hash:"",query:{},params:{id:"304543",slug:"luis-de-la-maza"},fullPath:"/profiles/304543/luis-de-la-maza",meta:{},from:{name:null,path:"/",hash:"",query:{},params:{},fullPath:"/",meta:{}}}},function(){var e;(e=document.currentScript||document.scripts[document.scripts.length-1]).parentNode.removeChild(e)}()